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Background 
Mechanical ventilation is one of the cornerstones of modern intensive care practice. 
Mechanical ventilation may, however, result in secondary lung damage, also referred to as 
ventilator-induced lung injury (VILI) and multi-organ failure.1-6 In a small number of patients, 
pulmonary gas exchange cannot sufficiently be improved by conventional mechanical 
ventilation.7-9 
Attempts have been made to develop new ventilatory strategies and modes of mechanical 
ventilation with the purpose of overcoming these limitations and adverse effects of 
conventional mechanical ventilation.10-24 One of these relatively new modes of mechanical 
ventilation is high-frequency oscillatory ventilation (HFOV).  
At the end of the 1960 s Öberg and Sjöstrand, while studying blood pressure regulation and 
the carotid sinus reflex in ventilated animals, found their measurements disturbed by 
respiratory synchronous variations in blood pressure.25,26 Therefore, they needed a method 
of artificial ventilation that would reduce this effect. Insufflation of the ventilating gas deep 
into the trachea via an endotracheal catheter reduced the anatomical dead space and, 
consequently, smaller tidal volumes at higher frequencies, 60 – 120 min-1, could be used. 
This reduced pressure variations in the airways and in the intrathoracic space, and 
diminished the cyclic circulatory effects of ventilation. The circulation remained stable and 
adequate gas exchange was obtained at lower inspiratory peak pressures, lower mean 
airway pressure and lower transpulmonary pressures. Experimental animals and later on 
newborns and small children accepted these ventilatory conditions without significant 
breathing against the ventilator. For this mode of ventilation Sjöstrand and co-workers 
introduced the term high-frequency positive pressure ventilation (HFPPV).25 Although 
originally designed for experimental physiological studies, HFPPV was recognised to have 
important clinical advantages and the method has since been developed for clinical 
application. In 1977 Klain et al. described the insufflation of small volumes of gas under high 
pressures (jets) with frequencies up to 200 min-1, later up to 600 min-1, into the trachea of 
dogs.27 This method was referred to as high-frequency jet ventilation (HFJV). In 1980 Bohn 
et al. and Butler et al. demonstrated that adequate gas exchange was also possible by 
generating oscillations in the airways at a frequency of 15 Hz.28,29 The oscillations could be 
generated either by a loudspeaker or an electronically driven piston pump. Earlier, 
Lunkenheimer et al. had found adequate CO2 elimination by comparable methods with 
frequencies between 20 – 40 Hz.30 This method, high-frequency oscillatory ventilation 
(HFOV), is characterised by the generation of pressure swings with, in contrast to HFPPV 
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and HFJV, an active withdrawal of air from the airways. Following experimental work in 
animals, the first large studies on the use of HFOV in human newborn patients were 
published at the end of the 1980s early 1990s.31-37 A few years later, its use in small 
paediatric patients was reported. 38,39 Based on the positive experiences in paediatric 
patients and with evolving technology, HFOV has now also found its way into adult and 
adolescent intensive care.40 High-frequency oscillatory ventilation has gained a definite 
place in the treatment of severe respiratory insufficiency. Although the use of this ventilation 
mode is not limited to acute respiratory distress syndrome (ARDS), most experience with 
HFOV in paediatric intensive care has been gained in this disease entity. However, it is well 
recognised that future studies should compare different algorithms of applying HFOV to 
determine the optimal techniques for achieving oxygenation and ventilation, and that the 
potential role of adjunctive therapies used with HFOV, including inhaled nitric oxide, requires 
further research.41 
 
In this thesis, we investigated the safety and efficacy of HFOV in paediatric patients and 
focussed on monitoring of effects during HFOV. 
Respiratory distress syndrome 
Acute respiratory distress syndrome 
Adult respiratory distress syndrome was first described in 1967 by Ashbaugh et al. in a 
series of 12 patients who developed a sudden onset of respiratory failure characterised by 
dyspnea, reduced respiratory system compliance and diffuse alveolar infiltrates on the chest 
radiograph, that resembled pulmonary oedema without evidence of prior lung disease or 
congestive heart failure.42 Later, it was recognised that the syndrome is not limited to adults, 
but also occurs in children. This led to a change in terminology to acute respiratory distress 
syndrome (ARDS).43 An important characteristic of ARDS is the inactivation of lung 
surfactant, covering the surface of alveoli and small airways in normal lungs and mainly 
consisting of lipoproteins. Surfactant reduces the surface tension of the alveolar liquid-air 
interface and prevents alveolar collapse. The absence or inactivation of surfactant causes 
alveolar collapse (atelectasis), leading to a reduction of functional residual capacity (FRC), 
an increase of right-to-left shunt, a decrease in respiratory system compliance and an 
increase in physiological dead space. These cumulative events eventually lead to a life 
threatening decrease in arterial oxygenation and increase in work of breathing. ARDS is a 
severe form of acute lung injury (ALI), a term that covers a wide spectrum of disease 
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severity between mild dyspnea and tachypnea to a rapidly fatal respiratory failure. Criteria 
for the diagnosis have been defined as: 44 
 
• Acute onset of impaired oxygenation; 
• Severe hypoxemia defined as a ratio of PaO2 / FIO2 of < 300 mmHg (40 kPa); 
• Bilateral diffuse infiltration on the chest radiograph; 
• Pulmonary artery wedge pressure < 18 mm Hg to exclude cardiogenic causes of 
pulmonary oedema. 
 
ARDS is defined as for ALI except for a greater degree of impairment of gas exchange, such 
that the PaO2 / FIO2 ratio is < 200 mm Hg (26.7 kPa). 
Neonatal respiratory distress syndrome  
A surfactant deficiency may lead to the neonatal respiratory distress syndrome (nRDS), the 
most common cause of acute respiratory failure in newborns, especially premature 
infants.45-47 Besides surfactant deficiency, structural immaturity of lung development plays a 
role in this disease. These abnormalities may lead to deteriorating lung mechanics and gas 
exchange, resulting in dyspnea, tachypnea and cyanosis in ambient air. 
New therapies have been developed, including antenatal glucocorticoid administration and 
endotracheal surfactant administration. Other, additional, strategies aim at reducing 
damaging effects of mechanical ventilation and exposure to high oxygen concentrations in 
the immature lung. One of these strategies is HFOV. Probably, however, a ventilator 
strategy aimed at optimising lung volume is more important than the specific ventilator used, 
for reducing the incidence of chronic lung disease.48,49 
Lung mechanics in ARDS 
The mechanical properties of the respiratory system are altered in ARDS. Compliance of 
either lung, its surrounding chest wall or both is decreased. Furthermore, FRC is decreased. 
A schematic representation of these changes is shown in Fig. 1.1. 
 
In ARDS, pulmonary oedema causes an increase in alveolar surface tension.50 The 
pressure needed to open a collapsed lung unit in ARDS is increased.51 Both phenomena 
lead to a shift of the pressure-volume (PV) curve to the right and a decrease in lung volume 
at zero airway pressure (FRC).  
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ARDS is characterised by considerable regional differences in lung aeration (Fig 1.2).52 In 
general, in a supine patient, the dependent lung zone (dorsal) is mostly affected and prone 
to atelectasis at low distending pressures. The non-dependent lung zone (ventral) is 
relatively healthy. Superimposed pressure by the gravitational force of the overlying tissue is 
thought to be one of the contributing factors to explain these regional differences. 
Alveolar closing pressures may be substantially smaller than alveolar opening pressures, 
yielding hysteresis in the PV curve (Fig 1.3).53,54  Lung volume and lung compliance at a 
given end-expiratory pressure will be higher following a manoeuvre aimed at opening 
previously collapsed lung units. 
 
Mechanical ventilation 
The majority of patients suffering from acute respiratory insufficiency require respiratory  
Fig. 1.2. CT scan of an animal with acute lung injury, induced by lung lavage, at two different static  
airway pressures: 5 cm H2O (left) and 40 cm H2O (right). The dark lung areas are well aerated, the light 
areas indicate atelectasis (from N. Weiler, with permission). 
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Figure 1.3. Schematic drawing illustrating the position of dynamic pressure volume loops to the overall 
pressure volume curve during conventional ventilation before (CMV) and after a sustained inflation 
(CMVSI). (From 54 with permission). 
support, with positive airway pressure and increased levels of inspired oxygen concentration 
to increase lung volume and improve oxygenation. These patients are intubated and 
mechanically ventilated. However, mechanical ventilation has adverse effects and, 
therefore, has limitations. It has been demonstrated that low end-expiratory pressure can 
augment lung injury, explained by repetitive opening and closure of distal lung units, leading 
to increased forces on adjacent tissue zones (atelectrauma).55 In rabbits it has been 
demonstrated that atelectasis leads to migration and activation of granulocytes, giving rise to 
a local pulmonary inflammatory response and damage of distant organs (biotrauma).56-58 It 
was suggested that an increased positive end-expiratory pressure (PEEP) is indicated in 
mechanical ventilation of the atelectasis-prone lung. However, together with high tidal 
volumes, this may lead to lung injury as a result of high end-inspiratory pressures 
(barotrauma) 59 and lung overstretching (volutrauma).60 High airway pressures may also 
lead to important detrimental haemodynamic effects.61 High airway pressure may increase 
intrathoracic pressure, thereby increasing central venous pressure, causing a decrease in 
venous return and a decrease in right and left cardiac preload. As a consequence, cardiac 
output and oxygen delivery to the body may decrease substantially.62 Limitation of positive 
airway pressure may therefore minimise the depression of oxygen delivery. 
12 
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Based on the above-mentioned considerations, a lung protective ventilation strategy with 
maintenance of adequate tissue oxygenation should aim at avoiding both alveolar end-
expiratory collapse and end-inspiratory overdistention. Although there is a large amount of 
experimental evidence, there is a limited number of clinical studies in which the beneficial 
effect on lung protection by an increased PEEP level and/or limited tidal volumes was 
convincingly demonstrated.63 Experimental studies have shown that ventilation with low tidal 
volumes by itself does not prevent lung injury and may even worsen lung injury when 
repetitive collapse of lung tissue is not prevented. PEEP levels currently employed in 
intensive care units around the world are below 6 cm H2O in 78% patients receiving 
mechanical ventilation,64 whereas it is known that high PEEP levels above 15 cm H2O may 
be needed to prevent repetitive collapse of alveoli and thus reduce shear stress.65 
 
Alternative and adjunctive therapy 
Recruitment 
In a diseased lung the reduction of atelectasis is based on two principles. First, collapsed 
alveoli need to be recruited by application of sufficient airway pressures. Secondly, once 
alveoli are open, sufficient end-expiratory pressure needs to be applied to prevent 
subsequent collapse during expiration. Staub et al. proposed that the behaviour of alveoli is 
quantal in nature.66 Once a critical opening pressure is reached, the collapsed alveolus pops 
open, resulting in an immediate large volume increase. As follows from the law of Laplace, 
which states that the pressure (P) necessary to keep a spherical structure with radius r open 
is twice the surface tension (T) divided by the radius (P=2T/r), the critical closing pressure 
will be lower than the opening pressure. 
The pressure volume relationship of the entire lung, as shown in Figures 1.1 and 1.3, will be 
the cumulative relationship of all alveoli within the lung, each with a different degree of 
injury, and thus of the opening and closure pressure. 
The inflation limb of the PV curve shows the lung volume changes during incremental airway 
pressures; initially the lung volume does not increase significantly despite an increasing 
airway pressure. Next, the lung volume increases and once the lung volume approaches the 
total lung capacity (TLC), the volume increase per unit pressure increase diminishes: the 
inflation limb flattens. The deflation limb represents changes in lung volume during 
decremental changes in airway pressures, starting at TLC. Again, as explained by the law of 
Laplace, lung volume is initially maintained as pressures are lowered, but eventually 
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decreases due to progressive alveolar collapse. It is now known that opening of collapsed 
lung units or recruitment occurs along the entire inflation limb of the PV curve.67 
Mathematical models and animal experiments have shown that adequate recruitment of 
collapsed alveoli, followed by optimal stabilisation with adequate PEEP levels will place 
ventilation on the deflation limb of the PV curve.68,69 This will improve compliance and limit 
end-expiratory atelectasis, repetitive reopening of collapsed alveoli, end-inspiratory 
pressures and regional overstretching. 
 
Spontaneous breathing efforts help to distribute tidal volume to the dependent zones in the 
proximity of the diaphragm that are most susceptible to collapse.70 Prone positioning of the 
ventilated patient is an especially attractive adjunct to recruitment, in that it applies and 
sustains rather high tractive forces in dorsal regions that are compressed in the supine 
position by the locally higher pleural pressure and the weight of the heart and mediastinal 
contents.71-73  
 
From these basic principles, various methods have been suggested to accomplish 
recruitment without repetitive tidal cyclic forces. How best to perform episodic recruitment 
manoeuvres, however, has not yet been determined and may well vary with the underlying 
pathophysiology. Recruitment of collapsed alveoli, as well as collapse of previously open 
alveoli, are not only pressure dependent, but also time dependent.74-76 Episodic PEEP 
increases,77 intermittent sighs,78-80 and sustained application of a pressure that achieves 
total lung capacity have been proposed and tested. Since most underlying lung diseases are 
inhomogeneous, regional overdistention of relatively healthy lung units is a major concern 
during lung recruitment. There is, however, little evidence that recruitment manoeuvres 
damage the lung when accompanied by sufficient end-expiratory pressure. Most 
experiments indicate that derecruitment is more harmful than recruitment.81,82 When 
successful, the benefits of each manoeuvre tend to fade over time, unless a sufficient end-
expiratory pressure is sustained by PEEP and/or prone positioning.83 
 
Although the concept of the “open-lung approach” is supported by increasing evidence, it 
should be stated that recruitment of collapsed lung units is not always possible. ARDS may 
result from direct pulmonary injury (pulmonary ARDS) or may be the result of indirect 
pulmonary injury by extrapulmonary causes. Diseases like pneumonia and ARDS caused by 
pulmonary disease are associated with predominant consolidation, whereas ARDS caused 
by extrapulmonary disease is associated with prevalent interstitial oedema and alveolar 
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collapse.  In diseases characterised predominantly by consolidation, application of PEEP 
induces only moderate lung recruitment, increased elastance of the respiratory system 
(reduction of respiratory compliance) and potential alveolar overdistention. When, on the 
other hand, interstitial oedema and alveolar collapse predominate, PEEP application 
induces lung recruitment with a decrease of respiratory system elastance (increase of 
respiratory compliance).84,85 
High-frequency oscillatory ventilation 
HFOV is a ventilatory mode in which an oscillator at a high frequency (5-15 Hz, 300-900 
breaths/min) administers a small tidal volume (around 2 ml/kg). These oscillations are 
superimposed upon a mean airway pressure, referred to as the continuous distending 
pressure (CDP). Lung volume and thus oxygenation is mainly determined by CDP, whereas 
ventilation is provided by the oscillations. Theoretically, HFOV is an ideal method for the 
ventilatory treatment of ARDS patients: The increased end-expiratory lung volume prevents 
alveolar collapse in the dependent lung zone, whereas the low tidal volume prevents end-
inspiratory overstretching of the relatively healthy alveoli in the non-dependent lung zone. 
However, early multi-centre studies showed increased morbidity in neonates when HFOV 
was compared to conventional mechanical ventilation (CMV). This was attributed to the lack 
of an adequate lung volume recruitment strategy and other methodological flaws. In the 
1990s, the safety of HFOV has been demonstrated in a number of studies in newborns, 
children and more recently in adults.86-89 At present, various experimental and clinical 
investigations are conducted to find the best lung-protective strategy, both for HFOV and 
CMV. 
Optimal lung volume 
One of the difficulties in the practical implementation of open lung ventilation is the lack of 
consensus on the definition of optimal lung volume. Lachmann et al. proposed the use of the 
physiological shunt fraction (Q’S/Q’T) to assess an open-lung condition. At a Q’S/Q’T below 
0.1, the lungs are assumed to be adequately recruited, an optimal lung volume is reached at 
the lowest airway pressure needed to achieve this condition, thereby minimising lung 
overdistention and cardiac output depression. In HFOV, the lowest ratio of pressure swings 
at the distal end and the proximal opening of the endotracheal tube (OPR), as well as the 
lowest oxygenation index (OI) have been described as indicators of optimal airway 
pressure.90,91 Determination of Q’S/Q’T requires access to the pulmonary artery for mixed 
venous blood sampling, which is not always suitable in adults and is usually not performed 
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in most paediatric patients. For the clinical assessment of lung volume, only indirect 
methods are currently available, such as chest X-ray and measurement of oxygenation. 
Direct measurement of lung volume during HFOV has not been established yet. Only by 
interruption of HFOV, and application of a gas dilution method during subsequent 
conventional mechanical ventilation, lung volume can be determined.92 Lung volume 
assessment through FRC measurement is difficult at the bedside, but alternative methods 
such as inductive plethysmography and electrical impedance tomography are promising.93-96 
Computed tomography was demonstrated to give information on regional lung aeration in a 
thoracic cross-section, to assess atelectasis and hyperinflation. It is, however, not available 
at the bedside, requires transportation of an often unstable patient and is associated with 
increased radiation load. Recently, two methods were proposed and tested experimentally 
to provide information to find the optimal CDP: Analysis of a quasi-static pressure-volume 
curve by supersyringe, obtained prior to HFOV application and estimation of mean lung 
volume change by respiratory inductive plethysmography during HFOV.97 The value of the 
pressure volume curve as a guide for mechanical ventilation has been disputed and 
currently is not available at the bedside.98   
Nitric oxide 
As was outlined above, the “open-lung approach” is not feasible in all patients. This may 
lead to failing mechanical ventilation as a result of decreased ventilation-perfusion matching. 
Inhalation of nitric oxide (NO) reduces pulmonary artery pressure and increases arterial 
oxygenation by improving ventilation-perfusion matching, without producing systemic 
vasodilatation in newborns with severe persistent hypertension of the newborn (PPHN), in 
children with pulmonary hypertension and in patients with severe ARDS.99-104 In adults with 
severe ARDS, however, clinical trials have shown no beneficial outcome.105-108 
Nevertheless, NO is still in use for rescue therapy in adults.109,110 In newborns suffering from 
PPHN, inhaled NO (iNO) improves oxygenation, reduces the amount of ventilatory support 
needed, and prevents progression to severe PPHN.111  
The effect of iNO is augmented by optimal recruitment of lung volume, as has been 
described in the combination of HFOV and iNO.112,113 
Outline of this thesis 
The aim of this thesis was to develop and evaluate a number of methods to improve volume 
targeted HFOV and the combination of HFOV and iNO: 
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• High-frequency oscillatory ventilation in paediatric patients. Three HFOV strategies were 
described. First, the “open-lung strategy” in diffuse alveolar disease, secondly the “low-
volume strategy” in air leak syndromes and thirdly the “open airway strategy” in 
obstructive small airway disease (Chapter 2). 
• In Chapter 3, a system for integrated measurement of ventilator settings, lung volume 
change and blood gases during high-frequency oscillatory ventilation is described. As 
outlined above, lung volume measurements are currently not available at the bedside, 
and lung volume optimisation during HFOV requires combined analysis of vital 
parameters, blood gas analysis and close observation of the patient. We tried to provide 
a method of facilitating this process both for clinical and research purposes. 
• The accuracy of respiratory inductive plethysmography (RIP) to estimate lung volume 
changes has been addressed in Chapter 4: accuracy of respiratory inductive 
plethysmography at varying PEEP levels and during different degrees of acute lung 
injury.  
• Given a reliable method of measuring lung volume changes with the potential to be used 
at the bedside, we questioned the value of the use of pressure volume curves to predict 
pressures needed to obtain and maintain an “open lung”, as has been described in the 
literature. This was done in a mathematical model of ARDS lungs (Chapter 5, static 
pressure-volume curve characteristics are moderate estimators of optimal airway 
pressures in a mathematical model of ARDS). 
• In the analysis of respiratory inductive plethysmography signals, obtained in piglet 
experiments and clinical application, we noticed airway pressure-dependent changes in 
ribcage and abdominal motion. We hypothesised that maximal breath-to-breath chest 
wall displacement measured with RIP would coincide with maximal respiratory system 
compliance (Chapter 6, breath-to-breath analysis of abdominal and rib cage motion in 
surfactant depleted piglets during high-frequency oscillatory ventilation). 
• As described above, the “open lung approach” is not feasible for all patients or may be 
insufficient in a selected group of patients. Some of these patients may benefit form the 
combination of HFOV and iNO therapy. It was speculated that the effect of iNO therapy 
was augmented by ventilating the lung at its optimal volume.112 In an attempt to provide 
an accurate means of dosing NO during HFOV we described the accuracy of nitric oxide 
dosage and measurement during HFOV comparing various set-ups (Chapter 7, bench 
test assessment of dosage accuracy and measurement inaccuracy in nitric oxide 
inhalational therapy during high-frequency oscillatory ventilation). 
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• Since large continuous gas flows are employed during HFOV, application of nitric oxide 
during HFOV may lead to the use of significant quantities of nitric oxide. In Chapter 8 
(occupational exposure during nitric oxide inhalational therapy in a paediatric intensive 
care setting), we describe the environmental consequences of this combined therapy. 
• In Chapter 9, the results are summarised and discussed, conclusions are given and 
future perspectives are presented. 
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SUMMARY 
Background: High-frequency oscillatory ventilation (HFOV) is a ventilatory mode using small 
tidal volumes with low phasic pressures at supraphysiologic frequencies. Beyond the 
neonatal period there are distinct lung diseases for which HFOV is used. Data of 35 children 
who deteriorated on conventional ventilation were retrospectively analysed in two tertiary 
paediatric intensive care units.  
 
Methods: Depending on the underlying pulmonary pathophysiology, three strategies were 
employed. First, the “open-lung strategy” designed to rapidly recruit and maintain optimal 
lung volume in diffuse alveolar disease (DAD) (n=27) and pulmonary haemorrhage (n=5). 
Second, the “low-volume”-strategy in persistent airleak (n=1) where after an initial identical 
approach, continuous distending pressure (CDP) is reduced until the airleak ceases. Third, 
the “open-airway”-strategy in obstructive airway disease (n=5) where CDP is used to recruit 
and stent the airways.  
 
Results: Seven patients died, two due to respiratory failure. Three patients developed an 
airleak. Nine patients developed chronic lung disease. There was a significant decrease of 
the oxygenation index (OI) in the survivors. In the two patients who died of respiratory 
failure, the OI increased.  
 
Conclusion: If certain conditions are met, HFOV appears a safe and effective mode of 
ventilation in paediatric respiratory failure.  
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INTRODUCTION 
Despite improvements in respiratory care, pulmonary disease remains an important cause of 
morbidity and mortality in children as well as in adults. Although positive pressure ventilation 
has reduced mortality, pulmonary complications due to oxygen toxicity and baro- or 
volutrauma remain high.1-4 High-frequency oscillatory ventilation (HFOV) has been 
suggested as an alternative for treatment of various forms of respiratory failure.5-11 In HFOV 
small tidal volumes with low phasic pressure changes are used at supraphysiological 
frequencies, superimposed on an adjustable continuous distending pressure (CDP). In 
1980, Bohn et al.12 and Butler et al.13 showed that it was possible to achieve adequate gas 
exchange with this mode of ventilation. 
In contrast to other forms of HFV, HFOV has an active expiratory phase.14 HFOV effectively 
decouples oxygenation from ventilation. As there is a near linear relationship between lung 
volume and oxygenation, changes in oxygenation are achieved by modulating the CDP. 
Ventilation depends on the oscillatory volume, determined by the amplitude and frequency.15 
During HFOV, higher mean airway pressures than those tolerated with conventional 
mechanical ventilation (CMV) can be applied to keep the lung open. Lower peak pressures 
and lower pressure swings cause less lung damage.  
While in 1989 the HIFI-trial, a prospective study including 10 neonatal intensive care units, 
did not demonstrate a benefit to the use of HFOV compared to CMV, much was learned 
during that and other studies which has altered the way we apply this therapy today.16-18 
Different modes of HFV and different strategies will lead to marked differences in outcome. 
Consequently, more recent studies show better results. In preterm infants with hyaline 
membrane disease, HFOV decreases the incidence of chronic lung injury.6,10,19 Furthermore, 
the effectiveness of HFOV in paediatric patients with airleak or diffuse alveolar disease 
(DAD) was demonstrated in a randomised clinical study.8,9 
We report our experience with HFOV in 35 paediatric patients who deteriorated on CMV. 
Three different HFOV-strategies were employed: the “high-volume” or “open-lung” strategy 
for DAD and pulmonary haemorrhage, the “low-volume” strategy for airleak and the “open-
airway” strategy for obstructive lung disease. Our objectives were to evaluate the safety and 
efficacy of HFOV using specific strategies according to the underlying disorder. 
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Table 2.1. Patient characteristics.a 
Number of patients 35  
Male : Female 
HFOV runs 
15:20 
38 
 
Main diagnosis ARDS 17 
 Pneumonia 10 
 Pulmonary haemorrhage 5 
 Bronchiolitis 4 
 Airleak 
PPHN 
1 
1 
 
Median range 
Decimal age 0.390 0.03 - 13.8 
Weight (kg) 5.750 2.6 - 65.0 
Days prior to CMV 2.0 0.2 – 36 
 
a: ARDS, acute respiratory distress syndrome; PPHN, persistent pulmonary hypertension of the 
newborn; CMV, conventional mechanical ventilation. 
PATIENTS AND METHODS 
Patients 
Between January 1994 and January 1998, we treated 35 children with HFOV in two tertiary 
care paediatric intensive care units. We retrospectively analysed the chart records. Patients 
characteristics are listed in Table 2.1. The main diagnosis was DAD in 27 patients (77%), of 
which 10 had pneumonia and 17 ARDS (11 due to sepsis, two due to mediastinitis after 
oesophageal surgery, one after anti-thymocyte-globuline treatment, one after submersion 
and two after neurotrauma). One patient showed both small airway disease and persistent 
airleak. She was put on HFOV primarily to hasten resolution of the airleak. 
The course of three children with severe ARDS was complicated by airleaks during CMV, 
which were drained with chest tubes and considered stable before starting oscillation. One 
patient had severe bronchopulmonary dysplasia (BPD), with continuous oxygen need at 
home before admission. Two other patients had mild BPD, one with intermittent oxygen 
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need at home (two episodes on HFOV), the other was already without oxygen supply before 
admission. 
Conventional Mechanical Ventilation. 
All patients were ventilated with either pressure regulated volume controlled or pressure 
controlled ventilation (Servo 300 and 900C, Siemens, Solna, Sweden). In our units severe 
respiratory failure is treated using a strategy that utilises increases in end-expiratory 
pressure and inspiratory time to increase mean airway pressure. If felt appropriate patients 
with DAD were put in prone position to improve their oxygenation. Furthermore, low tidal 
volumes were used to prevent overdistention, regardless of PaCO2-values, as long as pH 
was above 7.25 with a bicarbonate level above 19 mmol/l (permissive hypercapnia).  
All patients had arterial and central venous lines. They were sedated with a continuous 
infusion of midazolam and, if necessary, paralysed with vecuronium. According to arterial 
blood pressure, central venous pressure, diuresis, peripheral temperature and serum lactate 
levels, intravenous fluids and inotropes were administered. 
High-frequency oscillatory ventilation 
Informed consent was obtained before HFOV was instituted. HFOV was started, when 
clinical and radiological deterioration occurred on CMV and 1 or both of the following criteria 
were met: intractable respiratory failure with peak inspiratory pressures of more than 30 cm 
water despite the use of permissive hypercapnia for at least 2 h, or an oxygenation index 
(OI) above 13 demonstrated by two consecutive arterial blood gas measurements over a 6-h 
period. The OI is calculated as: FIO2 x 100 x CDP (cm water) divided by the PaO2 (mm Hg). 
HFOV was also started in patients with persistent pulmonary haemorrhage despite the use 
of high end-expiratory pressures, or radiographic evidence of barotrauma with unstable 
airleak, requiring additional chest tubes or continuing for more than 72 h. Former prematurity 
with residual BPD was not considered to be a contraindication for HFOV. Neither was 
obstructive airway disease with clinical evidence of increased expiratory resistance or 
hyperinflation on chest X-ray. We used an electromagnetically driven membrane oscillator 
(3100 A, SensorMedics Critical Care, Yorba Linda, California, USA). Three main strategies 
for HFOV were employed: 
1. The “high-volume strategy or open-lung strategy” for DAD and pulmonary haemorrhage.  
We aimed at an oxygen saturation (SaO2) above 90% at an FIO2 of less than 0.6, an arterial 
pH above 7.25 with a bicarbonate level above 19 mmol/l irrespective of the PaCO2, and 
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stable haemodynamics. Circulatory compromise was treated with optimising preload (CVP 
above 12 mm Hg) and by inotropic support. General supportive care remained unchanged 
during the transition. In children less than 10 kg, we used a frequency of 10 Hz, above 10 kg 
8 Hz. With persistent respiratory acidosis frequency was decreased to 8, 6 or 4 Hz -
frequencies. Pressure swings were adjusted according to chest wall vibrations and PaCO2. 
Inspiratory time was set at 33%. In one patient with persistent respiratory acidosis an 
inspiratory time of 50% was used. Since CO2 elimination is very sensitive to mucus 
accumulation in the endotracheal tube or airways, sudden rises in PaCO2 were treated by 
immediate suctioning. Bias gas flow was 20, 30 or 40 l/min as necessary to maintain CDP. 
We started with an FIO2 of 1.0 on the oscillator. CDP was initially set 3-4 cm higher than 
mean airway pressure on CMV, and subsequently increased according to SaO2 and chest 
X-ray. Priority was given to reduction of FIO2 above pressure. Lung inflation was considered 
satisfactory with diaphragm margins projected at the 9th posterior rib on chest X-ray. In 
patients with persistent hypoxemia with adequate circulation and no radiographic signs of 
lung overinflation, CDP was increased further until oxygenation targets were reached. 
Eventually, prone position was used, most of the time successfully. Management of 
hypoxemia in patients with suspected cardiac dysfunction was treated by optimising preload 
and contractility. If the therapeutic goals were not attained, the patient was considered a 
treatment failure. Once adequate oxygenation was achieved with an FIO2 below 0.4, 
attempts were made to reduce the CDP in 1-2 cm decrements. 
2. The “low-volume strategy” in airleak syndrome.  
Initial settings and management were the same as in the “open-lung” strategy. Once 
adequate oxygenation was achieved, immediate attempts were made to reduce CDP until 
the airleak ceased. Higher oxygen concentrations were accepted to keep CDP as low as 
possible with a PaO2 of at least 55 mm Hg. Priority was given to reduction of CDP above 
FIO2. 
3. The “open-airway strategy” for small airway disease.  
In patients with small airway disease, we used the same initial settings as described in the 
“open-lung” strategy, but high CDP was now used to up the small airways, allowing 
oscillations to move freely in and out the alveolus. Once the airways were opened, careful 
attention was paid to overinflation since the normal compliant alveoli were faced with 
relatively high CDP. Management of hypoxemia in these patients was directed at optimising 
preload (CVP>15-20 mm Hg) and contractility. The degree of lung hyperinflation on chest X-
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ray was not used to modify CDP.  To minimise dynamic airtrapping by spontaneous breaths, 
these patients were paralysed. In addition inspiratory times no longer than 33% were used 
and, if necessary, pressure swings were reduced as much as possible by the use of 
permissive hypercapnia. 
Nitric oxide administration during HFOV 
In 2 patients nitric oxide (NO) was added during HFOV because of persistent hypoxemia 
(persistent OI above 13 in 2 consecutive blood gas measurements despite adequate lung 
inflation and optimal haemodynamics). In 2 other patients NO was added because of 
pulmonary hypertension. NO was administered by a ball valve flow meter into the inspiratory 
limb of the circuit, 25 cm proximal to the endotracheal tube. NO flow was calculated 
according to the formula: NO flow = (Vvent x NOdel ) / (NOtank - NOdel), where Vvent is the 
ventilator flow, NOdel the required NO concentration in parts per million (ppm) and NOtank the 
NO concentration in ppm in the delivery tank. We have previously found this method to be 
accurate.20 In 3 patients, NO and nitric dioxide concentrations were measured with a monitor 
based on electrochemical cells (SensorNOx, SensorMedics Critical Care, Yorba Linda, 
California, USA). In these children a dose response curve was obtained with NO 
concentrations from 1 to 40 ppm. With each step measurements were made of PaO2, SaO2 
and, if available, the pulmonary artery pressure (PAP). 
Statistical analysis. 
Data in Tables 2.1 and 2.2 are reported as median and ranges. The oxygenation indices in 
Figs 2.1 and 2.2 are reported as mean values with standard deviation. The OI and PaCO2 
values were compared to baseline values on CMV. Data were compared using Wilcoxon’s 
signed ranks test (SPSS 7.0 for Windows, SPSS Software, Chicago, IL, USA). Statistical 
significance was assumed when the p-value was less than 0.05. 
RESULTS 
Conventional Mechanical Ventilation 
Median duration of CMV before beginning the high-frequency protocol was 2 days, ranging 
from a few hours to 36 days. Characteristics of CMV just prior to HFOV are listed in Table 
2.2. The OI at that time ranged from 6 to 42. The highest mean OI was found in the group of 
DAD.  
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Table 2.2. Characteristics on CMV 1 h prior to transition.a 
 Median (ranges) 
PIP (cm water) 34 (21-50) 
PEEP (cm water) 8 (2-19) 
MAP (cm water) 18 (9-35) 
PaO2 (mm Hg) 68 (37-190) 
PaCO2 (mm Hg) 47 (30-92) 
pH 7.33 (7.07-7.63) 
FIO2 0.8 (0.4-1.0) 
OI 20.5 (6.2-42.2) 
 
a: PIP, peak inspiratory pressure; PEEP, positive end expiratory pressure;  
MAP, mean airway pressure; OI, oxygenation index. 
 
 
Indications to start HFOV were: OI above 13 in 18 patients, PIP above 30 cm water despite 
the use of permissive hypercapnia in five patients, and the combination of both in five 
patients. In the remaining 10 patients, there was persistent pulmonary bleeding in one 
patient and persistent airleak in another. Three other patients had PIP above 30 cm water 
with high PaCO2 but with a pH still above 7.25. Because of the risk to increase the already 
existing pulmonary hypertension after cardiac surgery in two patients and due to persistent 
foetal circulation in the other patient, we did not allow the PaCO2 to rise further. In the 
remaining 5 patients, although mean airway pressure on CMV was not recorded, we 
assumed an OI >13. All of these patients either had a low PaO2 despite the use of high 
PEEP and high FIO2, either peak pressures above 30 cm water. At that time the children 
were clinically and radiologically rapidly deteriorating. 
High-frequency oscillatory ventilation 
Three patients had two episodes of HFOV, with a total of 38 HFOV episodes. Two patients 
were oscillated on a tracheotomy, in one of them HFOV was used twice. The median 
duration on HFOV was 11 days, the longest being 37 days. Prone position was used in eight 
patients. The highest CDP used was 45 cm water, the highest delta P 77 cm water. Twenty-
five (66%) patients, including the 5 patients with small airway disease, were paralysed. 
Thirteen patients never received muscle relaxants.   
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Fig. 2.1: The oxygenation index (OI) prior to (CMV) and during the first 72 h on HFOV of all survivors: 
4, 24, 48 and 72h represent the OI after stabilisation within 4 h on HFOV, and after 24, 48 and 72 h 
on HFOV respectively. Data are mean + S.D. Compared to the OI during CMV, differences with the 
OI at 4, 24, 48 and 72 h were significant (p<0.02). 
Gas-exchange variables 
Fig. 2.1 shows the OI prior to HFOV and 4, 24, 48 and 72 h after initiation in all survivors. 
The OI initially increased during transition to oscillatory ventilation. Subsequently there was 
a steady decrease of the OI in the survivor group from 20.1 + 9.0 to 11.9 + 9.8 (mean + SD). 
Compared to the OI on CMV, differences with OI after 4, 24, 48 and 72 h on HFOV were 
significant (p<0.02).  
Fig. 2.2 shows the individual OI of the non-survivors. In patients 3 and 6 who died from 
respiratory failure, a continuous increase of the OI is recorded. In the remaining patients, 
dying from non-pulmonary causes, no such increase is seen. Changes in PaCO2 values 
compared to baseline value on CMV were not significant.  
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Fig. 2.2: The individual OI of the non-survivors prior to and during the first 72 h on HFOV. Time points 
are the same as indicated in the legend to Fig. 2.1. Patients 3 and 6 died from respiratory failure. 
Effect of NO inhalational therapy during HFOV 
Four patients received NO during HFOV. The first patient was a 3-year-old girl admitted with 
severe ARDS, who developed pulmonary hypertension. HFOV and NO were started at the 
same time, NO in a dosage of 2 ppm gradually increasing to 40 ppm in two h. There was no 
effect of NO on the PaO2 or PAP. The second patient was a 2.5-month old girl with RSV 
bronchiolitis. NO (20 ppm) was started because of clinical deterioration with haemodynamic 
instability, pulmonary interstitial emphysema (PIE) and increasing OI. Within 6 h, there was 
a marked decrease in OI. NO was gradually weaned and could be stopped after 14 days. 
The third patient was admitted with a severe viral pneumonia. The course on HFOV was 
complicated by the development of PIE. Despite the combined use of HFOV, NO and 
corticosteroids, the patient died from respiratory failure (Table 2.3 patient 3). The last patient 
was a one-year-old boy with a complex congenital heart defect admitted with ARDS due to a 
super-infected RSV bronchiolitis. The course was complicated by a severe exacerbation of  
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Table 2.3. Non-survivors characteristics.a 
Patient Sex Diagnosis leading to HFOV Days on HFOV Cause of death 
1 M ARDS post BMX 14 FEL, bleeding after liver 
biopsy, limitation further 
treatment 
2 M ARDS post submersion 0.2 Circulatory collapse 
after initiation HFOV, 
died on CMV, brain 
death 
3 F Pneumonia 9 Progressive respiratory 
failure despite HFOV, 
NO and corticoid 
treatment 
4 F ARDS after ATG exposure 2 FEL relapse, sepsis, 
gut bleeding, limitation 
further treatment 
5 F Pulmonary haemorrhage 5 Withdrawal therapy in 
Omen syndrome 
6 F Pulmonary haemorrhage 8 CMV pneumonia after 
renal transplantation, 
progressive respiratory 
failure despite HFOV 
7 M Neurogenic ARDS 4 Brain death 
 
a: ARDS, acute respiratory distress syndrome; BMX, bone marrow transplantation; FEL, familial  
erythrophagocytic lymphohistiocytosis; CMV, conventional mechanical ventilation; NO, nitric oxide;  
ATG, anti-thymocyte globulines. 
 
 
an already existing pulmonary hypertension. One day after initiation of HFOV, NO was 
administered in increasing dosages up to 40 ppm without any effect on the PaO2 or PAP. 
Complications and outcome 
There were 31 survivors, 19 of them without chronic lung disease defined as more than 30% 
oxygen need 28 days after starting HFOV. Among the 12 patients with chronic lung disease, 
3 patients had pre-existing BPD, the 9 other patients had no prior lung disease. All patients 
except one were ultimately discharged home without supplemental oxygen. 
Table 2.3 shows the characteristics of the 7 non-survivors. Two patients can be considered 
as respiratory failure in spite of HFOV. Patient 3 died from progressing multi-organ failure 
including respiratory failure despite the use of HFOV, NO and steroids. Although initially 
responding well, patient 6 died after a third period of pulmonary haemorrhage in persisting 
respiratory acidosis, despite using the maximal power of the device. 
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Three patients developed an airleak during HFOV. Twelve (32%) needed additional fluids or 
more inotropic support during transition to improve their oxygenation. Twenty-one patients 
(68%) were weaned directly from HFOV to CPAP before extubation. The remaining patients 
were weaned on a conventional ventilator. In paralysed patients improving lung compliance 
sometimes resulted in higher PaCO2 and prompted to increase the pressure swings, 
improperly suggesting respiratory deterioration. In these patients, decreasing CDP resulted 
in better ventilation. Non-paralysed patients started to breathe spontaneously. 
DISCUSSION 
HFOV has been studied extensively in the treatment of neonatal respiratory failure. In 
preterm infants, early use of HFOV utilising a strategy designed to recruit and maintain 
optimal lung volume, has proved to lower the incidence of chronic lung disease.6,10,19 HFOV 
was also successfully used as a “rescue” treatment in term and near term infants with 
respiratory failure.21,22 Beyond the neonatal period there are two distinct groups of 
pulmonary diseases for which HFOV could be used effectively: DAD and airleak syndromes, 
with a ventilatory strategy depending on the underlying disorder.7-9 In paediatric patients, 
aggressive lung volume recruitment resulted in a significant improvement in oxygenation 
compared with a conventional ventilatory strategy designed to limit increases in peak airway 
pressures.8 Furthermore, despite of the use of higher mean airway pressures, the “open 
lung” strategy was associated with a lower frequency of barotrauma, indicated by the 
oxygen requirement at 30 days.8 
Recently, Fort et al reported the beneficial use of HFOV in adults in the treatment of ARDS 
utilising the lung volume optimisation protocol.5 A multicentre prospective trial comparing 
HFOV and CMV is currently in progress in adults to define whether the early use of HFOV 
will lead to improved survival with lower morbidity rates. 
In this study, we present our experience with HFOV as a rescue therapy in 35 paediatric 
patients with respiratory failure. Depending on the underlying cause we employed 3 different 
strategies: the “high-volume” strategy designed to rapidly recruit and maintain optimal lung 
volume by the use of high CDP in patients with DAD and pulmonary haemorrhage; the “low-
volume” strategy in patients with airleak where we accepted higher FIO2 and lower 
saturation looking for the lowest CDP to allow closure of the airleak; and the “open- airway” 
and low stretch strategy in small airway disease.  
We noticed that in the first group aggressive lung volume recruitment by increasing CDP 
was the mainstay for a successful transition. The major challenge in the transition was to 
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avoid under inflation rather than hyperinflation. Initially the team felt uncomfortable with the 
necessary high mean airway pressures. However, in normovolaemic patients circulatory 
effects of lung volume recruitment were minimal. Hypovolaemic patients sometimes failed to 
improve oxygenation, especially during transition. Adequate fluid administration improved 
haemodynamics as well as oxygenation.  
In the patients with small airway disease, CDP was used to open up and “stent” the airways. 
To our knowledge the latter group has never been included in a study of HFOV before. 
HFOV was considered a contraindication in treating patients with a pulmonary pathology 
characterised by prolonged expiratory time constants.7,8 However, preliminary results in our 
unit showed that HFOV can successfully be used in these patients, provided certain 
conditions are met.23,24 The critical hallmark in ventilating these patients is the use of a 
device with an active expiratory phase and with the possibility to set the expiratory time 
longer than the inspiratory time. This can be done with the SensorMedics 3100. The opened 
and more stable airway diameter leads to a stable time constant during exhalation, which 
enables ventilatory oscillations to move freely in and out of the alveoli. However, there is 
only a small margin for the ”best CDP” because once the airways have been opened, the 
normal compliant alveolus is suddenly faced with a high CDP. Careful attention must be paid 
to pulmonary overdistention by chest X-ray and by monitoring haemodynamics. 
As the data demonstrate, our approach produces an improvement in oxygenation in all 
survivors of the 3 groups, comparable to the results of previous studies.5,8 Due to the high-
volume strategy using high mean airway pressures to open up the lung, the OI rises during 
transition. In 4 patients additional administration of NO was tried during HFOV treatment 
because of ongoing hypoxemia or pulmonary hypertension. A discussion of the use of 
inhaled NO in improving oxygenation or decreasing pulmonary hypertension, is beyond the 
scope of this paper.23,25,26 
In the study of Arnold et al.,8 an increasing OI over time significantly predicted adverse 
outcome compared with a decreasing OI over time. In the study of Fort,5 the pre-treatment 
OI was the most significant variable that distinguished survivors from non-survivors. These 
data suggest that the OI, representing the pressure and oxygen cost for oxygenation, might 
be a potentially accurate tool to assess pulmonary insufficiency and mortality in respiratory 
failure. Our data support this hypothesis (Fig. 2.2). However most of our patients died from 
non-respiratory causes. 
Although the open-lung and open-airway strategy with the use of high mean airway 
pressures may feel uncomfortably aggressive to the treatment team, there are now 
convincing data that peak inspiratory pressures and phasic pressure changes in the alveoli 
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remain lower than during CMV.27 Small phasic changes may be critical in preventing further 
lung injury.28 Both repetitive overdistention and ongoing atelectasis contribute to progressive 
lung injury.18 Nowadays, also CMV strategies are directed to avoid baro-and volutrauma, by 
using pressure limited techniques with permissive hypercapnia, prone position, inverse ratio 
ventilation and PEEP levels set a few cm above the inflection point on the inflation limb of 
the pressure volume loop. Amato et al. demonstrated that pursuit for an open lung approach 
with CMV does have an impact on outcome.1,4 Prone positioning and permissive 
hypercapnia can be useful options with HFOV as well. During HFOV, the application of 
permissive hypercapnia will not affect lung inflation, because the lung can be fully recruited 
(CDP) and yet the stretch of the alveoli limited (deltaP). Permissive hypercapnia with 
conventional ventilators can give rise to reabsorption atelectasis: if not enough pressure is 
applied during inspiration, to open up the alveoli, they might collapse, especially when high 
oxygen concentrations are used which facilitates reabsorption. 
In contrast to most other studies, we allowed our patients to breathe spontaneously during 
HFOV, unless permissive hypercapnia is used to reduce pressure swings as much as 
possible. Only the patients with small airway disease are always paralysed to avoid 
additional airtrapping.  
An initial setting of HFOV requires medical expertise with the technique and a thorough 
understanding of the pathophysiology of the diseased lung. Once initiated, HFOV can easily 
be managed and nursing HFOV patients is not particularly complicated. Ventilation of 
patients is possible in various positions, giving the opportunity to profit from the beneficial 
effects of prone position.29 HFOV is also feasible in tracheotomy patients. 
We conclude that if managed properly, HFOV is effective and safe with very few side 
effects. It may be used as a primary ventilatory mode in paediatric patients with respiratory 
failure now. Recent experiences in the literature also offer perspectives for the application of 
HFOV in adult patients. 
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SUMMARY 
Primary objective: To describe and validate a system for integrated measurement of 
ventilator settings and dependent physiological variables during high-frequency oscillatory 
ventilation (HFOV).  
 
Methods: A custom interface was built for data acquisition. Lung volume change was 
determined by respiratory inductive plethysmography (RIP), modified to sampling rates of 
140 Hz. Blood gas analysis was obtained using a continuous intra-arterial blood gas 
monitoring system. FIO2 was measured by means of an electrochemical sensor. Pressure at 
the airway opening and trachea (microtip transducer) were sampled. Acquired data were 
sent to a laptop computer for analysis, display and storage. The system was tested during a 
lung recruitment procedure in an animal model of respiratory distress. Linearity of the RIP 
was checked by gas volume injection using a supersyringe.   
 
Main outcomes and results: The system operated successfully. Agreement between RIP-
measured volume with injected volume was excellent; bias was 5 ml; limits of agreement 
were 1 - 9 ml. Graphs were obtained, showing the relationship between imposed mean 
airway pressure and lung volume change, and oxygenation. 
 
Conclusions: The integration of ventilator settings and dependent physiological variables 
may provide useful information for clinical, instructional and research applications. 
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INTRODUCTION 
High-frequency oscillatory ventilation (HFOV) is a mode of mechanical ventilation in which 
lung volume is adjusted and maintained by a continuous distending pressure (CDP).1 
Superimposed small oscillations of airflow provide gas exchange with tidal volumes close to 
or lower than the anatomical deadspace at frequencies typically between 5 - 10 .sec-1. It has 
been suggested that CDP levels that are too low can adversely affect outcome,2 while 
excessive levels of CDP can lead to alveolar overdistention and barotrauma.3 Therefore, it is 
important to find the safe window of CDP in each individual patient, in each stage of the 
patient’s disease, to obtain an optimal lung volume. Currently, there is no clinical method for 
measurement of lung volume during HFOV, other than indirect methods such as chest X-ray 
and measurement of blood oxygenation. Recently, a number of methods have been 
experimentally investigated that are of potential clinical use. Brazelton et al. showed that 
lung volume changes can be monitored during HFOV by respiratory inductive 
plethysmography (RIP).4 Van Genderingen et al. showed that the tracheal pressure swings 
contain information on respiratory system compliance,5 which is related to optimal lung 
volume.6 Previously, we proposed use of the oxygenation index to identify the optimal lung 
volume.7 To clinically test these methods, there is a need for a safe and easy-to-use device 
for data acquisition and processing. We developed such a system and tested it in an animal 
model of acute lung injury.  
METHODS AND MATERIALS 
The measurement system 
The measuring system consists of a custom-built data acquisition system (High-frequency 
Oscillation Acquisition and Data Logging system: HOADL), connected to a laptop computer 
with software for data analysis, display and storage (Fig. 3.1). Electrical power was supplied 
by a safety transformer approved for medical use (Powersupply 14.5 volt 0.3 mA pn 763355, 
SensorMedics, Yorba Linda, CA). 
The HOADL hardware interface. The HOADL contains a number of interfaces to 
measurement devices and performs some measurements by itself. 
Lung volume changes. Lung volume changes were derived from respiratory inductive 
plethysmography (RIP).8 RIP measurement is based on the notion that the respiratory 
system is a two-compartment system comprising a rib cage and abdominal compartment. 
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Fig. 3.1: Schematic setup of the system during the test. Respiratory inductive plethysmography (RIP) 
was applied by using a rib cage and abdominal band. Fractional inspired oxygen concentration was 
measured at the gas exit of the blender. Tracheal pressure (Radi microtip transducer) and airway 
opening pressure were measured. Invasive blood gases (Paratrend) were continuously determined. All 
data were acquired by the HOADL custom interface and sent to the laptop computer. 
With plethysmographic measurement of both compartments, lung volume (change) can be 
derived. RIP uses thoracic and abdominal belts fitted with zigzag-shaped wires, which are 
placed in a resonator circuit. Inductance varies with extension of the bands, which in turn 
modulates the frequency of the resonator circuit. Resonator frequency is determined using a 
gated pulse counter. We integrated a commercially available Respitrace system circuit 
(Respitrace pn771727 (modified), SensorMedics, Yorba Linda, CA) in the HOADL. The 
standard Respitrace runs at 25 Hz, which is too low to detect dynamic changes during 
HFOV. We modified the circuit to increase sampling rate to 140 Hz with unaltered resolution.  
 
Pressure at the airway opening. Pressure at the airway opening (Pao) was measured at the 
Y-piece of the ventilator (143PC05D differential pressure transducer, Honeywell, Freeport 
Ill). The pressure signal was low-pass filtered (Butterworth 35 Hz) and sampled by a 12-bit 
analog to digital converter (ADC) at a rate of 140 Hz. 
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Tracheal airway pressure. Tracheal airway pressure (Ptrach) was measured with a microtip 
pressure transducer (PressureWire sensor, RADI Medical Systems AB, Uppsala, Sweden) 
inserted through the endotracheal tube. Pressure was converted to an analog voltage that 
was subsequently sampled by the ADC at a rate of 140 Hz. The internal low pass filter of the 
RADI system was set at 500 Hz. 
 
Fractional inspired oxygen concentration. Fractional inspired oxygen concentration (FIO2) 
was measured by means of an electrochemical sensor (galvanic oxygen sensor, Bird, Palm 
Springs, CA) placed at the air-oxygen blender. The ADC sampled the analog voltage 
generated by this sensor at 140 Hz. 
Blood gases. Blood gases (arterial oxygen tension PaO2, carbon dioxide tension PaCO2 and 
pH) were determined continuously by a commercial intra-arterial blood gas monitoring 
system (Paratrend 7, Philips Medical Systems, Boblingen, Germany). Data was sampled by 
the HOADL using a RS232 protocol. 
The sampled abdominal (RIPabd) and rib cage (RIPrc) counts, airway pressures, FIO2 and 
blood gas values were collected by a microcomputer (Basic Stamp 2sx microcontroller, 
Parallax Inc, Rocklin, CA) and sent to a laptop computer using a RS232 protocol.  
The HOADL software. 
The software was implemented in Delphi 5 (Borland, Scotts Valley, CA).  
 
Data acquisition: Blood gases were sampled at a rate of 0.1 Hz, all other data at 140 Hz. All 
data were collected into a dataset along with sampling time. 
 
Data calibration: A two point (at FIO2 0.21 and FIO2 1.0) calibration of the oxygen sensor 
was part of the system. To calibrate RIP to volume change (∆V) relative to functional 
residual capacity (FRC), the qualitative diagnostic calibration (QDC) procedure was 
performed, as previously described by Sackner et al.8 The method uses the equation  
∆V = M  *  (K  *  ∆RIPrc + ∆RIPab), in which ∆RIPrc and ∆RIPab are the rib cage and 
abdominal RIP changes relative to the values at FRC, respectively. K is a calibration factor, 
indicating the relative contribution of both compartments to volume, and M scales the sum to 
volume and is expressed in ml. In the QDC method, a number of undisturbed breaths are 
collected during 5 minutes uninterrupted mechanical ventilation. Breaths with similar tidal 
volume are selected, based on the uncalibrated sum signal (RIPrc+RIPab), including only 
breaths within one standard deviation of the mean. Then, the standard deviations of RIPrc 
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and RIPab are determined over the selected breaths. Calibration factor K is estimated by 
SD(RIPab) / SD(RIPrc). M is determined by injection of a known volume, e.g. tidal volume.  
Alternatively, a "standard ratio" K to weight relative gains of the rib cage and abdominal 
signals could be entered.9  With M and K known, every pair of RIPab and RIPrc was 
converted to a calibrated volume. 
 
Data processing and reduction: Mean and amplitude of proximal and tracheal pressure and 
RIP signals were calculated for each breath, followed by a median determination to obtain 
values each 10 s.  
 
Manual data entry: Remarks could be entered during the sampling process.  
 
Data processing: Calculations were performed, such as peak-to-peak detection to determine 
amplitudes. Derived quantities were determined such as the oxygenation index OI, defined 
as OI=CDP*FIO2*100/PaO2 7, the PaO2/FiO2 ratio, and the oscillatory pressure ratio OPR, 
defined as OPR=∆Ptrach/∆Pao,5 with ∆Ptrach and ∆Pao the pressure amplitudes measured 
at the airway opening and in the trachea, respectively. 
 
Data display: The screen display could be chosen: (a) Snapshots of raw data with fixed time 
axis; (b) trend graphs of mean airway pressure, lung volume and PaO2, e.g. over the last 15 
minutes; (c) X-Y plots: mean airway pressure against lung volume or PaO2.  
Data storage: Every 10 s, a 1 s epoch of raw data was stored in a file. Processed data such 
as mean and amplitudes of each signal, in combination with the values of PaO2, PaCO2 and 
pH and remarks were stored in a second file. 
System test  
Animal preparation. The system was tested during a routine training session with use of an 
animal model of acute lung injury to teach application of HFOV to clinicians. A 20 kg pig was 
sedated intravenously (midazolam 0.2 mg.kg-1.h-1 and sufentanyl 0.2 microg.kg-1.h-1). After 
oral intubation, the animal received conventional mechanical ventilation (Siemens Servo 
900, Siemens Elema, Solna, Sweden) with ventilator settings of FIO2 0.21, positive end-
expiratory pressure (PEEP) 2 cm H2O, respiratory minute volume 3300 ml, and frequency 16 
breaths per min. The animal was placed in supine position on a thermo-controlled operation 
table to maintain body temperature at 38oC. A catheter was inserted via the left femoral 
artery for continuous blood gas measurement. A catheter, inserted through the right jugular 
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vein was used for drug infusions. After surgery, the animal received vecuronium (0.2 mg.kg-
1.h-1) for muscle relaxation. The RIP bands were placed 5 cm cranial to the xiphoid (rib cage 
band) and halfway xiphoid and umbilicus (abdominal band) and secured.  
After the study, the animal was sacrificed using high dose pentobarbital. All procedures and 
protocols were reviewed and approved by the Animal Care and Use Committee at the 
University of Utrecht. Handling of the animal was in accord with local animal care guidelines. 
Protocol 
20 minutes after surgery, a 5 minute baseline recording was obtained during conventional 
mechanical ventilation. Calibration factor K (relative gain for the rib cage and abdominal 
signals) for RIP calibration was calculated from these data, using the QDC method. Then, 
the animal was disconnected from the ventilator and connected to a supersyringe (Model 
Series 5540; Hans Rudolph). RIP scaling factor M, was determined by injection of 500 ml 
ambient air. Next, the lungs were insufflated in randomised steps from 100 to 500 ml. 
Between each volume injection the animal was ventilated to assure return of end-expiratory 
lung volume to baseline.  
 
FIO2 was set to 1.0 and repeated lung lavage was applied with 35 ml.kg-1 warm saline until 
PaO2 was below 80 mm Hg,10 to obtain an animal model of acute respiratory distress. Then, 
high-frequency oscillatory ventilation (3100 A, SensorMedics, Yorba Linda CA) was initiated 
at an oscillation frequency of 8 Hz, initial mean airway pressure (CDP) 25 cm H2O, and 
relative inspiration time of 33% of the respiratory cycle. All lung volumes were related to lung 
volume at this initial CDP. Pressure amplitude was increased until vibrations were visible in 
the lower abdomen. CDP was increased in steps of 2-5 cm H2O to a maximum of 45 cm 
H2O, and thereafter decreased to 16 cm H2O.  After each step the animal was allowed to 
stabilise for 5-15 minutes. At a CDP of 45 cm H2O, FIO2 was lowered from 1.0 to 0.5, and 
maintained at this level. 
 
Next, the animal was switched back to conventional ventilation, and the volume injection 
procedure was repeated with 100, 200, 400 and 500 ml injections. 
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Fig. 3.2: Agreement between supersyringe-injected (Vinj) and RIP-measured volume (VRIP). Bias (centre 
line), defined as the mean difference, was 5 ml. Lower and upper limits of agreement (upper and lower 
lines), defined as bias ± 2 x standard deviation, were 1 and 9 ml. 
Statistical analysis 
Comparisons between supersyringe-imposed and RIP-measured lung volume change were 
analysed using a Bland-Altman analysis.11 
RESULTS 
Validation of RIP 
QDC procedure yielded calibration values K =0.66 and M=1.19. Linear regression of 
supersyringe-imposed versus RIP-measured lung volume changes demonstrated an 
excellent fit (r2=0.99). The average between-method bias was 5 ml; the 95% confidence 
limits of agreement were 1 - 9 ml (Fig. 3.2).  
Mean pressure-volume and mean pressure-oxygenation curves  
Pressure-volume curves were obtained by plotting mean airway pressure (CDP) versus 
mean lung volume change in respect to lung volume at the onset of HFOV (Fig. 3.3(a)). 
Relation between CDP and oxygenation was assessed from a CDP versus PaO2 plot (Fig. 
3.3(b)) and CDP versus OI plot (Fig. 3.3(c)). Lung volume increased with increasing CDP. 
With decrease of CDP, lung volume initially increased, followed by a gradual decrease. 
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Fig. 3.3: A: Relationship between imposed mean 
airway pressure (CDP) and mean lung volume 
change relative to baseline, determined by 
respiratory inductance plethysmography (RIP) 
during high-frequency oscillatory ventilation. B:  
Relationship between CDP and arterial oxygen 
tension (PaO2). Solid line, open circles: inflation 
limb with an inspired oxygen fraction (FIO2) of 1; 
dashed line, closed circles: deflation limb, where 
FIO2 was 0.5. C: Relationship between CDP and 
oxygenation index OI (=CDP*FIO2*100/PaO2). 
There was a marked volume hysteresis. PaO2 increased with increasing CDP, characteristic 
for lung recruitment. Prior to reduction of CDP, FIO2 was reduced to 0.5 with a subsequent 
fall in oxygenation. With decrease of CDP, PaO2 initially increased further, despite of the 
decreasing lung volume. With further decrease of CDP, oxygenation rapidly decreased. 
Dynamic measurements  
During HFOV with 8 Hz, dynamic variations of the rib cage and abdominal compartments 
were detected (Fig. 3.4). Asynchrony between the compartments was observed.  Tracheal 
pressure measurements were obtained and OPR was calculated for the deflation limb of the 
pressure volume loop only (Fig. 3.5). OPR reaches a nadir around 25 cm H2O. 
DISCUSSION 
The tested system functioned well in acquiring mean lung volume changes and oxygenation 
in response to changes in mean airway pressure and oxygen concentration during HFOV. 
The obtained quasi-static mean airway pressure-volume curve showed marked hysteresis. 
Clinically, this may be relevant information, as a similar lung volume and oxygenation level 
can be obtained at much lower CDP on the deflation limb, after a lung recruitment  
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Fig. 3.5: Ratio of distal and proximal airway pressure amplitudes (OPR), during decreasing mean airway 
pressure (CDP) and following complete recruitment of lung volume. OPR reaches a nadir around 25 cm 
H2O. 
Fig. 3.4: Tracing of rib cage (RIPrc; thin line) and abdominal (RIPab; thick line) motions using respiratory 
inductance plethysmography during high-frequency ventilation with 8 Hz. Tracings show the asynchrony 
between the two compartments. 
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manoeuvre, as compared to the inflation limb. This may have a lung-protective effect, and 
minimise ventilator associated lung injury.2 
We confirmed the linear behaviour of respiratory inductance plethysmography for the 
estimation of lung volume change imposed by the supersyringe, although this was limited to 
one subject. Linearity between supersyringe insufflated volumes and RIP measurements 
has been demonstrated previously by others.9,12,13 By modifying the Respitrace circuit to 
higher sampling rates, we were able to record rib cage and abdominal motions during HFOV 
at 8 Hz. The (a-)synchrony of movement may be studied in future investigations to further 
clarify the dynamics of high-frequency ventilation. 
We conclude that the system operated successfully to integrate ventilator settings and 
dependent physiological variables, and may prove to be a useful clinical, instructional and 
research tool. 
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SUMMARY 
Background: This study was performed to assess the accuracy of respiratory inductive 
plethysmographic (RIP) estimated lung volume changes at varying positive end-expiratory 
pressures (PEEP) during different degrees of acute respiratory failure. 
 
Methods: RIP measurements of inspiratory tidal volume (VTi) were validated in eight piglets 
during constant VTi ventilation at incremental and decremental PEEP levels and with 
increasing severity of pulmonary injury. RIP accuracy was assessed using Qualitative 
Diagnostic Calibration (QDC) derived calibration from the healthy state, from the disease 
state as the measurement error was assessed, and at various PEEP levels. Additionally, the 
influence of fixed calibration factors on RIP accuracy was assessed. 
 
Results: Best results (bias 3%, precision 7%) were obtained in healthy animals. RIP 
accuracy decreased with progressing degrees of acute respiratory failure and was PEEP 
dependent, unless RIP was calibrated again. When QDC was performed in the disease 
state as the measurement error was assessed, bias was reduced but precision not improved 
(bias -2%, precision 9%).  In healthy animals, fixed calibration factors could be used without 
reducing accuracy, whereas accuracy decreased with progressing pulmonary injury. 
 
Conclusions: RIP accuracy is within the accuracy range found in monitoring devices 
currently in clinical use. Most reliable results with RIP are obtained when measurements are 
preceded by calibration in pulmonary conditions that are comparable to the measurement 
period. When RIP calibration is not possible, fixed weighting of the RIP signals with species 
and subject size adequate factors is an alternative. Measurement errors should be taken 
into account with interpretation of small volume changes. 
 
 
 
Accuracy of RIP at varying PEEP and ALI 
 57 
INTRODUCTION 
Mechanical ventilation may lead to ventilator-associated lung injury as a result of alveolar 
overdistention as well as cyclic reexpansion of alveoli collapsed during expiration.1-4 Both 
experimental and clinical data suggest that mechanical ventilation which optimises lung 
volume can diminish the deleterious effects of mechanical ventilation.5,6  
A serious deficiency in current routine monitoring of patients receiving mechanical ventilation 
is the lack of simple, reliable and practical methods that can be used to measure mean lung 
volume (changes) during ventilation. Respiratory inductive plethysmography (RIP) is a non-
invasive monitoring technique, which is able to monitor and measure lung volume changes.  
RIP is based on the principle that the chest wall has two compartments, the rib cage and 
abdomen. Each compartment is associated with a single motion variable that can be 
measured with external sensors, and the sum of both variables can be calibrated against a 
known volume change to provide volumetric measurements. RIP generates dimensionless 
counts that can be calibrated to volume using the Qualitative Diagnostic Calibration (QDC) 
algorithm or the Least Mean Squares technique.7,8 RIP can be used to monitor tidal volume 
(VT) 9 and changes in end-expiratory lung volume (∆EELV).10 RIP has also been used to 
assess mean lung volume induced by the mean airway pressure during high-frequency 
oscillatory ventilation (HFOV) and may provide a clinical useful tool, provided its accuracy 
with changing airway pressures can be established.11 
Linearity of RIP with insufflated volume has been validated 10,12-14, although some have 
reported a limited precision of the method.15 
We studied the accuracy of RIP during conventional mechanical ventilation (CMV) to assess 
whether this accuracy depended on PEEP level or disease. 
MATERIALS AND METHODS 
Animal preparation  
The experiments were performed at the department of anesthesiology, Erasmus MC-Faculty 
Rotterdam; the study was approved by the local Animal Committee of the Erasmus 
University Rotterdam.  
Anesthesia was induced in 8 female Yorkshire pigs (weight 20 ± 1 kg) with 10 mg/kg ketamine 
(Ketalin 100 mg/ml, Apharmo, Arnhem, the Netherlands) and 0.5 mg/kg midazolam (Dormicum 
5.0 mg/ml, Roche Ned., Mijdrecht, the Netherlands) intramuscularly. After obtaining intravenous 
access a loading dose of 35 µg/kg fentanyl  (0.05 mg/ml, B. Braun Melsungen AG, Melsungen, 
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Germany) was given and continuous infusion of fentanyl  (35 µg/kg/h) and midazolam (9 
µg/kg/min) was started. After placing a 8-mm endotracheal tube via a tracheotomy, the animals 
were ventilated (AVEA, Viasys Healthcare, Palm Springs, CA) in volume controlled mode (VC) 
with the following settings: frequency 20/min, positive end-expiratory pressure (PEEP) 5 cm 
H2O, inspiratory time 0.8 sec (25%), inspiratory pause time 0.3 sec (10%) and 100% oxygen. 
Minute ventilation was set to deliver an inspiratory tidal volume (VTi) of 10 ml/kg. Inspiratory gas 
was humidified with a hygrophobe heat and moisture exchanger ("Sterivent S" Mallinckrodt, 
Mirandola, Italy). Muscle relaxation was achieved by continuous infusion of 2.5 µg/kg/min 
pancuronium bromide (Pavulon; Organon Technika, Boxtel, The Netherlands).  
Subsequently, the carotid artery was cannulated to obtain arterial blood pressures. A blood 
gas-monitoring sensor (Paratrend 7+/Trendcare, Diametrics Medical Ltd, High Wycombe, 
UK) was inserted into the right femoral artery to continuously analyse blood gases and pH. 
The right internal jugular vein was cannulated and a 5 Fr pulmonary artery catheter was 
introduced (TD catheter 4 lumen; Arrow Holland medical products, Houten, The 
Netherlands). The bladder was catheterised through the abdominal wall. Temperature was 
kept in the normal range by a heating pad.  
On completion of the experiments, the animals were killed with an overdose of pentobarbital. 
Measurements 
Hemodynamic and respiratory baseline measurements were performed prior to lung lavage 
and following stabilisation after surgery (prelavage measurements). Respiratory system 
compliance was derived according to Crs = VTi/(Pplat – PEEP), with VTi being inspiratory tidal 
volume and Pplat the plateau pressure.  
A system for integrated measurement of ventilator settings and dependent physiological 
variables as described in detail previously was used.16 In short, pressure at the airway 
opening was measured at the Y-piece of the ventilator (143PC05D differential pressure 
transducer, Honeywell, Freeport Ill). Inspiratory and expiratory flow were measured 
continuously at the airway opening using a flow probe (AVEA, Viasys Healthcare, Palm 
Springs, CA) and integrated to a volume signal (Vvent).17 Lung volume changes were 
derived from RIP. The thoracic belt was placed 4 cm above the xiphoid processus, the 
abdominal belt 4 cm above the umbilicus. Both belts were then secured by stitches and the 
position of the belts was checked at the end of experiments. The dimensionless counts of 
the abdominal (RIPabd) and ribcage (RIPrc) belts, airway pressure and Vvent were sampled 
at 140 Hz and stored for offline analysis.16 
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Experimental procedure 
Reference measurements 
Following stabilisation after instrumentation, respiratory variables (Paw, Vvent, RIPabd and 
RIPrc) were recorded during a 5-minute period of uninterrupted mechanical ventilation 
(HEALTHYQDC). These signals were used for calibration of the RIP, using the QDC 
algorithm. 
Then, the animals were ventilated with constant VTi and PEEP increasing from 5 to 20 cm 
H2O, with 5 cm H2O increments. This was followed by PEEP decrements of 5 cm H2O down 
to 5 cm H2O (HEALTHY) (Fig. 4.1). Time between PEEP changes was 5 minutes. Prior to 
PEEP change, physiologic variables were noted. 
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Fig. 4.1: Representative data record 
showing physiologic data (Paw and 
calibrated RIP volume signal) during a 
PEEP sequence in a healthy piglet. Signals 
are presented as 7 second snapshots per 
step and plotted as a function of time, with 
each PEEP step labeled on the horizontal 
axis. 
Subsequently, moderate lung injury was induced with a single lung lavage with 50 ml/kg 
warmed saline.18 To avoid development of respiratory acidosis, VTi was temporarily 
increased to maintain PaCO2 below 65 mmHg. Following a 30-minute stabilisation period, 
physiologic variables were noted (LAV1), and incremental and decremental PEEP steps 
were applied again at the initial VTi setting.  
Acute lung injury (ALI) was induced by repeated lung lavages with 50 ml/kg warmed saline 
until PaO2 was persistently below 80 mm Hg at 5 cm H2O PEEP, FiO2 of 1.0 and a tidal 
volume of 10 ml/kg.18 After the last lavage, the ventilator settings remained unchanged for 
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one hour. If PaO2 increased to values above 100 mmHg, lavages were repeated and 
stabilisation time reset. Thereafter, the lungs are assumed to be injured and atelectatic.18 
Following stabilisation at lavage target, measurements were repeated (lavage target 
measurements). Subsequently, PEEP was increased stepwise until Pplat reached 50 cm H2O 
and stepwise decreased to baseline. 
Ventilator-induced lung injury (VILI) was induced by ventilation with zero PEEP and VTi set 
to obtain Pplat of 50 cm H2O.19 These settings were maintained for 60 minutes. Physiologic 
measurements and incremental and decremental PEEP steps were repeated (VILI). 
 At the end of the experiment, PEEP was reduced to 5 cm H2O and physiologic variables 
were recorded after a stabilisation period (end experiment). 
Data processing 
Determination of VT 
VTi delivered by the ventilator (VTi,VENT) was determined from the Vvent signal as the 
difference between end-inspiratory and the preceding end-expiratory value. The same 
algorithm was used to determine inspiratory amplitudes of RIPabd, RIPrc and the summed 
RIP signals. 
 
Calibration of RIP signals 
To calibrate RIP to volume (∆V) above functional residual capacity (FRC), the QDC 
procedure was performed as described by Sackner et al.7 The method uses the equation 
∆V = M  *  (K  *  ∆RIPrc + ∆RIPab), in which ∆RIPrc and ∆RIPab are the rib cage and 
abdominal RIP changes relative to the values at end-expiratory lung volume, respectively. K 
is a calibration factor, indicating the relative contribution of both compartments to volume, 
and M scales the sum to volume and is expressed in ml. To perform the QDC, a number of 
undisturbed breaths were collected during 5 minutes of ventilation. Breaths with similar tidal 
volume were selected, based on the uncalibrated sum signal (RIPrc+RIPab), including only 
breaths within one standard deviation (SD) of the mean. Then, the SDs of RIPrc and RIPab 
were determined over the selected breaths. Calibration factor K was estimated by 
SD(RIPab) / SD(RIPrc). M was calculated by using mean VTi,VENT. With M and K known, 
every pair of RIPab and RIPrc was converted to a calibrated volume.  
 
To assess the validity of RIP at various end-expiratory lung volumes and in various disease 
states, RIP was calibrated using QDC on the HEALTHYQDC signals. Inspiratory tidal 
volume measured with RIP (VTi,RIP) per PEEP step was calculated, using the obtained QDC 
Accuracy of RIP at varying PEEP and ALI 
 61 
calibration factor. To assess the influence of factor K, we also used K = 0 (abdominal band 
only), K = 1 (weighing ribcage and abdominal band equally) and K infinite (ribcage band 
only), as well as values that have been used in other studies of 0.5 and 2.0.20,21 These 
values were compared with concomitant VTi,VENT. This procedure was performed for each 
disease state (HEALTHY, LAV1, ALI, VILI) and for each PEEP step. 
Next, to investigate the influence of end-expiratory lung volume on the validity of QDC, RIP 
was calibrated at each PEEP step in HEALTHY. VTi,RIP  was compared with concomitant 
VTi,VENT  for each PEEP step (excluding values used for calibration). To investigate QDC 
validity in different disease states, VTi,RIP was calculated for each PEEP step, with QDC 
calibration factors M and K obtained at PEEP of 10 (incremental PEEP), 20 and 10 
(decremental PEEP) cm H2O. This procedure was performed for each disease state 
(HEALTHY, LAV1, ALI, VILI). 
Statistical analysis 
Contiuous data of normal distribution are represented as mean + standard deviation (SD). 
Intragroup comparisons were computed using the paired T-test with Bonferroni’s correction. 
VTi,RIP was compared with VTi,VENT by means of Bland – Altman analysis.22 Bias is expressed 
as the mean of differences between both measurements (VTi,VENT, minus VTi,RIP), precision is 
expressed 2 standard deviations (2SD) of the relative differences. Root mean square error 
(RMSE) was used as a measure of accuracy. A p-value less than 0.05 was considered 
significant. 
RESULTS 
Data could be obtained in eight piglets in disease states state HEALTHY, LAV1 and  ALI.  
During infliction of VILI one animal died and two developed a pneumothorax. In one animal 
oxygenation did not significantly decrease during the induction of VILI (PaO2 286 mmHg 
after 60 minutes). The results of these four animals were excluded from analysis of VILI and 
end experiment data. Induction of VILI had to be terminated in the four remaining animals 
before 60 minutes as a result of decreasing PaO2 of 39 + 15 mmHg at zero PEEP. Analysis 
of VILI measurements is based on measurements in these four animals. 
Physiologic variables describing each disease state at baseline measurements are given in 
Table 4.1. Crs decreased significantly as a result of lavages. Following the first lavage, 
PaO2/FiO2 was below 400 mmHg and significantly decreased with further lavages. At VILI, 
PaO2/FiO2 was lower than the values at ALI.  
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Table 4.1.Ventilatory and blood gas values at baseline (PEEP = 5 cm H2O), except at VILI where  
measurements were obtained at the lowest PEEP with target PaO2 of 50 mm Hg.  
 
 Prelavage 
(healthy) 
 (n=8) 
Following 1 
lavage  
(n=8) 
At lavage 
target  
(n=8) 
At VILI target
(n=4) 
End 
experiment 
 (n=4) 
VTi (ml/kg) 10 + 1 12 + 1 a 12 + 1 a 12 + 1 13 + 1 
Crs (ml/cm H2O/kg) 0.75 + 0.14 0.58 + 0.13a 0.4 + 0.08 a,b 0.35 + 0.07 a,b 0.39 + 0.06 a,b 
PaO2 (mm Hg) 532 + 51 321 + 101 a 61 + 12 a,b 40  + 9 a,b,c 43 + 5 a,b,c 
PaCO2 (mm Hg) 52 + 6 61 + 3 a 61 + 5 a 47 + 7 c 64 + 6 a 
 
a: p<0.05 compared with healthy, b: p<0.05 compared with one lavage,  c: p<0.05 compared with 
lavage target 
 
 
 
Figure 4.1 shows a representative example of the PEEP sequence. With subsequent PEEP 
steps, VTi,VENT remained constant. At high PEEP levels in the healthy animal pressure 
amplitude (Pplat – PEEP) increased. Grouped data from a PEEP sequence in healthy 
animals are shown in Figure 2; incremental PEEP steps are shown in the left panels, 
decremental PEEP steps in the right panels. Hysteresis of end-expiratory lung volume is 
shown in Fig. 4.2; at identical PEEP levels, RIP estimated end-expiratory volume is lower 
during incremental PEEP steps (Fig. 4.2(a)) compared to decremental PEEP (Fig. 4.2(b)). 
Amplitudes of uncalibrated RIPrc (Fig. 4.2(c) and (d)) and RIPabd signals (Fig. 4.2(e) and 
(f)) and tidal volumes (Fig. 4.2(i) and (j)) measured from the calibrated RIP signals changed 
with changing PEEP. RIPrc amplitudes were lower during decremental PEEP than during 
incremental PEEP (p < 0.05), RIPabd amplitudes at 10 and 15 cm H2O decremental PEEP 
were higher than they were at equivalent values incremental (p < 0.05). RIP amplitude 
change also displayed hysteresis. There was no relation between RIP amplitude change of 
either band and summed end-expiratory uncalibrated RIP counts or respiratory system 
compliance (Crs) (Fig. 4.2(g) and (h)). The relative RIP measurement error, expressed as 
[VTi,vent – VTi,RIP]/ VTi,vent was not related to PEEP, but measurement standard deviation 
increased with increasing PEEP. 
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Fig. 4. 2: Grouped data from a PEEP sequence in healthy animals. Values are normalized to the initial 
value at PEEP = 5 cm H2O (incremental). Decremental PEEP steps are plotted in reverse order. 
*: Significant difference from value obtained at 5 cm H2O incremental PEEP, p<0.05. 
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Table 4.2. Measurement error as quantified by the bias (precision) of Respiratory Inductive 
Plethysmographic inspiratory tidal volume measurement, at various PEEP levels levels and in multiple 
disease states. Calibration using HEALTHYQDC signals. K = 0: chest wall belt changes ignored, K  = 1: 
weighing ribcage and abdominal belt equally, K = infinite: abdominal belt changes ignored. 
 
 QDC K = 0 K = 0.5 K = 1 K = 2 K = infinite 
Healthy 3 (7) 0 (18) 2 (11) 3 (7) 3 (10) 4  (15) 
Following 1 lavage 5 (10) a -2 (23) b 2 (14) b 5 (10) a 7 (13)  a,b 11 (24)  a,b 
At lavage target 8 (11) a 0 (25) b 4 (14) b 8 (12) a 10 (16) a 13 (30)  a,b 
VILI (n=4) 11 (11) a 0 (16) b 9 (10) a,b 10 (10) a 14 (13) a,b 18 (18)  a,b 
Overall 6 (12) 0 (21) b 4 (14) b 6 (11) 8 (15)  a,b 11 (25) b 
 
a: significant difference when compared to values derived during health, using identical calibration  
(P <0.05). b: significant difference when compared to QDC derived values (P <0.05). 
     
Table 4.2 lists the RIP measurement errors after QDC calibration in the healthy animal. The 
best results, bias and precision (defined as 2SD interval) <10% were obtained in the healthy 
animal, whereas the error increased with progressing disease severity. 
The use of K = 1 did not influence the measurement error compared to the use of calibration 
factors obtained with QDC in the healthy state. With K = 0 bias was reduced but precision 
increased. K = infinite resulted in both increased bias and precision (Table 4.2). 
When QDC was performed in the same disease state as the measurement error was  
 
 
Table 4.3 Measurement error as quantified by the bias (precision) of Respiratory Inductive 
Plethysmograpic inspiratory tidal volume measurement, at various PEEP levels and in multiple disease 
states. QDC calibration at PEEP of 10 (incremental PEEP), 20 and 10 (decremental PEEP) cm H2O, 
respectively. Data used for calibration were excluded from analysis of precision and accuracy. 
 
 QDC on PEEP 10 
(incremental) 
Bias (2SD) % 
QDC on PEEP 20 
(decremental) 
Bias (2SD) % 
QDC on PEEP 10 
(decremental) 
Bias (2SD) % 
Healthy 2 (8) -4 (9) a -3 (8) a 
Following 1 lavage 2 (9) a 0 (9) a -1 (9) a 
At lavage target 1 (11) a -1 (10) a 1 (14) a 
VILI (n=4) 3 (11) a -2 (8) a -3 (13) a 
Overall 2 (10) a -2 (9) a -1 (12) a 
 
a: Significant difference when compared to HEALTHYQDC derived QDC values (P <0.05). 
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Fig. 4.3: Measurement error (dots), 
expressed as root mean square error, 
with changing weight factor K in healthy 
animals (A) and animals at lavage target 
(B). Solid squares represent error 
obtained with calibration factors 
obtained from individual calibration in 
healthy animals (HEALTHYQDC), open 
diamond represents error obtained with 
calibration factors from individual 
calibration at PEEP = 20 cm H2O in 
lavaged animals. Dotted lines represent 
boundaries of minimal error + 10%. Note 
logarithmic scale on horizontal axis. 
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assessed (Table 4.3), we found a reduction in bias but not in precision. Figure 4.3 illustrates 
the dependence of accuracy on K. In the HEALTHY animals (Fig. 4.3(a))  maximal accuracy 
with fixed K was found with K = 1. Accuracy was slightly higher when individual QDC 
calibration was performed in the healthy state. Accuracy remained within 10% of maximal 
accuracy with fixed K between 0.5 and 1.8. In the ALI animals RIP accuracy with fixed K 
was significantly reduced (Fig. 4.3(b)). Here, accuracy remained within 10% of maximal 
accuracy with fixed K between 0.3 and 0.9. In this range of fixed K, accuracy was higher 
than with K derived from individual QDC calibration performed in the healthy state. QDC 
calibration performed in the same disease state as the measurement error was assessed, 
yielded higher accuracy than could be reached with fixed K. 
 K and M, obtained during QDC at different levels of PEEP, were not PEEP dependent 
(Table 4.4). 
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Table 4.4. Values for K and M obtained with QDC in healthy animals, at various PEEP steps 
. 
 K mean (sd) M mean (sd) (ml) 
Healthy PEEP 5 (incremental PEEP)  1.03 (0.45) 1.74 (0.31) 
Healthy PEEP 10 (incremental PEEP) 0.97 (0.41) 1.83 (0.44) 
Healthy PEEP 15 (incremental PEEP) 0.93 (0.19) 1.88 (0.41) 
Healthy PEEP 20 (maximal PEEP) 1.15 (0.70) 1.75 (0.47) 
Healthy PEEP 15 (decremental PEEP) 1.09 (0.38) 1.85 (0.47) 
Healthy PEEP 10 (decremental PEEP) 1.09 (0.17) 1.75 (0.31) 
Healthy PEEP 5 (decremental PEEP) 1.15 (0.69) 1.75  (0.47) 
 
All differences NS  
 
 
DISCUSSION 
This study assessed the validity of estimation of lung volume changes by respiratory 
inductive plethysmography during conventional mechanical ventilation at changing PEEP 
levels and at progressive degrees of acute respiratory failure in animals. A major finding of 
the present study was a decreasing accuracy of RIP-estimated lung volume changes with 
progressing degrees of acute respiratory failure, unless RIP was calibrated again. Best 
accuracy was obtained when calibration weight factor K was determined using QDC. The 
obtained results were in line with other studies,12,23 but we obtained better precision than 
earlier investigators did using older versions of the RIP hardware.15,24  
Optimal results (minimal bias) of RIP-estimated volume changes were obtained when 
calibration was performed in a representative pulmonary condition, e.g. the disease state the 
animal was in, and above the minimal end-expiratory lung volume. As a consequence, RIP 
accuracy decreases when pulmonary conditions change significantly, e.g. with deterioration 
or improvement of the disease. Thus, RIP should not be used to monitor long-term changes. 
When these conditions can be met, measurement error is within a range of about +10%. For 
purposes of clinical monitoring during relatively short procedures, such as lung volume 
recruitment and subsequent titrating of volume or compliance targeted ventilation, this may 
be acceptable (even though the accuracy is limited) given the ease of use of RIP, the fact 
that measurement does not interfere with treatment, and the ability to measure tidal 
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Table 4.5. Measurement errors of other measurement devices. RIP accuracy obtained with QDC 
performed at 10 cm H2O incremental PEEP and in the same disease state as the measurements were 
performed is given (Table 4.3). 
 
Device Bias (%) 2 SD (%) measures reference 
Siemens Servo 300 18 12 VT 32 
Respiratory Inductive 
Plethysmograpy 
-2 9 VT/relative 
EELV changes 
Present 
study 
Hot wire anemometer (Florian) 6.3  5 VT 33 
Babylog 8000 -5.5 3 VT 34 
 
 
 
 
volumes as well as end-expiratory lung volume changes. RIP accuracy is within the 
accuracy range found in monitoring devices currently in clinical use (Table 4.5), and its use 
provides additional information. PEEP induced lung volume recruitment and compliance 
change in a surfactant-depleted piglet is shown in Fig. 4.4 as an example. This could 
possibly alleviate the need for partitioning respiratory mechanics to differentiate between 
acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease.25 
Omitting QDC and assuming a fixed weight factor K would facilitate clinical RIP application, 
especially during none conventional ventilation modes such as HFOV, where measurement 
of lung volume is cumbersome. Weighing both signals equally did not influence bias or 
precision compared with the use of calibration factors obtained in healthy animals. This 
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suggests that QDC is valid during mechanical ventilation, but is not mandatory. Calibration 
of the dimensionless RIP counts to a known volume is, however, still needed to obtain a 
calibrated volume. Equal weighing of the signals was adequate, as was found by others 
using RIP in piglets.11 In other species this may not be the case, due to anatomic or 
physiologic differences. In spontaneous breathing healthy infants a K of 0.5 – 1.0 has been 
found adequate 12,20 whereas in healthy adults a K  of 2.0 was found.21  If knowledge of 
relative rather than absolute changes in lung volume is of interest, the use of uncalibrated 
summed RIP signals may be sufficient.11,26 However, we have shown that RIP accuracy is K 
dependent and in our experiments optimal K decreased with increasing lung injury (Fig. 4.3). 
Underestimation of VTi,VENT by VTi,RIP may in part be explained by the volume reduction when 
gas is compressed; isovolumetric pressure change of the lung, sometimes referred to as 
compressible volume of the lung. When a given volume is inflated in a container with infinite 
compliance and zero volume, the volume change of the container will be the inflated volume. 
At the other extreme, when the same volume is injected into a container with infinite 
pressure and low compliance, the volume change will be negligible. We did not measure 
functional residual capacity (FRC). Using FRC measured by others in piglets following 
pulmonary lavage 27 we calculated a compressible volume of 7% in a lavage target animal at 
PEEP 5 cm H2O up to 30% at a PEEP of 25 cm H2O. This would account for a difference of 
about 25% of externally measured volume changes in these animals with RIP calibrated at 
PEEP 5 cm H2O (incremental) and comparing VTi,VENT and VTi,RIP at PEEP 5 and 25 cm H2O. 
A further explanation for the varying precision may be found in interindividual changes in 
thoracic shape with changing PEEP. With increasing lung volume, the shape of the thorax 
changes; in the upper portion of the ribcage lateral displacement is minimal with inspiration 
(‘pump handle’ motion) whereas ventral displacement is minimal in the lower portion of the 
rib cage (‘bucket handle’ motion).28 We placed the thoracic belt at the caudal part of the 
chest. In humans, in this region chest expansion with inspiration is mainly in the frontal plane 
rather than in the transversal plane, leading to a change in cross-sectional shape. It has 
been shown that inductive sensors are sensitive to both cross-sectional perimeter and area 
variations, and that (depending on the deformation) these sensors measure either perimeter 
or area.29 Watson et al. have demonstrated a linear relationship between RIP output and 
cross-sectional area.30 However, the relation between self-inductance of the RIP coils and 
cross-sectional area varies with ellipticity or shape of the cross-section.31  
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CONCLUSION 
Our results suggest that when RIP is used during mechanical ventilation, most reliable 
results are obtained when measurements are preceded by a calibration in comparable 
pulmonary conditions to the measurement period. In practice, this may not always be 
feasible and practical. When RIP calibration is omitted, a fixed weight factor K may be used 
which may, however, result in less accuracy. Our study demonstrated an unpredictable 
dependence of PEEP. Despite this limitation, RIP is a measurement method comparable to 
other techniques of lung volume change measurement. Measurement errors should be 
taken into account with interpretation of small volume changes.  
When lung conditions change, RIP partially loses its accuracy; during mechanical ventilation 
RIP should not be used as a device to monitor lung volume changes during a prolonged 
period of time. The potential advantage of the technique is its use during relatively short 
procedures, such as lung volume recruitment and subsequent decrease in airway 
pressures.11 A device that provides clinicians with integrated information on ventilator 
settings and dependent physiologic variables may prove to be a valuable asset,16 but this 
remains to be demonstrated in clinical tests.  
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SUMMARY 
Objective: To study the value of objective pressure-volume characteristics to predict optimal 
airway pressures and the development of atelectasis and overstretching during a structured 
lung volume recruitment procedure with subsequent reduction of airway pressures. 
Methods: We used a mathematical model of a lung with adjustable characteristics of acute 
respiratory distress syndrome (ARDS) characteristics. Simulations were performed in 5 
grades of ARDS in the presence of pure alveolar or combined alveolar-small airway closure 
as well complete or incomplete lung volume recruitability. For each simulation, optimal end-
expiratory pressure was determined. A static pressure-volume curve was constructed and 
objective characteristics of this curve calculated. The predictive value of these 
characteristics for end-expiratory atelectasis, overstretching and optimal end-expiratory 
pressure was assessed. 
Results: Simultaneous alveolar recruitment and overstretching during inflation were more 
pronounced than alveolar derecruitment and overstretching during deflation. End-expiratory 
pressure needed to prevent significant alveolar collapse in severe ARDS resulted in 
maximal safe tidal volumes that may be insufficient for adequate ventilation using 
conventional mechanical ventilatory modes. Plateau pressures well below the ‘upper corner 
point’ (airway pressure where compliance decreases) resulted in significant alveolar 
overstretching. 
Conclusions: A recruitment manoeuvre followed by subsequent reduction of airway pressure 
limits end-expiratory atelectasis, overstretching and pressure. None of the objective 
characteristics of the pressure-volume curve were predictive for end-expiratory atelectasis, 
overstretching or optimal airway pressure. 
DEFINITIONS AND ABBREVIATIONS 
Transmural pressure (Ptm) pressure difference over the alveolar wall resulting from alveolar recoil 
Chest wall pressure (Pcw) elastic recoil pressure exerted by the chest wall 
Superimposed pressure (Ps) gravitationally determined, superimposed pressure on the alveoli in a 
lung compartment 
Airway pressure (Paw) alveolar and airway pressure during no-flow conditions with 
Paw=Ptm+Ps+Pcw 
Transpulmonary pressure 
(Plungs) 
Pressure difference over the lung compartment, originating from 
alveolar recoil and superimposed pressure, defined by 
Plungs=Ptm+Ps=Paw-Pcw for aerated alveoli 
Threshold closing pressure 
(TCP) 
the transmural pressure at which an alveolus or small airway closes 
Threshold opening pressure 
(TOP) 
the transmural pressure that must be exceeded for a closed alveolus  
to open 
 
Characteristics of the static pressure – volume curve 
INTRODUCTION 
The administration of positive end-expiratory pressure (PEEP) is aimed at preventing the 
end-expiratory collapse of diseased pulmonary areas in order to reverse severe hypoxemia 
resulting from pulmonary shunting, a hallmark of acute respiratory distress syndrome 
(ARDS). In patients with ARDS, alveolar and systemic inflammatory responses can be 
attenuated by minimising overinflation and cyclic recruitment/derecruitment of the lung, via a 
reduction of tidal volume and an increase in PEEP.1 The pressure-volume curve (P-V curve) 
of the respiratory system has long been used as an orientation for setting the optimal PEEP 
in patients with acute lung injury and ARDS.2-4 
Generally, analysis of the P-V curve has been done by eye; a method that has been shown 
to be affected by inter- and intra-observer variability.5 Further confusion has arisen due to 
the lack of rigorous definitions of terms such as (upper and lower) inflection point. This 
makes it difficult to compare the results of different studies. Since the inflection of a curve is 
a mathematical term that refers to the point of a function where concavity changes direction, 
the use of uniform, objective and reproducible parameters to describe a P-V curve has been 
advocated (Fig. 5.1).6 
The objective of this study was to gain insight into the physiological implication of the P-V 
curve, using a mathematical model.  We hypothesised that objective and reproducible 
parameters to describe a P-V curve could be used to define optimal airway pressure during 
mechanical ventilation. 
Pressure (cm H2O)
Vo
lu
m
e 
(l)
Inflection point (Pinf)
Lower corner pressure (Pcl)
Upper corner pressure (Pcu)
Fig. 5.1: Example of pressure-volume loop characteristics, adapted from 6. 
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METHODS 
The model 
We used the mathematical ARDS lung model as described by Hickling,7 which we modified 
to include air trapping, degree of alveolar recruitability, degree of ARDS severity and chest 
wall characteristics. The lungs of a supine patient (15 cm ventro-dorsal diameter) were 
modelled as multiple lung units or 'alveoli', each with an exponential pressure-volume 
relation, resulting in a progressively decreasing lung compliance with increasing lung 
volume.8 The model consisted of 30 compartments, representing  'horizontal slices' of lung.  
Each compartment consisted of 9000 lung units, which encountered a gravitational 
superimposed pressure (Ps) from 0 in the ventral compartment (non dependent zone) to a 
maximal value in the dorsal compartment (dependent zone). Each lung unit was assigned 
an individual threshold closing pressure (TCP), to simulate either alveolar or small airway 
collapse, and a threshold opening pressure (TOP), to simulate reopening. A transmural 
pressure (Ptm) below TCP led to the total loss of volume in the case of alveolar collapse, 
and led to volume maintenance (air trapping) in the case of small airway collapse. We 
performed simulations with alveolar closure only, as well as with 25% of airway closure and 
75% of alveolar closure. Small airway volume was ignored. The mechanical characteristics 
of the chest wall were included in the model, by calculation of chest wall recoil pressure 
(Pcw) at the instantaneous total lung volume (V), assuming chest wall characteristics 
adopted from Grassino et al.9 Airway pressure was computed (under no-flow conditions) as 
 
Paw=Ptm+Ps+Pcw  (1) 
 
The extent of atelectasis (%atelectasis) and overstretching (%overstretching) was 
determined at each static lung condition. %Atelectasis was determined from the proportion 
of closed units to total recruitable units. An alveolus was assumed to be overstretched when 
its volume exceeded 98% of its volume at infinite pressure (achieved at a transmural 
pressure of 23.3 cm H2O). The sequential steps of each simulation were: Ptm was fed into 
the computer model; the status (open/closed) was determined per alveolus; individual 
alveolar volume was computed and summed to total lung volume; Pcw and subsequently 
Paw were determined. Finally, the degree of atelectasis and overstretching was computed. 
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Table 5.1. Threshold opening (TOP) and threshold closing (TCP) pressures used in the model 
ARDS grade TOP mean (sd) (cm H2O) TCP mean (sd) (cm H2O) 
0 4.5 (2) 2 (2) 
25 10 (2.9) 2.5 (2.4) 
50 14.5 (3.8) 4.5 (2.9) 
75 20 (3.8) 8 (3.4) 
100 24.5 (4.8) 13 (3.8) 
 
Simulation of ARDS severity 
The degree of ARDS severity was simulated, on a linear scale from 0 (healthy lungs) to 100 
(severe ARDS). Ps increased linearly with ARDS severity, ranging from 0.23 cm H2O per cm 
height in healthy lungs to 0.69 cm H2O/cm in the most severe ARDS.10 In the simulation of 
healthy lungs, this led to a superimposed pressure ranging from 0 cm H2O in the non 
dependent lung zones to a maximum of 3.3 cm H2O in the most dependent lung zones. In 
the most severe ARDS, superimposed pressure ranged from 0 cm H2O to a maximum of 10 
cm H2O in the most dependent regions of the lung. The TOP and TCP had a Gaussian 
distribution, with their mean and standard deviation depending on ARDS severity (Table 
5.1). Values for TOP and TCP were adopted from Crotti et al.11 Negative values for TOP and 
TCP were eliminated, and TCP could not exceed TOP in all lung units. In addition, the 
degree of lung volume recruitability ranged from 100% in healthy lungs to 60% in ARDS 
grade 100. A non-recruitable lung unit remained closed at all time. A linear vertical gradient 
was chosen for the distribution of non-recruitable lung units, with the largest number in the 
lowermost part of the lungs. 
Static pressure-volume curve 
Starting with all recruitable lung units open, zero end-expiratory pressure (ZEEP) was 
applied. Then, Paw was increased in steps of 0.5 cm H2O to 50, and decreased to ZEEP, in 
steps, to determine the static pressure-volume (P-V) relation of the model lung. Functional 
residual capacity (FRC) was determined. The P-V curve shape was characterised by fitting 
the P-V curve to a predefined sigmoid equation and secondly by using this equation to 
extract the following characteristic points for both inflation and deflation limbs : the lower 
corner pressure (Pcl), where compliance increased significantly; the pressure at the 
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inflection point (Pinf), where the curve changes from convex to concave; and the upper 
corner pressure (Pcu), where compliance substantially decreased (Fig. 5.1). Percentage 
atelectasis and overstretching were determined at each lung condition. 
Sustained inflation and tidal inflation 
Safe airway pressures were determined atelectasis and overstretching were limited: starting 
with all recruitable lung units open, ZEEP was applied. Paw was increased to the sustained 
inflation pressure (Psi) when the lungs were deemed adequately recruited (%atelectasis less 
than 2.5%). From Psi, the minimal safe end-expiratory pressure (PEEPmin: %atelectasis 
less than 5%) was determined. A tidal inflation was then simulated, increasing Paw to the 
maximal safe plateau pressure, (Pplat,max) during tidal ventilation, defined as the Paw 
where overstretching was maximal 5% or where more than 50% of the atelectatic lung units 
at PEEPmin had been recruited. The volume increase between PEEPmin and Pplat,max 
was the maximal acceptable tidal volume (VTmax). 
Prediction of safe airway pressures 
The predictive value of the P-V characteristics obtained from the inflation (I) and deflation 
(D) limbs as potential determinants of safe airway pressures was investigated in accordance 
to the atelectasis and overstretching criteria. The inflation characteristics were compared to 
the obtained sustained inflation pressure Psi. Both inflation and deflation P-V characteristics 
were compared to the safe minimal (PEEPmin) and maximal (Pplat,max) pressures for tidal 
ventilation.  
Data analysis 
Data are presented as means + standard deviation, or as median [interquartile range] when 
data were not normally distributed. Wilcoxon signed rank test was used to compare means, 
Pearson bivariate correlation test was used to assess the relation between variables. P<0.05 
was considered to be significant. Precision and bias of P-V characteristics as estimators of 
several airway pressures (e.g. PEEPmin) were calculated according to Bland and Altman.12 
Characteristics of the static pressure – volume curve 
ARDS grade 100
-40 -20 0 20 40 60
Pressure (cm H2O)
vo
lu
m
e 
(l)
chest wall
respiratory system lungs
6
3
0
healthy lung
-40 -20 0 20 40 60
Pressure (cm H2O)
vo
lu
m
e 
(l)
chest wall
lungsrespiratory system
6
3
0
Fig. 5.2: Examples of pressure-volume relationships of the components of the simulated respiratory 
system for the simulated healthy lung (left panel) and severe ARDS (right panel). Dotted line indicates 
FRC. Thick solid line indicates volume above FRC. Pressure for the respiratory system is equivalent 
to airway pressure, pressure for the modelled lungs is equivalent to transpulmonary pressure and 
pressure for the modelled chest wall is equivalent to pleural pressure.
RESULTS 
Static P-V curve 
Figure 5.2 displays the pressure-volume relationship of the chest wall and lungs in the case 
of healthy and severely injured lungs. In severe ARDS, FRC is markedly reduced; the 
pulmonary P-V curve (Plungs-V) is shifted to the right, due to increased TOP and Ps. The 
chest wall curve (Pcw-V) had a biphasic shape: exponential at low lung volumes and linear 
at higher lung volumes. In the healthy lungs, Pcw-V is linear above FRC, and the non-linear 
shape of the total P-V curve (Paw–V) is mainly determined by the lungs component. In 
severe ARDS, the Paw-V curve shape has changed, firstly, by the non-linear Pcw-V relation 
at low airway pressures on account of the lower FRC, and secondly, by the right-shifted 
Plungs-V curve. Interestingly, the total P-V curve shows a lower corner point around 20 cm 
H2O, whereas there is no clear inflection nor a lower corner point in the transpulmonary 
curve above FRC. 
For all 20 simulations, a static P-V curve with an inflation and deflation limb was obtained, 
and the P-V characteristics calculated (examples in Fig. 5.3). FRC decreased from 2688 + 8 
ml in the healthy lungs to 1977 + 71 ml in ARDS grade 100 (p<0.01, r=-0.98). Average 
values for Pcl, Pinf and Pcu for both inflation and deflation limbs are presented in Table 5.2. 
These characteristics were found at significantly (p<0.05) lower values on the deflation limb 
than on the inflation limb, showing the hysteresis of the modelled lungs. There was a  
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Fig. 5.3: Static pressure-volume curves (healthy 
lung (top left), ARDS grade 50 (top right) and 100 
(bottom left), complete recruitability), with maximal 
Paw of 60 cm H2O (solid lines). Pressure-volume 
characteristics (closed circles: inflation limb, open 
circles: deflation limb) are determined on this 
curve. Then, from ZEEP, inflation is initiated to Psi, 
with subsequent reduction of Paw to ZEEP (dotted 
line). 
 
positive correlation with ARDS grade for most variables: Pcl,I increased from 0 in grade 0 to 
17 in grade 100 (r=0.97); Pinf,I from 15 to 30 (r=0.93); Pcu,I from 29 to 43 (r=0.79); Pcl,D 
from 1 to 6 (r=0.84). Degree of recruitability changed some of the characteristic pressures: 
with decreasing recruitability, Pcu,D and Pinf,D decreased (r=0.52 and 0.84 respectively), 
while Pcl,I increased (r= -0.46). Airway closure did not significantly influence the P-V 
characteristics included in our analysis, although it influenced P-V slope. In small airway 
closure, FRC was significantly higher compared to alveolar closure alone (2407 + 254 ml vs 
2363 + 273 ml, p< 0.01). Pressure-volume characteristics were also assessed for the 
transpulmonary pressure (Plungs) – volume curve, where Plungs = Ptm+Ps = Paw-Pcw. 
Pinf,I for the Plungs-V curve was not different from the Paw-V curve while Pcl,I was slightly 
higher (1 + 1 cm H2O). All other Plungs-V characteristics were at slightly lower Paw (2 + 2 
cm H2O)   (and volume) than their Paw-V counterparts (p<0.05, Table 5.2).  
With decreasing recruitability, Pcl,D decreased (p < 0.05, r = 0.85).  
 80 
Characteristics of the static pressure – volume curve 
 81 
Low
er corner point, deflation 
Inflection point, deflation 
U
pper corner point,deflation 
D
eflation 
Low
er corner point, inflation 
Inflection point, inflation 
U
pper corner point,inflation 
Inflation 
C
haracteristics Plungs-V 
curve 
B 
PEEPm
in 
Low
er corner point, deflation 
Inflection point, deflation 
U
pper corner point,deflation 
D
eflation 
Low
er corner point, inflation 
Inflection point, inflation 
U
pper corner point,inflation 
Inflation 
C
haracteristics Paw
-V curve 
A 
1 (3) # 
14 (3) *,#
28 (4) #
 
34 (6) *,#
21 (7) *
9 (7) *,#
 Paw
 m
ean (sd) in cm
 
H
2 O
 
 
13 (8) 
3 (3) * 
16 (3) *
30 (4)
 
36 (7) *
22 (6) *
8 (7) * 
 
Paw
 m
ean (sd) in cm
 
H
2 O
 
 
32 [6 – 59] 
11 [0 –
50]
1 [0 –
41]
2 [0 –
12]
17 [1 –
40]
24 [10 –
75]
 %
atelectasis 
 
5 [5 – 17] 
17 [6 –
54]
3 [0 –
27]
0 [0 –
3]
1 [0 –
6]
16 [1 –
39]
24 [10 –
75)
%
atelectasis 
 
0 [0 – 1] 
0 [0 –
9]
0 [ 0 –
57]
62 [0 –
98]
0 [0 –
71]
0 [0 –
37]
 %
overstretching 
 
0 [0 – 17] 
0 [0 –
1]
0 [0 –
9]
9
[0 –
57]
64 [25 –
98]
4 [0 –
71]
0 [0 –
37]
%
overstretching 
 
0.18 
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(Pearson) 
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0.83
0.71
0.39
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in (p<0.05, Pearson bivariate correlation). #: D
ifference betw
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Table 5.2.  Static P-V characteristics for the Paw
-V (A) and Plungs-V
 curve (B) and optim
al airw
ay pressure (PEEPm
in). Airw
ay pressure, and 
percentage atelectasis and overstretching found at the characteristic points in the static P-V curve and at PEEPm
in. Values are presented as 
m
eans (SD
) or m
edian [range]. Bias: m
ean difference betw
een PE
EPm
in and static P-V characteristic (positive value: above PEEPm
in), lim
its 
of agreem
ent: 2 * standard deviation of differences betw
een PEEPm
in and static P-V characteristic. 
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Fig. 5.4: Static pressure-volume curves (healthy lung (left), ARDS grade 50 (center) and 100 (right), 
complete recruitability) (lower panel) and development of atelectasis and overstretching (upper panel) 
during increase of airway pressure from zero to Psi, followed by a reduction of airway pressure to zero. 
Arrows indicate direction of pressure change. Closed circles indicate PEEPmin, where %atelectasis is 
5%. In severe ARDS (right) this could not be achieved without marked overstretching; here PEEPmin 
was defined as the Paw where %atelectasis equalled %overstretching. With Paw increasing from zeep 
to Psi, lung volume initially increases as the result of volume increase in alveoli that were open at 
ZEEP (FRC). With further increase in Paw, increase in lung volume results of a combination of opening 
of collapsed alveoli and elastic volume increase in open alveoli, at the cost of developing significant 
overstretching. With decreasing Paw from Psi, initially overstretching is reduced, with further 
decreasing Paw atelectasis reoccurs. In the example of severe ARDS (right) with increasing Paw 
during inflation, atelectasis is reduced (A), the volume of reopened lung units abruptly increases toward 
overstretching (B). When Paw is then decreased, initially alveolar opening is maintained (C) with 
concomitant overstretching (D). With further Paw reduction some of the lung units collapse (E), while 
other units reduce their volume but remain open, giving rise to a steep reduction of %overstretching 
(F). 
Sustained inflation and tidal inflation 
Figure 5.4 shows the amount of atelectasis and overstretching in three simulations (upper 
panels), and the course of lung volume (lower panels), during a Paw increase from ZEEP up 
to Psi, and subsequent decrease towards ZEEP. With increasing Paw, lung volume 
increased and atelectasis progressively decreased. When atelectasis reached the 2.5% 
criterion, the amount of overstretched alveoli was already substantial (12 [2–28]%). 
Decrease of Paw initially reduced the amount of overstretching, and finally increased 
atelectasis. Both the volume and atelectasis patterns show the hysteresis of the model lung. 
Psi (mean Psi=31 + 12 cm H2O) increased with ARDS grade (p<0.01, r=0.89). 
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The 5% atelectasis criterion was not achieved without marked overstretching in the most 
severe ARDS grades. In these cases, PEEPmin was defined as the Paw where 
%atelectasis equalled %overstretched. This led to an average PEEPmin = 13 + 8 cm H2O, 
and a median %overstretching 0 [0-17]%. PEEPmin increased with ARDS severity (Fig. 5.5, 
left panel) (p<0.01, r=0.85). Pplat,max initially increased with ARDS severity and 
subsequently decreased (Fig. 5.5, left panel) (NS). The maximal safe tidal volume (VTmax) 
decreased with ARDS severity (Fig. 5.5, right panel) (p<0.01, r=-0.85). In ARDS grades 0 
and 25, reopening of endexpiratory collapsed alveoli (maximum 2.5%) was the limiting factor 
for Pplat,max, whereas in higher ARDS grades, Pplat,max was determined by the threshold 
of overstretching (maximum 5%). 
Prediction of safe airway pressures 
The Paw needed to reduce %atelectasis to 2.5% (Psi) increased with ARDS severity from 
13 to 44 cm H2O. At Psi in severe ARDS 77 + 23% of alveoli were overstretched. Pcl, Pinf or 
Pcu of the inflation P-V limb did not correlate well with Psi. Psi varied from 2 + 0.2 cm H2O 
below Pinf for the healthy lungs to 1 + 2 cm above Pcu in the severest ARDS grades. 
%Atelectasis and %overstretching found at PEEPmin and various characteristic pressures 
of the P-V curve are given in Table 5.2. With exception of Pcu,D, there was a significant 
relation between PEEPmin and each P-V curve characteristic, although the agreement was 
poor evidenced by the bias and wide limits of agreement (Table 5.2). 
If, on the P-V deflation limb, Paw was reduced to a level equivalent to the inflection point on 
the inflation limb of the Paw-V curve, this resulted in %atelectasis of 0 [0 – 8]% and 
%overstretching of 0 [0 – 52]%, indicating that this pressure was sufficient to prevent 
significant atelectasis but may not be the lowest pressure possible to obtain this goal.  
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Fig. 5.5: Right panel: Calculated PEEPmin (closed circles) and Pplat,opt (open circles) plotted against 
simulated ARDS severity. Left panel: Calculated VTmax decrease with increasing simulated ARDS 
severity. 
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Paw, atelectasis and overstretching were lower at deflation limb Pcl, Pinf and Pcu than on 
equivalent inflation limb characteristics (p<0.05).  
Correlation between P-V characteristics and Pplat,max was weak; maximal correlation was 
found for Pcu of the inflation limb of the Paw-V curve (R=0.65, bias of 13, limits of 
agreement between 2 and 24 cm H2O) and Pcu of the inflation limb of the Plungs-V curve 
(R=0.65, bias of 11, limits of agreement between 1 and 22 cm H2O). The difference between 
limits of agreement was lowest for the upper corner point of the inflation limb of the Plungs-V 
curve. Pcl, Pinf and Pcu neither correlated or agreed well with Pplat,max. 
DISCUSSION 
The main finding from this study was that analysis of the static pressure-volume curve did 
not yield robust predictors for either Psi, PEEPmin or Pplat,max. 
The pressure needed to recruit a significant number of previously collapsed alveoli (Psi) 
increased with increasing severity of ARDS, the minimal PEEP needed to avoid significant 
atelectasis (PEEPmin) increased, while the maximal safe plateau pressure (Pplat,max) 
tended to decrease. As a result, the maximal safe tidal volume (VTmax) decreased to levels 
that may be insufficient for adequate ventilation using conventional mechanical ventilatory 
modes. 
The model 
The model used was previously described by Hickling.7,13 We modified this model, in that we 
added variability of ARDS severity with threshold opening and closing pressures as well as 
vertical hydrostatic pressure gradients adapted from the literature.10,11 In Hickling’s papers, 
the lungs were completely collapsed at ZEEP (in fact transmural pressure) and chest wall 
influences were neglected. To be able to inflate the lung from ZEEP, airway pressure –
rather than transmural ZEEP- and to relate volume changes to changes in airway pressures, 
a simulated chest wall with fixed characteristics was added to the model. Impairment of 
chest wall elastic properties may vary with the underlying disease responsible for ARDS.14 
Chest wall compliance may be normal in ARDS caused by pulmonary disease, but is 
markedly decreased in ARDS secondary to an extrapulmonary cause.15 A decreased chest 
wall compliance would lead to an increase of pleural pressure and therefore airway pressure 
at a given transmural pressure or lung volume. As a result, Psi, PEEPmin, lower and upper 
corner points and inflection point would have been found at higher values. The shape of the 
Plungs-V curve is not influenced by changes in chest wall properties. The exact shape of the 
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Paw-V curve however cannot be determined without sufficient data on the low lung volume 
Pcw-Volume curve. Since data on low lung volume chest wall mechanics in humans is 
lacking, variable chest wall mechanics were not incorporated into the model.  
It has been suggested that in ARDS, not only alveolar but also small airway collapse may 
play a role.16 This was incorporated in our model and simulations with alveolar closure only 
and with 75% alveolar and 25% small airway closure were performed. These percentages 
could not be based on the literature and were chosen arbitrarily.  
Although in early ARDS it is claimed to be possible to recruit lung volume to a point were 
there is little or no atelectasis and optimal gas exchange,17 this may be impossible in ARDS 
that has existed for a longer period with associated ventilator induced lung injury. In the 
fibroproliferative phase of ARDS, deposition of elastic system fibres takes place and this 
may contribute to alveolar mechanical dysfunction and remodelling that occur in acute lung 
disease.18 Also, when the prevalent pathology is lung tissue consolidation such as in 
pneumonia, application of pressure should induce only a moderate lung volume recruitment 
and possible alveolar overdistention. We modelled the altered alveolar function as non-
recruitability, with a vertical distribution gradient towards the dependent lung zones. 
Simulations were performed with lungs that could either be completely recruited (as a model 
of early ARDS) as well as with lungs with part of their alveoli not recruitable even at infinite 
airway pressure as a model of damaged or partly fibrotic lungs. In our model, the extent of 
this simulated damage was linearly related to ARDS severity. 
Current knowledge of micromechanics of the injured lung is limited. In order to construct a 
mathematical model, some assumptions (e.g. distribution of alveolar and small airway 
closure, the acceptable amounts of atelectasis, reexpansion of collapsed alveoli and 
overstretching) had to be made. 
In vivo, both recruitment and derecruitment show some time dependence,19 and this was not 
incorporated in our model. Time dependence of recruitment and derecruitment could limit 
the amount of recruitment occurring during a tidal inflation in ARDS. A study of pulmonary 
injury in pigs showed that most of the recruitment during inspiration and derecruitment 
during expiration occurred within 1.4 second,20 a finding supported by others.21 We studied 
the influence of pressure at static end inspiration and expiration in the static P-V manoeuvre 
and tidal ventilation at no flow conditions and assuming extremely long inspiration and 
expiration. At low frequencies, stress relaxation in the viscoelastic elements is essentially 
completed at end inspiration and inertive contribution to respiratory mechanics is 
negligible.22,23 Resistive contribution to respiratory mechanics is most evident at low 
frequencies.24 Since at no-flow the influence of resistance is eliminated, and assuming 
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viscoelastic time constants of approximately 1.5 second we believe that our model is 
realistic for mechanical ventilation at low rates (e.g. below 10 breaths.minute-1) and can be 
used to generate hypotheses that could be tested clinically. Although methodologically 
superior, incorporation of frequency dependent viscoelastic properties into our model would 
have significantly complicated the model used. With extrapolation of our findings to higher 
ventilatory frequency ranges therefore, the increase of inertia and decrease of viscoelastic 
effects should be taken into account. 
Static pressure-volume curve 
As is illustrated by figure 5.2, changes of slope of the Plungs-V curve (which may be seen 
as the lower corner point and inflection point) were found at lung volumes at or below FRC, 
at negative airway pressures.  Since the Paw-V curve does show a clear lower corner point 
around 20 cm H2O, this means that the lower corner point of the Paw-V curve may represent 
a chest wall property rather than a characteristic of the lung. At low lung volumes, chest wall 
compliance is minimal, pleural pressures are negative and Pcw-V relationship is 
exponential. At higher lung volumes in the range of vital capacity, the Pcw-V relation is more 
linear. This results in a biphasic Pcw-V curve with a change in curvature at low lung 
volumes, as can be seen in figure 5.2. Our model was not exposed to negative airway 
pressures and only P-V curves at volumes at or above FRC were analysed. The Plungs-V 
curves did not display a symmetrical biphasic shape, whereas the used fit method assumed 
such a pattern. Quantification of the effect of this on the accuracy of the fit is beyond the 
scope of this study, but has been addressed by Harris et al.;6 the calculation of Pinf is not 
affected, yet Pcl and Pcu may be affected and calculated values that fall outside the range 
of available data should be disregarded. In all calculations we performed, Pcl for the Plungs-
V curve was found outside the range of available data and below FRC. This warrants care in 
the use of Pcl for the Plungs-V curve. 
With increasing Paw from ZEEP, volume initially increased while atelectasis was more or 
less constant as is illustrated by figure 5.4. Initial volume increase was the result of elastic 
alveolar volume increase rather than volume increase due to opening of previously 
collapsed alveoli. In general, the lower corner point has been regarded as the opening 
pressure of noncompliant, dependent alveoli.2 This is not supported by our results. The 
lower corner point or ‘lower inflection point’ is influenced by a number of factors, including 
chest wall elastic properties.14 In our model, most alveolar recruitment occurred around the 
inflection point of the P-V inflation limb. In severe ARDS, significant recruitment of collapsed 
alveoli may take place above Pcu,I. The upper corner point is thought to be the point at 
Characteristics of the static pressure – volume curve 
 87 
which parts of the lungs become overdistended. In our model, alveolar overstretching was 
present throughout the inflation limb of the P-V curve –depending on the severity of disease- 
and became substantial in all simulations, except the simulation of the healthy lung, between 
Pinf and Pcu. Alveolar volume and overstretching is related to absolute Plungs. With 
increasing ARDS severity Pinf and Pcu will shift to higher values and thus do not relate to 
the development of alveolar overstretching. The phenomenon where alveolar recruitment 
and lung overinflation can be observed simultaneously in different parts of the lung 
parenchyma after PEEP administration has been demonstrated by CT findings.25 A 
decreasing rate of recruitment during inflation can create an ‘upper inflection point’ which is 
unrelated to overdistention.7 Our results show that the inflation characteristics of the Paw-V 
curve are not uniquely related to alveolar recruitment and overdistention. 
Following complete alveolar recruitment, decreasing Paw resulted in reduction of lung 
volume, initially with a decrease of alveolar overstretching while alveoli remained open. In 
other words, the pressure-volume relationship, but also pressure-atelectasis and pressure-
overstretching display hysteresis. As a consequence, a procedure aimed at opening 
collapsed alveoli may facilitate subsequent reduction of Paw with avoidance of atelectasis, 
overstretching and high Paw.  
Between the upper corner point and inflection point of the deflation limb, significant 
overstretching decreased, while significant atelectasis reappeared in the pressure range 
between Pinf and Pcl.  
Sustained inflation and safe tidal volume 
We defined Psi as the inflation pressure needed to obtain less than 2.5% (recruitable) 
atelectasis and PEEPmin as the end-expiratory pressure where at most 5% recruitable 
alveoli were collapsed. These criteria were chosen arbitrarily. It is believed that significant 
end-expiratory atelectasis plays a role in the development of ventilator induced lung 
injury26,27 and there is evidence that sufficient PEEP should be applied to ‘keep the lung 
open’ and to prevent tidal recruitment.4,17,28,29 It is not known however, which threshold of 
atelectasis may be considered acceptable or safe. Healthy subjects, following induction of 
anaesthesia, develop 5% atelectasis or more. In our simulations we arbitrarily regarded 5% 
end-expiratory atelectasis as the upper limit for defining PEEPmin, having previously 
simulated a sustained inflation to recruit all but 2.5% of recruitable alveoli. There was no 
benefit in increasing recruitment pressure above this point, since alveoli with high opening 
pressures also had high closing pressures and thus collapsed during tidal deflation, unless 
very high PEEP was applied. 
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In severe ARDS, with high closing pressures, high PEEP was needed to prevent significant 
alveolar collapse. When recruited, the increase in alveolar volume was immediate to a value 
appropriate for that transalveolar pressure, and when pressure was subsequently reduced 
below the threshold closing pressure, the alveolus abruptly collapsed.8,13,30 As a result, in 
situations with high threshold closing pressures, an open alveolus will have a high volume; 
alveoli with excessive threshold closing pressures were either collapsed or overstretched. 
When end-expiratory collapse and tidal overstretching were to be avoided, in severe ARDS, 
high PEEP was needed, while the safe maximal plateau pressure seems to be related to the 
hyperinflation pressure that is relatively constant. In our model, with increasing severity of 
disease, PEEPmin increased, Pplat,max remained constant, and as a result the maximal 
safe tidal volume decreased (Fig. 5.5) to a level at which CO2 removal with conventional 
mechanical ventilation may not be adequate. If the assumptions in our model are correct, 
this finding suggests that a ventilation mode with smaller tidal volumes may be of benefit, 
such as high-frequency oscillatory ventilation, especially in severe ARDS. Clinical trials are 
needed to clarify whether this hypothesis is correct. 
Prediction of safe airway pressures 
It has been proposed to use the pressure-volume curve as a guide for optimal ventilatory 
settings at bedside, with the goal of limiting lung damage related to mechanical ventilation.2,4 
Several variables can be identified. The shape of this curve is described, in ARDS, as 
having three main segments; a segment with minimal compliance, an intermediate segment 
of maximal compliance, and a final segment where compliance is reduced again.3 We 
analysed the limits of each of these segments (Pcl and Pcu) and a point on the segment 
with maximal compliance (Pinf ) on their value as a guide to adjust ventilator settings.  
A pressure 2 cm H2O above the lower corner point of the inspiratory limb has been 
advocated as a predictor of minimal required PEEP,2,4 whereas others found this point to be 
a poor predictor of alveolar closure.31 In our experiments, we found median PEEPmin 5 cm 
above Pcl, with limits of agreement between 3 cm H2O below Pcl and 13 cm H2O above Pcl, 
depending mainly on the severity of ARDS. In general, correcting for the bias (difference 
between actual and measured value) can enhance precision of a measurement method or 
indicator, but accuracy (the limits of agreement) can not be enhanced by numerical 
correction since it represents a non-systematic error. Intuitively, it seems that PEEPmin 
should be related to maintenance of alveolar volume and hence threshold closing pressures. 
We therefore expected that the deflation limb characteristics would be more related to 
PEEPmin than would inflation limb characteristics, as is supported in the literature.3,13 The 
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good correlation between inflation characteristics and PEEP min reflects the fact that the 
range of TOP, Ps and TCP were related to ARDS severity. The inflation characteristics are 
mainly determined by TOP, and PEEPmin by TCP and Ps. Alterations of the relationship 
between TOP and TCP  and  Ps in the model would have altered the relationship between 
inflation characteristics and PEEPmin.  
 
Since optimal PEEP and tidal volume, especially in severe ARDS, are compromises 
between atelectasis and overstretching, and pulmonary and cardiovascular function, one 
single value of best PEEP probably does not exist but rather is represented by a range of 
pressures. Our findings support the finding that neither the ‘lower’ nor the ‘upper’ inflection 
point’ provides reliable information to determine safe ventilator settings in the acute 
respiratory distress syndrome. Recruitment probably continues throughout the inflation 
pressure-volume curve and studies of the deflation pressure-volume curve, reinflations after 
partial deflation, or decremental PEEP trials after a recruitment manoeuvre are needed to 
determine optimal open-lung positive PEEP.32 Other than measuring lung volume, variables 
like cardiac output, shunt, arterial oxygenation, blood pressure or lung compliance 33 may 
yield superior indicators of optimal airway pressures during mechanical ventilation. Systems 
that can be used at the bedside and that integrate measurement of respiratory system 
mechanics and cardiovascular effects of ventilation may aid in the determination of optimal 
ventilator settings.34,35 
 
In conclusion, static pressure-volume characteristics in our model proved to be moderate 
estimators of Psi, PEEPmin and Pplat,max. This may mainly be caused by the fact that the 
effects of alveolar recruitment and collapse, elastic volume changes and alveolar 
overstretching mutually influence the shape of the P-V curve, and the individual contribution 
is lost in the shape of these curves. In contrast to our findings, in clinical studies static P-V 
curve characteristics was considered to reflect optimal PEEP . This may be caused by the 
fact that these studies were performed on patients suffering from severe ARDS and hence 
comparable threshold opening and closing pressures. Our study demonstrated that the 
relation between PEEPmin and static P-V curve characteristics however is not fixed and 
depends mainly on severity of ARDS. 
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SUMMARY 
Objective: To evaluate abdominal and rib cage breath-to-breath displacement during a 
stepwise decrease of mean airway pressure (mean Paw) following a lung volume 
recruitment procedure in surfactant-depleted piglets during high-frequency oscillatory 
ventilation (HFOV).  
Design and setting: Prospective, observational study in a university research laboratory. 
Animals: Eight piglets weighing 12.0 ± 0.5 kg, surfactant depleted by lung lavage. 
Interventions: In each piglet, a quasi-static pressure volume loop was constructed and 
compliance of the respiratory system calculated. After initiation of HFOV, lung volume was 
recruited by slowly increasing Paw to 40 cm H2O. Then, mean Paw was decreased in steps 
until PaO2/FiO2 was below 100 mm Hg. Proximal pressure amplitude remained constant. 
Measurements and main results: At each setting, arterial blood gases were obtained and 
physiological shunt fraction calculated. Abdominal (VT,A) and rib cage (VT,R) tidal 
displacement was determined using respiratory inductive plethysmography (RIP). During 
HFOV, there was maximum in tidal volume (VT, determined by calibrated RIP) in seven of 
eight piglets. At maximal mean Paw, VT,A and VT,R were in phase. Phase difference 
between VT,A and VT,R increased to a maximum of 178 + 28 degrees at minimum mean 
Paw. VT,A remained relatively small (0.71 + 0.17 ml/kg). VT,R increased from 1.6 + 0.4 ml/kg 
to 3.3 + 1.1 ml/kg. A minimum in VT,A and a maximum of VT was found near the optimal 
mean Paw, defined as the lowest mean Paw where shunt fraction is below 0.1. 
Conclusions: During HFOV, rib cage and abdominal motion displayed a significant airway 
pressure dependent asynchrony. Maximal VT and minimal VT,A coincided with optimal 
respiratory system compliance, oxygenation and ventilation, suggesting a potential clinical 
relevance of monitoring VT and abdominal displacement during HFOV.  
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INTRODUCTION 
Lung injury may be augmented by mechanical ventilation of patients with acute respiratory 
distress syndrome when large tidal volumes are used (volutrauma) or at low end-expiratory 
lung volume (atelectrauma).1-6 High-frequency oscillatory ventilation (HFOV) is a ventilatory 
mode in which a small tidal volume (1-2 ml/kg) is administered at a high frequency (5-15 Hz, 
300-900 breaths/min). The mean airway pressure, referred to as continuous distending 
pressure (CDP) mainly determines lung volume and oxygenation. Ventilation is provided by 
the oscillations. The level of CDP applied is a major determinant of patient outcome.7,8 
Today there is no clinical monitoring tool to determine the optimal level of applied CDP, 
other than via indirect parameters, i.e. blood oxygenation and arterial blood pressure. 
Previously, we have described the use of the oxygenation index, physiologic shunt fraction, 
electrical impedance tomography and tracheal pressure amplitude measurements as 
estimators of optimal CDP during HFOV.9-12 Electrical impedance tomography is not yet 
available as a clinical tool. Measurement of tracheal pressure requires introduction of a 
pressure transducer into the endotracheal tube and pressure measurement in the trachea is 
sensitive to mucus and fluid accumulation on the sensor. Calculation of the oxygenation 
index is clinically available, but the results may not be available instantaneous at the 
bedside. In search of an easy applicable method that may give instantaneous 
measurements at the bedside we assessed the use of respiratory inductive 
plethysmography (RIP) during HFOV. 
Respiratory system compliance (Crs), the ratio of tidal volume and pressure amplitude, was 
proposed as an indicator to adjust conventional mechanical ventilation (CMV) at safe airway 
pressures.13-,15  Maximal Crs coincides with the occurrence of minimal atelectasis and 
minimal overdistention. During HFOV there is no clinically acceptable method to determine 
the tidal volume. Tidal volume displacement of the lung leads to displacement of two 
compartments; the rib cage and abdomen. RIP is a non-invasive technique to measure lung 
volume changes. RIP is based on the principle that the chest wall has two compartments, 
the rib cage and abdomen. Each compartment is associated with a single motion variable 
that can be measured with external sensors (RIP), and the sum of both variables can be 
calibrated against a known volume change to provide volumetric measurements.16 This 
method has been used to estimate mean lung volume changes during HFOV.17,18 We 
hypothesised that monitoring of rib cage and abdominal displacement may also be used for 
breath-to-breath analysis during HFOV and that maximal tidal motion of the respiratory 
system components would reflect maximal respiratory system compliance when a constant 
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pressure amplitude is administered to the airway opening. If this is valid the monitoring of rib 
cage and abdominal motion using RIP during HFOV may aid in adjusting ventilator settings 
during HFOV. 
MATERIAL AND METHODS 
Animal preparation 
All animal experiments were performed according to the Guide for the Care and Use of 
Laboratory Animals, published by the National Institutes of Health (NIH publication 85-23, 
revised 1985) and approved by the Animal Care Committee of Erasmus University 
Rotterdam, The Netherlands. 
Eight Yorkshire piglets (12.0 ± 0.5 kg body weight) were anaesthetised with a sodium 
pentobarbital (30 mg.kg-1) bolus followed by a continuous infusion (8.5 mg.kg-1.h-1). The 
piglets were ventilated through a tracheal cannula in a volume controlled mode using a 
ventilator allowing for lung volume estimation by the open helium washin method.19 
Frequency was 10 breaths per minute, FIO2 1 and PEEP 5 cm H2O. I:E ratio was 1:1, with an 
inspiratory pause of  0.6 s. VT was adjusted to achieve normocarbia (PaCO2 38-45 mm Hg). 
An arterial line was inserted in the aorta for measuring aortic blood pressure (Pao). A four-
lumen catheter was inserted into the superior vena cava to measure central venous 
pressure (Pcv) and to infuse fluids (5 ml.kg-1.h-1 saline) and anaesthetics. All pressure 
catheters were flushed (3 ml.h-1) with normal saline containing 10 I.U. ml-1 heparin. The 
bladder was catheterised to retain urinary output. After the surgical procedures pancuronium 
bromide (0.3 mg.kg-1.h-1) was given to suppress spontaneous breathing. Repeated lung 
lavages were applied with 35 ml.kg-1 saline until PaO2 was below 80 mm Hg.20 PEEP was 
set at 2 cm H2O.  
Respiratory inductive plethysmograph 
Respiratory inductance plethysmography was applied to assess rib cage and abdominal 
motion. Before lung lavage, a thoracic gauge was placed 4 cm above the xiphoid processus, 
an abdominal gauge 4 cm above the umbilicus. Both gauges were then secured by stitches 
and the position of the gauges was checked at the end of experiments. The distension of the 
abdominal (RIPabd) and ribcage (RIPrc) gauges, and airway pressure were sampled at 200 
Hz and stored for offline analysis. RIP was calibrated to lung volume using the Qualitative 
Diagnostic Calibration (QDC) method.  VT was estimated by means of calibrated RIP. 
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Measurements and lavage procedure 
Baseline measurements were performed during conventional ventilation (CMV) after lavage 
(postlavage measurements). Arterial blood gas samples were analysed with ABL3 and 
OSM2 hemoximeters (Radiometer, Copenhagen, Denmark). Respiratory system compliance 
was derived according to Crs = VT/(Pplat – PEEP) with Pplat the plateau pressure. In addition, 
the functional residual capacity (FRC) of the lungs was estimated using an open helium 
washin method. A pressure-volume manoeuvre was performed to construct a quasi-static 
PV curve of the respiratory system. Following exposure to ambient pressure, the lungs were 
manually inflated in steps of about 3.5 ml.kg-1 air with 3-4 s. pauses up to an airway 
pressure of 40 cm H2O, followed by deflation in similar steps. Airway pressure was 
measured at the airway opening (Viggo-Spectramed DT-NN, Oxnard, CA). After insertion of 
an endotracheal tube, HFOV (SensorMedics 3100A, Yorba Linda, CA, USA) was initiated 
with a frequency of 8 Hz, an inspiratory time of 33% and bias flow of 20 L/min. These 
settings were kept constant during the experiment. Initial CDP was set 3 cm H2O higher than 
the mean airway pressure during CMV. Proximal pressure amplitude was set at 54 ± 6 cm 
H2O, and kept constant during the experiment.  
After the experiment the tube was removed and CMV was resumed at the initial settings. 
After a 30 minutes stabilisation period the postlavage measurements were repeated (end 
experiment measurements) to check stability of the model.  
Experimental procedure 
CDP was increased in 3 cm H2O steps to 40 cm H2O to obtain total lung recruitment. CDP at 
PaO2 of 450 mm Hg was defined as CDPopen. Next, CDP was lowered to CDPopen and then 
lowered in 3 cm H2O steps until PaO2 was below 100 mm Hg. At each CDP, RIPabd and 
RIPrc, blood gases, and blood pressures were measured after a 10 minute stabilisation 
period. 
Data analysis 
To mathematically describe the deflation quasi-static PV curves, the individual curves were 
fitted to a sigmoid equation as described by Venegas and Harris.21,22 Mean curves were 
determined by averaging the fit parameters. Amplitudes were determined from the rib cage, 
abdominal and total RIP signal, calibrated with QDC. The phase difference between the 
proximal airway pressure, rib cage and abdominal signal were determined, by application of 
the maximal linear correlation method to the first harmonic of the signals.23 Data are 
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Table 6.1: Physiological variables during conventional mechanical ventilation. Values at end 
experiment were tested against postlavage. Data are represented as mean (SD). 
 Prelavage Postlavage End experiment 
PaO2/FIO2 (mm Hg) 490 (48) 60 (11) 96 (61) 
Q'S/Q'T 0.01 (0.02) 0.46 (0.08) 0.39 (0.14) 
PaCO2 (mm Hg) 42 (2) 52 (5) 60 (8) * 
Crs  (ml.cm H2O –1.kg-1) 1.20 (0.16) 0.54 (0.06) 0.55 (0.07) 
Q'T (ml.s-1.kg-1) 1.9 (0.3) 1.9 (0.4) 1.9 (0.5) 
Pao (mm Hg) 90 (9) 85 (12) 83 (18) 
Ppa  (mm Hg) 16 (2) 26 (5) 32 (6) * 
Pcv  (mm Hg) 4.3 (0.9) 4.2 (1.2) 3.7 (1.1) 
heart rate (min-1) 171 (18) 119 (16) 154 (40) * 
*: p<0.05. 
 
presented as means + SD. Data with normal distribution were compared using Student’s t-
test. The CDP values were compared using the Wilcoxon signed rank test. P < 0.05 was 
accepted as statistically significant. 
RESULTS 
Lung lavage produced a large increase of Q’S/Q’T, and a decrease of Crs. Comparison of the 
baseline measurements postlavage and end experiment revealed statistically significant 
increases in PaCO2, Ppa and heart rate (Table 6.1). 
During the recruitment phase of HFOV, CDPopen was 29 ± 3 cm H2O. CDP was decreased 
from 40 cm H2O to CDPopen and then decreased in steps to 9 ± 1cm H2O. In the first 
experiment oxygenation deteriorated rapidly when CDP was lowered from 10 to 7 cm H2O; 
only part of the measurements could be completed before we increased CDP. In the 
following seven experiments we performed smaller CDP decrements (1-2 cm H2O) at the 
end of the deflation phase. 
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Fig. 6.1: Results in one subject. Quasi-static pressure volume curve of the respiratory system (A). Solid 
line represents fitted curve data as described by Venegas and Harris. Compliance curve (B) was 
constructed from the pressure volume curve. 
BAA 
Inflation phase: PaO2 increased substantially from 55 ± 12 to 525 ± 37 mm Hg. Q’S/Q’T 
decreased from 0.53 + 0.10 at initial CDP of 17 + 2 cm H2O to 0.06 + 0.03 at maximal CDP 
of 40 cm H2O. Deflation phase: Oxygenation did not change significantly until CDP = 13 ± 4 
mm Hg and then decreased to 90 ± 131 mm Hg. Q’S/Q’T increased 0.06 ± 0.03 to 0.61 ± 
0.20. PaCO2 decreased from 82 ± 11 to 43 ± 5 mm Hg at CDP = 18 ± 2 cm H2O, remained 
constant until CDP = 13 ± 4 mm Hg and in six animals increased again.  
PV curve and RIP 
An excellent fit was found between the sigmoid model and the PV curve (r2 from 0.9987 to 
0.9994) (example in Fig. 6.1A). Crs was computed from the fitted PV curve (Fig. 6.1B). From 
the averaged fit parameters, a PV curve was constructed (Fig. 6.2A), and Crs calculated 
from this curve (Fig. 6.2B). Maximal Crs was 1.5 ± 0.4 ml/cm H2O/kg and was found at 12.5 ± 
1.9 cm H2O. Typical patterns of the RIP signals at maximal and minimal CDP are shown in 
Fig. 6.3. The relative amplitude and phase of the rib cage and abdominal signal depend 
largely on the imposed CDP. The total RIP signal is CDP dependent as a consequence of 
the phase difference of the individual signals.  
Rib cage motion was significantly larger than abdominal motion (Fig. 6.2 C and D). In 
addition, rib cage amplitude increased twofold with decreasing CDP. Abdominal amplitude 
was characterised by a nadir (0.35 ± 0.18 ml/kg) at a CDP of 13.8 ± 2.1 cm H2O, and was 
significantly different from the initial value (0.71 ± 0.17 ml/kg).  
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Figure 6.2: Averaged quasi-static respiratory system pressure volume curve (A), following lung volume 
recruitment. The sigmoid curve was constructed by using the average curve fitting parameters for of the 
eight piglets for the deflation limb, according to the equation V = a+b/(1+e-(P-c)/d)) with V=volume, 
P=airway pressure and a, b,c and d the parameters obtained from the fitting procedure.36 Symbols 
represent pressure and volume at pressure of maximal compliance (square) and at maximal airway 
pressure reached (circle) for individual PV curves. Average respiratory system compliance (Crs; B) was 
calculated from the averaged quasi-static PV curve. Symbols represent pressure and compliance of 
each subject at maximal compliance (square) and maximal airway pressure reached (circle). 
Respiratory inductive plethysmograph estimated displacement of abdomen (∆AB; C) and rib cage 
(∆RC; D) and respiratory system displacements (VT; E). Phase difference (∆phase); between 
abdominal (AB) and rib cage (RC) movement (F), between proximal airway pressure (Paw) and rib 
cage (G) and abdominal (H) movement. *: Significant difference with value at maximal CDP (p < 0.05). 
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Figure 6.3: Signal amplitudes of Respiratory inductive plethysmograph (RIP) rib cage (thin line) and 
RIP abdominal (thick line) gauges at continuous distending pressure 40 (A) and 10 (B) cm H2O in 
one subject. Summed RIP signal at CDP 40 (C) and 10 (D) cm H2O. Note the reduction in amplitude 
of the summed signal resulting from the phase difference between rib cage and abdominal 
displacement.  Signals are aligned to t=0 msec at maximal airway pressure. 
Table 6.2: Tidal volume at start and end of deflation and at maximal VT in eight piglets. 
 VT at max CDP 
(ml/kg) 
max VT 
(ml/kg) 
CDP at max Vt
(cm H2O) 
VT end 
deflation 
(ml/kg) 
CDP end 
deflation 
(cm H2O) 
piglet 1 2,1 3,0 10 3,0 10 
piglet 2 1,0 1,3 22 0,6 9 
piglet 3 1,6 2,4 25 1,4 8 
piglet 4 1,5 1,7 13 1,4 7 
piglet 5 1,9 2,3 13 2,2 9 
piglet 6 1,8 2,6 13 2,6 9 
piglet 7 1,1 1,2 25 0,4 12 
piglet 8 2,0 2,2 22 2,1 9 
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In one of eight piglets, after initial increase of VT with decreasing CDP no subsequent 
reduction in VT was observed with further decreases of CDP. In the remaining seven 
piglets a clear maximum VT was found (Table 6.2). In these seven piglets VT increased 
significantly from 1.6 + 0.4 ml/kg at a CDP of 40 cm H2O to 2.0 + 0.6 ml/kg (p < 0.05) at 
CDP 19 + 6 cm H2O. With further reduction of CDP to its final value of 9 + 1 cm H2O, VT 
significantly decreased again to 1.5 + 0.8 ml/kg (p < 0.05). Maximal Crs, obtained during a 
PV manoeuvre, of 1.46 + 0.30 ml/kg was found at an airway pressure of 12 + 3 cm H2O, 
which is lower than the CDP coinciding with maximal VT (P < 0.05). 
At CDP of 40 cm H2O rib cage and abdominal motion were in phase, and became 
increasingly out-of-phase to about 180 degrees with decreasing CDP. This phase shift was 
mostly attributed to the abdominal pattern, depicted in the phase lag between Paw and both 
RIP signals (Fig. 6.2F, G and H). 
To assess optimal ventilatory conditions, we determined best CDP, where oxygenation was 
still adequate and CDP was as low as possible to avoid adverse circulatory effects. This 
criterion was previously defined as the lowest CDP where physiologic shunt fraction was just 
below 0.1. With this criterion, best CDP was 14 ± 2 cm H2O (Table 6.3). Abdominal 
amplitude nadir was the best estimator of best CDP. PaCO2 was minimal around this CDP 
(Table 6.3). CDP at maximal VT tended to be higher than best CDP and CDP at maximal Crs 
tended to be lower than best CDP, but the differences did not reach statistical significance. 
DISCUSSION 
The main results of this study are that CDP at maximal VT is a good estimator of best CDP, 
optimal ventilatory conditions coincide with a minimum in abdominal motion, maximal VT 
during HFOV does not reflect respiratory system compliance as determined from a PV 
manoeuvre and relative amplitude and phase of the rib cage and abdominal motion are 
strongly dependent on imposed mean airway pressure. 
We imposed constant proximal airway pressure amplitudes and therefore changes in 
abdominal and rib cage motion reflect changes in respiratory system impedance. Peslin et 
al. have suggested that the human abdomen and rib cage can be modelled as two parallel 
pathways, with elastic, viscous and inertive characteristics.24 The rib cage is a low 
compliance, low inertance, underdamped system with a high resonant frequency, whereas 
the abdomen is a high compliance, high inertance, overdamped system with a low resonant 
frequency.25 
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PaC
O
2  (m
m
 H
g) 
PaO
2  (m
m
 H
g) 
Q
'S /Q
'T  
Abdom
inal am
plitude (m
l/kg) 
Airw
ay pressure (cm
 H
2 O
) 
 
82 (11) * 
525 (37) 
0.06 (0.03) 
0.71 (0.17) * 
41 (1) * 
at m
axim
al 
C
D
P 
50 (8) 
501 (61) 
0.08 (0.03) 
0.60 (0.34) * 
18 (6) 
At m
axim
al 
V
T 
43 (6) 
472 (143) 
0.10 (0.09) 
0.35 (0.18) 
14 (2) 
At m
inim
al 
abdom
inal 
tidal 
displacem
en
t
43 (5) 
509 (40) 
0.07 (0.02) 
0.42 (0.18) 
14 (2) 
At best C
D
P 
46 (3) 
354 (201) * 
0.20 (0.23) * 
0.54 (0.24) 
12 (3) 
At m
axim
al 
C
rs 
Values displayed are m
eans (S
D
. * differences statistically significant (P<0.05) in com
parison to values at best C
D
P. 
50 (6) * 
91 (132) * 
0.55 (0.3) * 
0.62 (0.21) 
9 (1) * 
at m
inim
al C
D
P 
Table 6.3: Physiologic variables during decrem
ental C
D
P steps, at m
axim
al C
D
P, C
D
P w
here tidal volum
e w
as m
axim
al, abdom
inal tidal 
displacem
ent w
as m
inim
al and best C
D
P w
here Q
'S /Q
'T < 0.1 and at end deflation. A
dditionally values at C
D
P equivalent to airw
ay pressure at 
m
axim
al respiratory system
 com
pliance obtained during a PV m
anoeuvre are included. D
ata are presented as m
eans (SD
). C
D
P continuous 
distending pressure, V
T tidal volum
e, C
rs respiratory system
 com
pliance, Q
'S /Q
'T  physiologic shunt fraction, PaO
2 partial arterial oxygen pressure, 
PaC
O
2 partial arterial pressure of carbon dioxide. 
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With decreasing CDP, pulmonary compliance initially increases and impedance decreases 
as a result of release of alveolar overdistention. As a result, the summed displacement of 
abdominal and rib cage would increase. We assume that rib cage compliance also 
increases leading to a decrease in rib cage impedance. Abdominal impedance, dominated 
by its inertance, remains relatively constant. This accounts for the more pronounced 
changes in rib cage displacement and relatively stable abdominal displacement. At optimal 
rib cage compliance, its resonance frequency may approach ventilator frequency applied, 
giving rise to an additional redistribution of chest wall displacement from the abdomen 
towards the ribcage. This would account for the observed decrease in abdominal 
displacement. Our results did however not show coinciding increases in rib cage 
displacement. RIP assumes that ventilation is confined to two compartments, a rib cage and 
abdominal, that can be assessed by two gauges measuring their lateral displacement. 
However, the compartments may also exhibit a cranial displacement,26 indicating a third 
degree of freedom that is not measured using RIP. With increasing mean lung volume, 
outward rib displacement may decrease significantly in favour of cranial displacement, which 
would lead to an underestimation of rib cage displacement at higher lung volumes using 
RIP. This in part may account for the fact that the decrease in abdominal displacement is not 
reflected in a significant increase in RIP estimated rib cage displacement. Furthermore, the 
changes in abdominal displacement were relatively small in comparison to the absolute rib 
cage displacements. The observed decrease and subsequent increase of abdominal 
displacement may thus reflect maximal chest wall compliance.  
  
The pressure-volume curve (PV curve) of the respiratory system has been described as an 
orientation for setting optimal PEEP in patients with acute lung injury and ARDS.27-29 We 
hypothesised that maximal VT would coincide with maximal respiratory system compliance. 
On the basis of the results, we had to reject the hypothesis, since the airway pressures at 
which both variables are maximal differ significantly. The airway pressure at which 
respiratory system compliance was maximal was not statistically different from best CDP, 
but Q'S/Q'T at this pressure had risen significantly to unacceptable high values, precluding its 
use as a clinical estimator of best CDP. 
We used the pressure volume relationship, obtained during a quasi-static PV manoeuvre as 
an estimate for the PV relation during HFOV. It has been suggested that best PEEP can be 
determined from maximal compliance of the PV curve. Recently, it was shown that steady-
state end-expiratory lung volume is not well predicted by the quasi-static P–V curve.30 The 
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consequence is that respiratory system compliance may differ between the quasi-steady 
state and HFOV condition. 
 
Recently VT measurement using a hot-wire flowmeter was validated for use during HFOV. 31-
33 At the time these experiments were conducted, this was not available in our laboratory. 
This technique may be used in future research to measure VT changes during HFOV. In 
contrast to RIP however, it does not measure mean lung volume changes and the relative 
contribution of abdominal and rib cage displacement to respiratory system displacement. 
 
Our study was limited to surfactant depleted paralysed animals. The value of decreasing 
abdominal displacement as an estimator of optimal airway pressure is influenced by the 
relative contribution of lung, rib cage, and abdominal and diaphragmatic impedance. These 
contributions may differ between species as a result of different anatomy. Furthermore, 
increased chest wall impedance itself may be the cause of respiratory insufficiency.34,35 
Further research is needed to assess the biomedical and clinical value of monitoring 
abdominal tidal displacement. 
   
In summary, we demonstrated in seven of eight surfactant depleted piglets the presence of 
a maximum tidal chest wall displacement during HFOV with decremental airway pressure. 
This maximum coincided fairly well with the optimal airway pressure. In addition we have 
shown that, in surfactant depleted piglets, abdominal tidal motion decreases in the pressure 
range where respiratory system compliance, oxygenation and ventilation are optimal. We 
therefore consider monitoring of tidal volume and abdominal tidal displacement during 
HFOV, as potential clinically applicable methods, that may be used bedside, but further 
research is needed to clarify the biomedical and clinical relevance.  
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SUMMARY 
Objective: The objective of this study is to determine the accuracy and precision of 
chemiluminescence and electrochemical nitric oxide (NO) measurements and accuracy of 
NO dosage with electronic mass flow controllers (MFC) versus rotameters during NO 
inhalational therapy.  
 
Methods: NO flow was delivered to a high-frequency oscillator and mixed with ventilator 
flow. NO and NO2 concentrations were measured simultaneously with a standard 
chemiluminescence analyser and a modified electrochemical analyser. Dosage accuracy 
was assessed with gas flows adjusted with either MFC's or rotameters. Accuracy of both 
analysers was validated with both NO and ventilator flow regulated with a MFC.  
 
Results: In dry air, without pulsatile pressure, MFC controlled NO and ventilator flow resulted 
in an accuracy expressed as the ratio of calculated concentration to measured concentration 
(RCM) of 0.995 (CI: 0.983-0.988) when measured with chemiluminescence. When the 
ventilator rotameter was used instead of a MFC, RCM was 0.856 (95% confindence interval 
(CI): 0.835-0.877). With a rotameter for both NO and ventilator flow, RCM increased to 
1.175 (CI: 0.793-1.740) with an increase of confidence interval limits. Chemiluminescence 
was sensitive to humidification of the ventilatory gases (p < 0.05), slightly sensitive to the 
addition of oxygen and to pulsatile pressure (not significant). RCM obtained with the 
modified electrochemical analyser was in close agreement with chemilurninescence RCM, 
although 95% CI were wider with electrochernical analysis.  
 
Conclusions: During high-frequency oscillatory ventilation (HFOV), standard rotameter flow 
control of both NO and ventilator flow results in unpredictable NO concentrations that would 
be clinically unacceptable. When one MFC was used for NO flow control, with ventilator flow 
controlled with a rotameter, this resulted in moderate dosage accuracy. To achieve a still 
higher accuracy, MFC flow control for both NO and ventilator flow is indicated. During 
HFOV, standard chemiluminescence analysers cannot be considered to be the gold 
standard for determination of the NO concentration delivered. Measurement of NO 
concentration may not be mandatory for determination of inhaled NO dose during HFOV, but 
may be used to monitor for unsafe or unwanted events. 
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INTRODUCTION 
Inhalation of nitric oxide (NO) reduces pulmonary artery pressure and increases arterial 
oxygenation by improving ventilation-perfusion matching, without producing systemic 
vasodilatation in newborns with severe persistent pulmonary hypertension of the newborn 
(PPHN),1-3 in children with pulmonary hypertension 4 and in patients with severe adult 
respiratory distress syndrome (ARDS).5 lt has been suggested that NO inhalational therapy 
may be less successful without optimal lung volume management and that some patients 
benefit from combined treatment of inhaled NO and high-frequency oscillatory ventilation.3,6 
lnhalation of gas mixtures containing high concentrations of NO and NO2 can be rapidly 
lethal in humans,7 and long term effects of NO exposure are unknown. Therefore, accurate 
monitoring of NO and NO2 concentrations is considered to be important. Three 
measurement methods are currently in use in intensive care practice: chemiluminescence 
analysis, infrared monitoring and systems based on electrochemical cells. This last method 
has the advantage of relative modest costs. All of these methods may be sensitive to high 
oxygen concentrations, humidity and pressure. These limitations may not always be taken 
into consideration in every set up for NO inhalational therapy. 
The aim of this study was to assess the accuracy of NO dosage with two types of flow 
controllers, as well as the accuracy of chemiluminescence and electrochemical analysis in 
measuring NO concentration during HFOV, in an effort to describe a system for NO 
inhalational therapy with optimal accuracy both for clinical and research purposes. This 
study has been performed as a bench test without involvement of human subjects, enabling 
assessment of the influence of various ventilator settings on the accuracy of NO dosage and 
measurement. 
MATERIALS AND METHODS 
Nitric oxide system set-up 
NO was provided in tanks containing 800 parts per million (ppm) nominal value NO in 
nitrogen (N2) (Linde AG, Düsseldorf, Germany). The certificate of analysis stated an 
analytical value of 796 ppm with a relative accuracy of  + 2%. Using the chemiluminescence 
analyser, we found a NO concentration of 798 ppm. The applied NO concentrations in the 
ventilatory circuit at each ventilator setting were 1, 2.5, 5, 10, 20 and 40 ppm. Dosage 
calculation was based on the measured concentration of 798 ppm, using formula (3) 
(appendix). 
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Fig. 7.1. Schematic drawing of the 
experimental setup. Chem = 
chemiluminescence analyser; electr 
= electrochemical monitor; MFC = 
electronic mass flow controller. The 
oscillator loudspeaker is drawn in 
the centre of the figure. See text for 
explanation. 
NO flow was fed into the inspiratory limb of the patient circuit, just distally from the 
humidifier. Gas was sampled for NO and NOx concentration measurement in the inspiratory 
limb just before the tube connection site (Fig. 7.1). 
Ventilator 
The ventilator used in this experiment was a 3100A HFOV ventilator (SensorMedics Corp., 
Yorba Linda, CA). Frequency and inspiratory fraction were set at respectively 10 Hz and 
0.33 and were not altered. Mean airway pressure (MAP) setting was cycled through 10, 20, 
30 and 40 cm H2O, where ventilator flow was sufficient to obtain these values. Ventilator 
flow was set at 10, 15 or 20 l/min. Pulsatile pressure was set to either 0 or 40 cm H2O. 
Oxygen was set to 21% or 100%. The measurements were performed in dry gas and 
repeated in humidified and heated gas (approximately 95% relative humidity at a 
temperature of 36 oC). Gas concentrations were simultaneously measured with 
chemiluminescence and electrochemical analysers. The tube connector of the ventilator 
circuit remained plugged during measurements. 
Flow controllers 
In NO inhalational therapy, both NO flow and flow of the air-oxygen mixture are regulated 
independently. In our experimental set-up, NO flow was regulated either with a 0-1 I/min 
electronic mass flow controller (MFC) (accuracy, measured at 21 oC room temperature and 
pressure of 101.4 kPa, -0.4% to 0.3% full scale (FS) (F-201C-FA, Bronkhorst Hi-Tec, 
Veenendaal, The Netherlands), or with a standard 0-1 l/min rotameter (accuracy + 10% FS) 
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(SNL 41375 Ln/N2, Brooks, Veenendaal, The Netherlands). Ventilator flow could be 
regulated either by the 0-40 l/min ventilator rotameter (accuracy 2.5 l/min or 10% FS, 
whichever is greater, using air or oxygen at 21 oC and 103.4 kPa) or by a 0-30 l/min mass 
flow controller (accuracy -0.9 to 0.4% FS) (F-201AC-FA, Bronkhorst Hi-Tec, Veenendaal, 
The Netherlands), in which case the ventilator rotameter was bypassed (Fig. 7.1). 
Measurements were performed, comparing the use of a combination of 2 MFC's, the 
ventilator rotameter combined with a MFC for NO flow, and application of two rotameters. 
Humidifier 
A standard humidifier (MR 730, Fisher & Paykel, Auckland, New Zealand) was used in 
conjunction with heater wires in the ventilatory circuit. Temperature was set at 36 oC, heater 
wire delta temperature at -1 oC, resulting in a 1 oC increase in temperature of inspiratory 
gas. This humidifier was bypassed for dry gas measurements. 
Chemiluminescence NO/NOx analyser 
Chemiluminescence is the reference method for automatic measurement of nitrogen oxide 
concentrations in 21% oxygen at ambient pressure and in dry gas.10  In the reactor, NO 
reacts with ozone, the release of photons being detected by a photomultiplier tube. NOx 
measurement is obtained by reduction of the higher nitrogen oxides to NO in a heated (400 
oC) molybdenum converter (3 NO2 + Mo-? 3 NO + MoO3) prior to entrance into the reactor. 
Thus, NO2 is not measured directly, but calculated as the difference between NO and NOx 
measurements. The difference between NOx and NO measurements can be considered as 
a specific NO2 measurement.8 
We measured NO and NO2 concentrations using a standard chemiluminescence analyser 
(CLD 700 AL, Eco Physics, Diirnten, Switzerland) which was calibrated by means of a 
certified reference gas (802 ppm  + 2%, Messer Griesheim, Moerdijk, the Netherlands). 
Calibration was repeated prior to and after completion of the experiment, revealing no signs 
of drift  (<0.1 ppm). The range of measurement is 0.001-100 ppm, 95% response time is 70 
seconds. 
Electrochemical NO/NO2 monitors 
Simultaneous with chemiluminescence analysis, NO and NO2 concentrations were 
measured with an electrochemical combined NO and NO2 monitor (SensorNOx, Sensor 
Medics Europe, Bilthoven, the Netherlands). Ninety- percent response time is less than 30 
seconds. The monitor uses active side stream sampling at a rate of 200 ml/min. Prior to the 
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experiment both NO and NO2 analysers were calibrated against 100% nitrogen (zero 
values), at a NO concentration of 48 ppm and a NO2 concentration of 5 ppm (gas 
calibration). Chemiluminescence validated gases were used to calibrate the electrochemical 
analyser. Calibration was repeated after completion of the experiment, revealing no signs of 
drift  (< 0.1 ppm). 
 
Protocol 
Simultaneous chemiluminescence and electrochemical analysis of NO concentrations 
resulted in two measured NO concentrations or a measurement set. Calculated NO 
concentrations (derived from rotameter and/ or MFC flowrates) were compared to the 
measured concentrations (by chemiluminescence and/or electrochemistry). 
Statistical analysis 
We used the method described by Bland and Altman to evaluate the agreement between 
the calculated and the measured concentrations.9 Individual differences between two 
methods (Di = Xi- Yi) were plotted, against their mean [(Xi + Yi)/2] and the distribution of 
these differences and their relation to the individual means were analysed. Since in this 
study the individual differences increased with their mean, a log transformation of the 
parameters was performed, resulting in a plot of Di = log(Xi) -log(Yi) against log ((Xi + Yi)/2). 
Bias was then calculated as the mean difference (d) and the standard deviation (s) of the 
differences. 95% confidence interval (CI) for the bias was calculated as d + √ (s2/n), where n 
is the sample size and t the appropriate point of the t distribution at p = 0.05 with n -1 
degrees of freedom. The results were related to the original scale of measurement in 
computing their anti-logs. This resulted in a dimensionless ratio, we refer to as the ratio of 
calculated to measured concentration (RCM). Values are expressed as mean, 95% CI limits 
are noted between brackets, unless otherwise noted. The mean RCM is an estimate of the 
systematic error of either calculation (flow) or measurement. The 95% CI width is an 
estimate of the precision of either calculated or measured concentration. Based on these 
calculations (Table 7.1), for each covariate (humidity, oxygen content, HFOV pulsatile 
pressure) the systematic error (Table 7.2) and precision (Table 7.3) of chemiluminescence 
and electrochemical analysis were compared using the Wilcoxon signed rank test. 
Probabilities of less than 0.05 were considered to be significant. 
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RESULTS 
The results are presented in Table 7.1. 153 Measurement sets were obtained from dry gas 
mixtures (Table 7.1, series A-F), 108 sets from humidified gas mixtures (Table 7.1, series G-
J). 
With the use of a MFC both for NO and ventilator flow, a RCM was found of 0.995 indicating 
a mean overestimation by chemiluminescence of 0.5% of the calculated value (series A). 
When the ventilator flow meter was used instead of a MFC for ventilator flow control, a RCM 
of 0.856 was found (series B). When flows were regulated with two rotameters for NO flow 
and ventilator flow control, RCM increased to 1.175 with an increase of confidence interval 
limits (series C). 
Subsequently, the influence of oxygen (comparing series A versus D, E versus F, G versus  
I, H versus J), humidification (series A-G, D-I, E-H, F-J) and pulsatile pressure (series A-E, 
D-F, G-H, I-J) were studied using two mass flow controllers to manage ventilator and NO  
flow. Humidification, and to a lesser and statistical non significant extent pressure and 
oxygen content, resulted in increase of RCM deviation from 1.0 and widening of confidence 
interval limits. There was no significant difference in accuracy (systematic error or bias) of 
chemiluminescence and electrochemical analysis for each covariate, with the exception of  
 
 
 Table 7.2: Systematic error (or bias) of chemiluminescence (chem) and electrochemical analysis 
(electro), calculated  for each covariate. Systematic error is expressed as a percentage of the calculated 
value derived  from MFC NO and ventilator flow.  
 
Covariate Measurement 
sets 
Mean bias 
chem (%) 
Mean bias 
electro (%) 
Significance 
Overall A, D-J -6.6 -9.4 NS (p > 0.05) 
Dry gas A, D - F 0.5 -5.0 S (p < 0.05) 
Humid gas G, H - J -13.6 -13.9 NS (p > 0.05) 
21% O2 A, E, G, H -5.2 -10.1 NS (p > 0.05) 
100% O2 D, F, I, J -8.0 -8.8 NS (p > 0.05) 
No pulsatile 
pressure 
A, D, G, I -6.4 -8.3 NS (p > 0.05) 
Pulsatile pressure E, F, H, J -6.7 -10.6 NS (p > 0.05) 
NS, difference not statistically significant; S, difference statistically significant. 
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Table 7.3: Precision of chemiluminescence (chem) and electrochemical analysis (electro), calculated for 
each covariate. Mean width of the 95% confidence interval is expressed as a percentage of the 
calculated value derived  from MFC NO and ventilator flow. 
 
Covariate Measurement 
sets 
Confidence interval 
width chem (%) 
Confidence 
interval width 
electro (%) 
Significance 
Overall A, D-J 4.3 15.3 S (p < 0.05) 
Dry gas A, D - F 4.0 11.8 S (p < 0.05) 
Humid gas G, H - J 4.6 14.4 S (p < 0.05) 
21% O2 A, E, G, H 4.0 15.4 S (p < 0.05) 
100% O2 D, F, I, J 4.4 15.6 S (p < 0.05) 
No pulsatile 
pressure 
A, D, G, I 2.8 13.6 S (p < 0.05) 
Pulsatile pressure E, F, H, J 5.8 17.6 S (p < 0.05) 
 
S, difference statistically significant. 
 
the measurements in dry gas where chemiluminescence accuracy was higher (Table 7.2). 
NO2 concentrations, measured with the electrochemical analyser, varied from 0 ppm to a 
maximum of 0.6 ppm. Highest NO2 concentrations were found with the use of 40 ppm NO 
and FIO2 of l.0 and a ventilator bias flow of 10 l/min. 
Precision of electrochemical analysis was lower for all covariates in comparison to 
chemiluminescence measurement (Table 7.3). 
DISCUSSION 
Any unit, designed to deliver and measure NO for inhalational therapy in combination with a 
continuous flow ventilator, will typically consist of a NO source, gas flow controller and a 
monitor for NO and NO2 concentration in either the inspired or expired gas. Each of these 
components will have a certain inaccuracy. When combined in a system and added to a 
ventilator, inaccuracy of the single components will add to system inaccuracy. Furthermore, 
during artificial ventilation, NO will be heated, humidified, pressurised and mixed with 
oxygen affecting NO and NO2 concentrations and measurement accuracy. 
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Mass flow controllers and rotameters 
In dry gas and 21% oxygen, chemiluminescence is considered to be the reference method 
for measuring NO concentrations.10 Under these conditions, the NO concentrations 
measured with chemiluminescence when two MFC were used are in excellent agreement 
with the calculated concentrations (maximal overestimation of 1.7%, Table 1 series A). No 
significant influences of oxygen content on NO concentration was measured (series A and 
D). In contrast to the chemiluminescence analyser, the MFC will not be influenced by 
humidification, heating or pressurisation of the gas mixture. In experimental and clinical 
circumstances therefore, the calculation of concentration with the use of two MFC's can be 
regarded as a reference method for NO dosage. This will be of principal importance in 
clinical or experimental research where the highest accuracy in NO dosage is needed. 
The standard rotameter used has an inaccuracy of +10% FS. This inaccuracy has its largest 
influences when using low flow rates. Furthermore, a standard rotameter will be influenced 
by static and dynamic ventilator backpressure. In dry air with 21% oxygen and with the 
chemiluminescence as a reference, the combination of a MFC controlled NO flow and a 
rotameter controlled ventilator flow results in slightly higher dosage (RCM 0.856) and wider 
95% CI (0.835- 0.877) (series B) in comparison to MFC flow controlled ventilator flow (series 
A). In the worst situation, this could lead to a NO dose 16.5% higher than calculated. 
However, the wide 95% CI limits found with the use of two rotameters excludes accurate NO 
dosage, since in the worst case a NO dosage 74% higher than intended may be delivered 
(series C). 
Thus, during HFOV, NO cannot be accurately titrated when NO flow is regulated with a 
standard rotameter. 
Chemiluminescence 
Chemiluminescence measurements are in excellent agreement with calculated NO 
concentrations during HFOV with 21% oxygen and without humidification of the gas mixture 
(series A and E). The pulsatile pressure generated by the ventilator only minimally 
influences measurement accuracy (series E, not significant). Although the 
chemiluminescence analyser is sensitive when oxygen is added to the gas mixture (series 
D), this difference is also not significant. The decrease in analyser sensitivity due to the 
change of FIO2 from 0.21 to 1.0 is about 1% (previous measurements, data not included). In 
addition, the chemiluminescence analyser appears to be sensitive to humidification of the 
Combined iNO and HFOV, accuracy of dosage and measurement 
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gas sample (series G to K). Therefore, sampled humidified gas should be dried prior to entry 
in the analyser. 
Because in the chemiluminescence analyser the NO2 concentration is determined as the 
difference between NO and NOx, NO2 measurements are not accurate in situations where 
NO concentration exceeds NO2 concentration. Accordingly, the value of standard 
chemiluminescence as a method for monitoring NO and NO2 concentrations in NO 
inhalational therapy is limited. 
Electrochemical analyser 
The SensorNOx was designed to reduce the effects of humidity, pulsatile pressure and high 
oxygen concentration on gas measurements. Nevertheless, the SensorNOx monitor was 
found to be sensitive to pressure and humidification. 
In humidified gas, the systematic error of the electrochemical analyser did not differ from the 
chemiluminescence results, although the precision was significantly lower. This can be 
primarily attributed to relatively small absolute measurement errors in the low concentration 
range. For purposes of monitoring NO concentration based on calculation and accurate flow 
regulation, when small measurement errors are not relevant, electrochemical measurement 
of NO concentrations with the SensorNOx monitor is as useful as that obtained with a 
chemiluminescence analyser. 
Heating and humidification 
In the calculation of NO flow required to obtain the desired NO concentration, the 
contribution of water vapour is not taken into account. Humidification and heating of a gas 
mixture containing NO will lead to a 4.46% NO concentration reduction at an ambient 
pressure of 100 kPa and temperature of 36 oC. This, at least in part, explains the lower 
concentrations measured with both chemiluminescence and electrochemical analysis in 
humidified gas. 
The standard chemiluminescence analyser underestimates NO concentration by 6.13% of 
the real NO concentration in humid gas (unpublished communication, Eco Physics, Dürnten, 
Switzerland). To date, standard chemiluminescence cannot he regarded as the gold 
standard for NO and NO2 measurement during artificial ventilation, and calculation of NO 
concentration from MFC controlled gas flows is more reliable. A chemiluminescence 
analyser has now been developed with a permapure gas dryer for clinical use. 
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Should NO and NO2 concentrations be measured during NO inhalational therapy? 
We found the calculation of NO concentration with the use of two MFC's to be an excellent 
reference method. In a setting with humidified air, variable oxygen concentrations and 
pulsatile pressure within the ventilatory circuit, a moderate disagreement between calculated 
and measured concentration exists both with chemiluminescence and electrochemical 
analysers. Since accuracy of dosage exceeds the accuracy of measurement, the rationale to 
monitor NO concentration in NO inhalational therapy can be argued. Conversely, to detect 
human and technical errors in NO dosage, monitoring of NO concentration may be 
warranted. In these circumstances the electrochemical analyser used in this study provides 
adequate accuracy. The electrochemical analyser is equipped with acoustic alarms, its 
accuracy is comparable to the standard chemiluminescence analyser during artificial 
ventilation, its precision is lower but acceptable, it has a relatively short response time, and 
its costs are relatively low. 
Conclusions 
If it is considered important to measure NO2, an accurate method should be used (not 
standard laboratory chemiluminescence analysis). For research purposes when a high 
degree of accuracy and precision is needed, the use of a MFC both for NO and ventilator 
flow is mandatory. A lower but acceptable accuracy will be obtained when only NO flow is 
regulated with a MFC, and NO concentrations are calculated. In the laboratory setting it 
appears that ventilator flow can still be safely regulated with the standard flow controller of 
the oscillator, during HFOV. NO dosage can be based on calculation of the gas flow needed. 
Potentially measurement of NO concentration can then be used to monitor for unsafe or 
unwanted events like a change in ventilator flow without adjustment of NO flow, although 
further studies are needed to confirm these results in the clinical setting. 
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APPENDIX 
 
The NO concentration in the inspiratory gas can be calculated as: 
 [NO]insp = ([NO]bottle x NO)/ total        (1)V
. 
V
. 
Since total is formed by ventilator flow and NO flow, this leads to: V
. 
[NO]insp = ([NO]bottle x NO)/( NO + vent)     (2)V
.
V
. 
V
. 
 
 
. which can be rewritten to:  VNO = ( vent x [NO]insp)/([NO]bottle – [NO]insp)    (3)V. 
 
 
 
where [NO]insp = NO concentration in the inspiratory gas (ppm), [NO]bottle = NO 
concentra n in the NO/N2 bottie (in our experiment 798 ppm) NO = NO/N2 gas flow 
(ml/min), Vtotal = total gas flow in the ventilator circuit (ml/min), vent = set ventilator gas 
flow (ml/min). 
, V
V
. 
. tio. 
 
 121 
Chapter 7 
 122 
REFERENCES 
1. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low dose inhalational nitric oxide in persistent 
pulmonary hyper- tension of the newbom. Lancet 1992; 340: 819-820 
2. Roberts JD, Polaner DM, Lang P, Zapol DM. Inhaled nitric oxide in persistent pulmonary 
hypertension of the newbom. Lancet 1992; 340: 818-819 
3. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment 
of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide.J 
Pediatr 1993; 123: 103-108 
4. Lonnqvist PA, Winberg P, Lundell B, Selldén H, 0lsson GL. Inhaled nitric oxide in neonates and 
children with pulmonary hypertension. Acta Paediatr 1994; 83: 1132- 1136 
5. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult 
respiratory distress syndrome. N EngJ Med 1993; 328: 399-405 
6. KinsellaJP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of 
the newbom. Pediatrics 1993; 91: 997-998 
7. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with the higher 
oxides of nitrogen during anaesthesia. Br J Anaesth 1967; 39: 388-392 
8. Moutafis M. Hatahet Z, Castelain MH, Renaudin MH, Monnot A, Fischler M. Validation of a 
simple method assessing nitric oxide and nitrogen dioxide concentrations. Intensive Care Med 
1995; 21: 537-541 
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of 
clinical measurement. Lancet 1986; 1: 307-310 
10. Zapol WM, Falke KJ. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J 
Med 1993; 329: 206-207 
 
 
 
 
 
 
 Chapter 8 
Intensive Care Medicine 1996; 22: 954 - 958 
 
DG Markhorst, T Leenhoven, JW Uiterwijk, J Meulenbelt, AJ van Vught 
Occupational exposure during nitric oxide inhalational therapy 
in a paediatric intensive care setting 
Chapter 8 
 124 
SUMMARY 
Objective: To determine the amount of occupational exposure to nitric oxide (NO) and 
nitrogen dioxide (NO2) during NO inhalational therapy.  
 
Design: In a standard paediatric intensive care room, 800 ppm NO was delivered to a high-
frequency oscillator and mixed with 100% O2 to obtain 20 ppm NO in the inspiratory gas 
flow. NO and NO2 concentrations in room air were measured using a chemiluminescence 
analyser. Air samples were taken from a height of 150 cm at a horizontal distance of 65 cm 
from the ventilator in a nonventilated and in a well-ventilated room with and without an 
expiratory gas exhaust under normal intensive care environmental conditions. 
  
Setting: Paediatric intensive care unit in a university children‘s hospital.  
 
Measurements and results: Maximal concentrations of NO and NO2 were reached after 4 h 
NO use. Without exhaust, in a nonventilated room, environmental NO and NO2 
concentration rose to a maximum of 0.462 and 0.064 ppm, respectively. With the use of an 
expiratory gas exhaust, NO and NO2 concentrations were 0.176 and 0.042 ppm, 
respectively. With normal air-conditioning, these values were 0.075 and 0.034 ppm, 
respectively, without the use of an expiratory gas exhaust. With expiratory gas exhaust 
added to normal air-conditioning, values for NO and NO2 were 0.035 and 0.030 ppm, 
respectively. 
 
Conclusions: The use of 20 ppm NO, even under minimal room ventilation conditions, did 
not lead to room air levels of NO or NO2 that should be considered toxic to adjacent 
intensive care patients or staff. Slight increases in NO and NO2 concentrations were 
measurable but remained within occupational safety limits. The use of an exhaust system 
and normal room ventilation lowers NO and NO2 concentrations further to almost 
background levels.  
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INTRODUCTION 
Inhalation of nitric oxide (NO) reduces pulmonary artery pressure and increases arterial 
oxygenation by improving the matching of ventilation with perfusion, without producing 
systemic vasodilation in patients with severe adult respiratory distress syndrome (ARDS) 1 
as well as in newborns with severe persistent pulmonary hypertension of the newborn and 
children with pulmonary hypertension.2 -5 It has been found that inhaled NO may be less 
successful without optimal pulmonary management and that some patients benefit from a 
combined treatment of inhaled NO and high-frequency oscillatory ventilaton (HFOV).4,6. 
Although these preliminary reports of inhalational NO therapy are encouraging, 1-6 many 
questions remain to be answered before its routine application can be recommended. NO is 
present throughout the organism as a signal molecule regulating vasomotor tone and 
platelet function. It is a messenger molecule in the immune system and it functions as a 
neurotransmitter. In addition, it is a short-lived and extremely potent radical. In air, in the 
presence of oxygen, it is rapidly converted into NO2. The reaction velocity is dependent on 
oxygen concentration, pressure, and temperature.7 
Inhalation of gas mixtures containing high concentrations of NO and NO2 can be rapidly 
lethal in humans.8 Long term effects of low-dose NO exposure are unknown, and NO might 
have carcinogenic properties.9,10 Therefore, concern remains regarding the safety of NO 
inhalational therapy. The aim of this study was to assess the potential environmental 
exposure of intensive care staff and adjacent patients to NO and NO2 pollution during NO 
inhalational therapy combined with HFOV. 
MATERIALS AND METHODS 
Ventilator 
We used a 3100A HFO ventilator (SensorMedics Corp, Yorba Linda, CA). Ventilator settings 
were set to values frequently used for paediatric and neonatal intensive care patients: mean 
airway pressure 20 cmH2O, pressure amplitude 25 cmH2O, total gas flow 20 l/min. During 
the experiment, no humidification of inspiratory gasses was used. The fraction of inspired 
oxygen (FIO2) was set at a maximal value of 0.975. NO flow and flow of the air-oxygen 
mixture were regulated wilt digitally controlled mass flow controllers (accuracy 1% full scale) 
in combination wilt a NO-dosing controller unit (Bronkhorst Hi-Tec, Veenendaal, The 
Netherlands; SensorMedics, Bilthoven, The Netherlands). The tube connector remained 
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Fig. 8.1: Perspex NO exhaust 
placed around the expiration valve. 
Waste gasses are extracted toward 
the hospital vacuüm system. I: 
inspiratory limb (transected), F: 
fresh gas inlet, N: NO inlet, Ex: 
perspex exhaust, Ev: expiration 
valve, Vac: connection to vacuüm 
system. 
closed during the experiment. NO was provided in tanks containing 800 ppm NO in N2 
(Linde AG, Düsseldorf, Germany). 
NO exhaust 
In the 3100A HFO ventilator, expiration gasses and bias flow leave the patient circuit via a 
balloon valve. To minimise environmental pollution, we used a Perspex capsule placed 
around this expiration balloon (Fig. 8.1). Waste gas was then directed towards the wall 
vacuum system. In the text, this device is referred to as an exhaust. 
Environmental circumstances 
The experiments were performed in one of our standard paediatric intensive care rooms, of 
dimensions 5 x 4.3 x 2.8 m (volume 60 m3). Air temperature was around 22 °C, relative air 
humidity was around 45%. To create a worst-case scenario, in which the influence of NO 
and NO2 efflux on environmental conditions would be maximal, we performed the 
experiment in a closed room without natural room air ventilation and air-conditioning 
(situation 1). Further measurements were performed using the exhaust without normal room 
air ventilation and air-conditioning (situation 2), normal room air ventilation and air-
conditioning without the use of the exhaust (situation 3) and, finally, with normal room air 
ventilation and air-conditioning with the use of the exhaust (situation 4). During 
measurements, care was taken to minimise movements in the room, in an effort to minimise 
undesired air movement. 
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Measurement of NO and NO2 concentrations 
The reference method for measurement of NO concentrations in 21% oxygen is 
chemiluminescence. NO reacts with ozone in a reactor, the release of photons being 
detected by a photomultiplier tube. NOx measurement is obtained by reduction of the higher 
nitrogen oxides to NO in a heated (400 oC) molybdenum converter (3 NO2 + Mo ? 3 NO + 
MoO3) prior to entrance into the reactor. Thus, NO2 is not measured directly, but calculated 
as the difference between NO and NOx measurements, which can be considered as a 
specific NO2 measurement.11 We measured room air NO and NO2 concentrations using a 
chemiluminescence analyser (CLD 700 AL, Eco Physics, Dürnten, Switzerland), which was 
calibrated using a certified reference gas (Messer en Griesheim, Moerdijk, The 
Netherlands). Calibration was repeated prior to and after completion of the experiment, 
revealing no signs of drift. The range of measurement is 0.001-100 ppm, and the 95% 
response time is 70 s. The decrease in analyser sensitivity due to the change of O2 
concentration from 21 to 100% is about 1 %. NO and NO2 measurements  
were recorded with a pen recorder (BD 112, Kipp en zonen, Delft, The Netherlands). 
Environmental gasses were sampled during a 12-hour period via a sampling tube, which 
was suspended at a height of 150 cm above floor level, at a horizontal distance of 65 cm 
from the ventilator circuit expiration valve, at an angle of 45°. This position was chosen 
because it was considered to be a typical working position of staff nearest to the system. 
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Fig. 8.2: Nitric oxide (circles) and nitric dioxide (squares) concentrations at 100 cm height, as a function 
of distance from the expiration valve, without ventilation or exhaust. 
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Prior to and after completion of each measurement, background NO and NO2 concentrations 
were measured. Additionally, we measured the NO and NO2 concentrations after a 12-hour 
period in the worst-case situation (situation 1), without normal room air ventilation and air-
conditioning at a height of 100 cm above floor level at distances of 15, 30, 50, 100, and 200 
cm from the expiration valve.  
RESULTS 
Concentrations of NO and NO2 were highest in proximity to the expiration valve (Fig. 8.2). 
Due to air turbulence, measurements did not stabilise less than 15 cm from the expiration 
valve. Concentrations decreased rapidly with increasing distance from the ventilator, and 50 
cm from the expiration valve, NO and NO2 concentrations did not differ substantially from 
background concentrations. 
Maximal NO and NO2 concentrations measured 150 cm above floor level, 65 cm from the 
expiration valve, are shown in Table 8.1. Background concentrations were 0.002 ppm NO 
and 0.022-0.028 ppm NO2. Maximal concentrations were reached after 4 h, stabilising 
thereafter. Room air concentrations of bath NO and NO2 were highest when natural room air 
ventilation and air-conditioning were shot off (situation 1). Using the expelled-air exhaust 
(situation 2), NO room air contamination was reduced by 62%. With normal room air 
ventilation and air-conditioning but without exhaust (situation 2), an 84% reduction of room 
air NO concentration could be achieved relative to situation 1. With additional use of the 
exhaust (situation 4), the NO concentration was 92% lower than in situation 1. 
In comparison to situation 1, an expelled-air exhaust reduced the NO2 room air  
concentration by 31 %. Room air NO2 contamination in this situation, after correction for 
atmospheric NO2, was reduced by 55%. In situation 3, normal room air ventilation and air-
conditioning, without the exhaust device, lowered NO2 concentration by 47% relative to 
situation 1. The use of normal air-conditioning in combination with the exhaust lowered NO2  
concentration 53%, when compared to situation 1. 
 
Table 8.1. Maximal concentrations of NO and NO2 in room air, after a stabilisation period of 12 h, 
150 cm above and 65 cm from the expiration valve. 
 
 NO / NO2 (ppm) 
 Without air-conditioning With air-conditioning 
Without exhaust 0.462 / 0.064 0.075 / 0.034 
With exhaust 0.176 / 0.044 0.035 / 0.030 
Combined iNO and HFOV, occupational exposure 
DISCUSSION 
Although NO inhalational therapy seems to be a promising tooI for the management of 
patients with severe pulmonary hypertension,1,5,6,12,13 more data on safety and long-term 
effects, optimal timing of treatment, as well as dose-response relations are needed. We 
performed this study to obtain information about the environmental impact of NO inhalational 
therapy. 
Inhalation of gas mixtures containing high concentrations of NO2, and to a lesser extent NO, 
can be lethal in humans and can cause severe acute lung injury with pulmonary oedema 
and marked methemoglobinemia,8 inhibition of DNA synthesis and deamination of DNA,9,10 
alteration of the inflammatory response of alveolar macrophages,14 and prolongation of 
bleeding time.15  As with most therapeutic agents, these side effects are likely to be dose 
dependent.16 NO2 causes oxidative damage by generating radicals. Damage of pulmonary 
cells and pulmonary macrophages leads to ARDS and a less efficient response to 
infections.17,18 From healthy-volunteer studies, it may be concluded that, in normal persons, 
bronchial airway resistance may be increased at concentrations greater than 1.5 - 2 ppm.19-
21 At these low NO2 concentrations, it has not yet been proven that patients with chronic 
obstructive disease or asthma are more susceptible to bronchial reactivity.18,22-25 
In the present study, the maximal NO2 concentration measured near the expiration valve 
was 0.064 ppm. This concentration was measured in a small room (60 m3) without normal 
ventilation, expelled-gas exhaust, or scavenging, thus in the worst situation. These findings 
are in accordance with other studies.26 Occupational exposure should be seen in the 
perspective of atmospheric NO and NO2 concentrations (Fig. 8.3). The maximal room air 
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Fig. 8.3: Nitric oxide (NO, black 
bars) and nitric dioxide (NO2, 
grey bars) room air 
concentrations in the intensive 
care room during nitric oxide 
inhalational therapy, in 
comparison to the highest 
measured environmental 
outdoor air concentrations in 
Utrecht, a Dutch city of 300,000 
inhabitants, and to Dutch mean 
outdoor concentrations (Sit 1 – 
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concentrations of NO and NO2 we measured were comparable to values measured in Dutch 
cities, although these values were relatively high.27 In the United States, the ambient air 
quality standard for NO2 is 0.05 ppm averaged over 1 year. Maximal 30-min and 24-hour 
outdoor NO2 values can be 0.45 ppm and 0.21 ppm, respectively.28 The Occupational Safety 
and Health Administration bas listed the 8-hour time-weighted average safe level at 25 ppm 
for NO and 5 ppm for NO2.29 In homes with gas stoves, the NO2 level ranges from 0.025 to 
0.075 ppm.28 In kitchens with gas cooking appliances, peak NO2 levels may even reach 
0.20-1.0 Ppm.30 Epidemiologic and laboratory evidence for humans has not conclusively 
demonstrated adverse effects of NO2 exposure at these indoor concentrations.22  Therefore, 
the NO and NO2 concentrations measured in the present study may be considered not 
harmful for intensive care staff and adjacent patients. 
In our experiments, a high-frequency oscillator was used, requiring high gas flow rates. As a 
consequence, NO inflow must also be high, which will result in a high emission of NO into 
the environment. NO administration with a conventional ventilator will have less influence on 
environmental NO and NO2 contamination, because the ventilatory flow rates are lower and, 
therefore, the required NO inflow rates will also be lower. Furthermore, our experiments 
were performed in a relatively small room (volume 60 m3), resulting in limited dilution of 
expiratory gasses. During our experiment, the tube connector remained closed. When 
ventilating a patient with NO, same of the inspired NO will be bound to haemoglobin, thereby 
reducing the amount of expired NO. 
Hence, we conclude that the use of 20 ppm NO inhalational therapy combined with HFOV, 
at least under our experimental conditions - a small intensive care room, with one HFO 
ventilator, providing 20 ppm in 100% O2 in use - will not lead to room air NO and NO2 levels 
that could be considered toxic to intensive care staff or adjacent intensive care patients. 
Environmental effects may be measurable but will be minimal and well within occupational 
safety limits.  
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DISCUSSION 
The aim of this thesis was to develop and evaluate a number of methods to improve volume-
targeted high-frequency oscillatory ventilation (HFOV) and the combination of HFOV and 
inhaled nitric oxide (iNO). 
 
In this thesis, we describe our first experiences with HFOV in paediatric patients and 
introduce three HFOV strategies (Chapter 2). First, the “open-lung strategy” in diffuse 
alveolar disease, secondly the “low-volume strategy” in air leak syndromes and thirdly the 
“open airway strategy” in obstructive small airway disease. Although at the time of the study, 
HFOV was used as a rescue therapy for failure of conventional mechanical ventilation 
(CMV), in two of 38 HFOV runs in 35 patients a HFOV failure was encountered. Nine 
patients developed chronic lung disease following HFOV and one patient was discharged 
with supplemental oxygen therapy. Three patients developed an airleak during HFOV. 
During transition from CMV to HFOV increased circulatory support was needed in a 
significant number (32%) of patients, but with this support the transition was tolerated well. 
Generally, circulatory effects of HFOV in normovolaemic patients are minimal, but in 
hypovolaemic patients adequate fluid administration may improve haemodynamic stability 
as well as oxygenation. From these data, we conclude that HFOV is effective and safe with 
few side effects in paediatric patients. In addition, we found the use of the “open airway 
strategy” in obstructive small airway disease to be successful as an alternative to more 
conventional modes of ventilation. However, there may only be a small margin for the 
optimal airway pressure, since the relatively high pressure needed to maintain airway 
patency might lead to overdistention of compliant alveoli. 
 
An initial setting of HFOV requires medical expertise with the technique and a thorough 
understanding of the pathophysiology of the diseased lung.  In the operation of a modern 
military aircraft, complexity of information combined with time stress creates difficulties for 
the pilot under combat conditions. This bears some analogy with recruiting lung volume 
during initial HFOV and subsequent reduction of airway pressure, in which the physician has 
to obtain information from close observation of the patient, the ventilator, vital signs monitor 
and blood gas analysis. This stream of information then has to be combined into a 
pathophysiological hypothesis and therapeutic strategy within a short period of time. In an 
effort to enhance this information gathering process, we developed, tested, and described a 
system that integrates measurements obtained from the ventilator, continuous blood gas 
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analyser and lung volume changes (Chapter 3). The system, in part based on respiratory 
inductive plethysmography (RIP), was modified to sample at high rates, in order to record rib 
cage and abdominal displacement during HFOV. The linearity and accuracy of the device for 
the estimation of lung volume changes is confirmed. The relation between continuous 
distending pressure and lung volume, oxygenation, oxygenation index (OI), and the ratio of 
pressure amplitudes at the distal end and the proximal opening of the endotracheal tube 
(OPR) as well as the changes of these dependent variables with time were made available 
in real time. OI and OPR can be used as estimators of optimal continuous distending 
pressure (CDP) during HFOV.1,2 Clinically, however, the value of OPR may be limited, since 
its measurement necessitates the introduction of a pressure transducer into the main 
airways for which the patient has to be disconnected from the ventilator, which in turn will 
lead to the loss of lung volume. Furthermore, the method is sensitive to fluid and mucus 
accumulation on the pressure transducer. We felt that the integration of ventilator settings 
and dependent physiological variables may provide useful information for clinical, 
instructional and research applications.  
 
We studied the accuracy of measurements of lung volumes with the device at different end 
expiratory pressures (PEEP) with changing severity of acute lung injury, with the intention to 
predict its accuracy of mean lung volume changes during HFOV (Chapter 4). The standards 
of measurement of end-expiratory lung volume during mechanical ventilation, inert gas 
(nitrogen, helium, argon or SF6) washin or washout techniques or whole body 
plethysmography were not available in our laboratory. We therefore chose to assess the 
linearity of tidal volume measured with RIP with the inflated tidal volume measured with a 
pneumotachograph at the airway opening as an alternative to mean lung volume or end-
expiratory lung volume measurement. 
The system can be calibrated to a known volume. With changing degree of lung injury, most 
accurate results were obtained when measurements are preceded by a calibration in 
pulmonary conditions that are comparable to the measurement period. Furthermore, 
accuracy proved to be unpredictably PEEP dependent. Calibration of the device during 
HFOV is not feasible routinely, in the absence of a standard for mean or tidal volume 
measurements during HFOV. Discontinuation of HFOV and calibration during a period of 
CMV would be an unattractive alternative. Omitting calibration and weighing both RIP 
signals (obtained from rib cage and abdominal displacement) equally does not significantly 
reduce accuracy. Accuracy is dependent on the weight factor used, and this weight factor 
may be species dependent. Despite these limitations, we find RIP to be comparable to other 
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techniques of lung volume change measurement currently in clinical use. We have shown 
that with this technique, it is possible to measure both relative mean lung volume changes 
and tidal volume changes.  
The next question we tried to answer, assuming the accuracy of RIP measurements of lung 
volume (change) is considered acceptable for clinical purposes, was to assess the value of 
the pressure-volume (PV) relationship in mechanical ventilation (Chapter 5). The use of PV 
characteristics to set PEEP during CMV or CDP during HFOV has been addressed in 
numerous studies. In a mathematical model of the ARDS respiratory system, we 
demonstrated that opening of collapsed lung units (recruitment) may take place with 
increasing airway pressures until high pressures are reached. During this procedure 
previously collapsed lung units may open and immediately become overdistended. This 
phenomenon is most pronounced in the severest simulated ARDS grades. The 
characteristics of the inflation limb of the P-V curve are not uniquely related to alveolar 
recruitment and overdistention, but also to chest wall properties and rate of recruitment. 
Following complete alveolar recruitment, decreasing airway pressure results in reduction of 
lung volume, initially with a decrease of alveolar overstretching while alveoli remain open. In 
other words, the pressure-volume relationship, but also pressure-atelectasis and pressure-
overstretching display hysteresis. As a consequence, a procedure aimed at opening 
collapsed alveoli may facilitate subsequent reduction of airway pressures with avoidance of 
atelectasis, overstretching and high airway pressures. Between the upper corner point and 
inflection point of the deflation P-V curve, significant overstretching decreases, while 
significant atelectasis reappears in the pressure range between the inflection point and 
lower corner point. In general, optimal PEEP is thus found between the lower and upper 
corner pressures of the deflation P-V curve, but this knowledge is irrelevant due to the wide 
range between these boundaries. The good correlation between P-V characteristics and 
optimal PEEP or CDP reported in the literature may be limited to a group of animals or 
patients of comparable body size and with comparable degree of acute lung injury. In our 
model, we found static pressure-volume characteristics to be moderate estimators of optimal 
airway pressures. We further have shown that optimal PEEP increases with the degree of 
lung injury, while the safe plateau pressures do not. As a consequence, tidal volumes that 
can be applied with avoidance of end-expiratory collapse and end-inspiratory overdistention 
decrease with increasing disease severity to a level that may result in inadequate 
conventional mechanical ventilation. If the assumptions in our model are correct, this finding 
suggests that a ventilation mode with smaller tidal volumes may be of benefit, such as high 
frequency oscillatory ventilation, especially in severe ARDS. 
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As an alternative to tracing lung volume during lung volume optimisation and subsequent 
reduction of air way pressure to its optimal value, we hypothesised that RIP estimated chest 
wall displacement would be maximal at the airway pressure where either respiratory system 
or lung compliance would be maximal. 
 
RIP measures inductance change in zigzag-shaped gauges fitted in elastic belts placed 
securely around rib cage and abdomen. As a result of rib cage and abdominal displacement, 
the belts and gauges will stretch and inductance of the resonator circuit in which the gauges 
are placed will change. The inductance change of each circuit forms a signal, which has a 
linear relationship with cross-sectional area. Assuming thoracic and abdominal height is 
fixed during breathing, an estimate of volume change can be made. Respiratory system 
volume changes are calculated from the summed signal, assuming synchronicity between 
both belts. During HFOV, however, a clear mean airway pressure-dependent phase 
difference between rib cage and abdominal displacement was demonstrated (Chapter 6). In 
seven of eight piglets a clear maximum tidal chest wall displacement could nevertheless be 
determined at a mean airway pressure approximating the optimal airway pressure. This 
optimum airway pressure had been defined as the lowest airway pressure where 
physiological shunt was still below 0.1. Following a lung volume recruitment manoeuvre, rib 
cage amplitude increased with decreasing mean airway pressure, without a clear maximum. 
Interestingly, abdominal displacement was relatively stable during this procedure, but was 
reduced at airway pressures around the pressure coinciding with optimal respiratory system 
compliance, oxygenation and ventilation. These changes probably reflect pressure-
dependent impedance changes of the components of the respiratory system. Monitoring of 
tidal volume and abdominal displacement during HFOV may prove to be of clinical value 
during HFOV. Since these experiments were performed in paralysed surfactant deficient 
animals the findings cannot be extrapolated to human ARDS patients, but may form a basis 
for further research. 
 
Not in all patients, it is possible to improve oxygenation by lung volume optimisation. For 
these patients, adjunctive therapies have been designed.  One of these adjunctive therapies 
is the addition of nitric oxide to the respiratory gases (iNO). The effect of iNO is augmented 
by optimal recruitment of lung volume, as has been described in the combination of HFOV 
and iNO.3,4 At the time, iNO was considered an investigational drug, its use limited to studies 
and compassionate use. Nitric oxide was not available as a medical gas, and therapeutic 
dosing systems were not available. In an attempt to provide an accurate means of dosing 
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nitric oxide during HFOV, we described the accuracy of nitric oxide dosage and 
measurement during HFOV comparing various set-ups (Chapter 7). We demonstrated that 
the inaccuracy and pressure sensitivity of standard rotameters even in the absence of HFOV 
pulsatile pressures resulted in clinically unacceptable inaccurate iNO dosage during HFOV. 
Highest dosage accuracy could be obtained when both NO and ventilator bias flow were 
controlled by a mass flow controller. For practical clinical purposes however, we concluded 
that the combination of rotameter-controlled ventilator bias flow and mass flow controlled-
NO flow was adequately predictable although a dose 16% above the calculated dose may 
be delivered. This is not not necessarily a clinically significant effect, since typically iNO is 
titrated on effect. For purposes of monitoring NO concentration based on calculation and 
accurate flow regulation, when small measurement errors are not relevant, electrochemical 
measurement of NO concentrations with an electrochemical sensor, designed to reduce the 
effects of humidity, pulsatile pressure and high oxygen concentration on gas measurements, 
is as useful as that obtained with a chemiluminescence analyser. Based on our work, a 
commercially available device has been developed for nitric oxide dosage and monitroing of 
therapy during HFOV. 
Nitric oxide is present throughout the body and acts as a messenger molecule, affecting not 
only vascular tone but also platelet function and the immune system. In the presence of 
oxygen it is rapidly converted into nitric dioxide. Inhalation of gas mixtures containing high 
concentrations of NO and NO2 can be rapidly lethal in humans. Long-term effects of low-
dose NO inhalational exposure are unknown, but NO might have carcinogenic properties. 
The safety of medical and nursing staff and adjacent patients in the proximity of a patient 
receiving iNO in combination with HFOV, where high gas flow rates are typically used, were 
of concern. For this reason we assessed the potential environmental exposure of intensive 
care staff and adjacent patients to NO and NO2 pollution during NO inhalational therapy 
combined with HFOV (Chapter 8). We found increased levels of both molecules, but within 
occupational safety limits. Concentrations decrease with increasing distance to the ventilator 
exhaust valve, and can further be decreased by the use of waste gas exhaust system.  
In the years following these studies, therapeutic use of nitric oxide did meet the initial 
expectations and its use has been limited to a selected group of diseases. 
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PERSPECTIVES 
HFOV has gained a definitive place in paediatric intensive care, and with the recent 
availability of a more potent oscillator it may gain a place in adult intensive care as well. 
Conventional mechanical ventilation has changed in recent years. The importance of 
reducing tidal volumes in combination with recruitment procedures in acute lung injury has 
gained interest, but is still not generally accepted. Irrespective of the ventilation mode, 
clinical evidence on the long-term beneficial effects of these strategies has to be sought. In 
HFOV, the optimal recruitment manoeuvre (e.g. gradual increase of airway pressure, single 
sustained inflation, rapid sequence inflations) has not been defined, nor is it clear to which 
value the recruitment pressure should be increased.  
Our studies have shown the limited value of volume measurement and the P-V relation as 
estimators of optimal airway pressures. Nevertheless, it may prove of value during 
recruitment pressures, since in our mathematical model with inflation above the upper 
corner pressure of the inflation P-V curve little volume was gained that could be maintained 
without significant overdistention with end-expiratory pressure.  
For determination of the optimal CDP during HFOV, the oxygenation index has been shown 
to be of value, but this parameter usually is not available directly at the bedside. With 
electrical impedance tomography (EIT) global and regional information on lung mechanics 
and potentially perfusion can be assessed. At present, however, the application of 16 
separate electrodes in a potentially unstable patient is impractical and the interface to the 
user is far from optimal. Development of an easy to apply “electrode belt” and improved 
graphical interface would strongly improve the applicability of EIT. 
Initial optimisation of lung volume with HFOV has been addressed in this thesis and work of 
others.  
Little is known about the phase of HFOV weaning with reduction of airway pressures. 
Protocol-based ventilator weaning, for instance daily or even more frequent determination of 
CDP at which the lung collapses and reopens, may reduce intensive care unit length of stay. 
These protocols yet have to be designed. 
Maintenance of spontaneous breathing and avoidance of muscular paralysis results in 
improved pulmonary function, gas exchange, systemic blood flow and tissue oxygenation. In 
larger patients however, patient breathing activity during HFOV interferes with operation of 
the ventilator and may lead to increased work of breathing. The development of a system 
that would allow the oscillator to support breathing efforts may lead to a better tolerance of 
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HFOV in adult patients, a reduced use of sedatives and muscle relaxants and even hasten 
recovery. 
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Chapter 1 
In a significant number of patients, defienct or abnormal surfactant leads to respiratory 
insufficiency. In preterm infants, a surfactant deficiency may lead to the neonatal respiratory 
distress syndrome (nRDS), whereas an abnormal surfactant may lead to the acute 
respiratory distress syndrome. Patients suffering from a respiratory distress syndrome lack a 
normal function of lung surfactant and their lungs tend to collapse leading to severe hypoxia. 
Measurements of respiratory system mechanics reveal a disturbed pressure-volume 
relation. Experimental and clinical studies have demonstrated the benefits of elevated end-
expiratory pressures during mechanical ventilation, provided that collapsed lung units have 
been opened using adequately high airway pressures; recruitment of lung volume. High-
frequency oscillatory ventilation (HFOV) is an alternative ventilation mode, in which lung 
volume can be recruited and maintained while high end-inspiratory pressures and cyclic 
reexpansion of end-expiratory collapsed lung units may be avoided. In Chapter 2 our initial 
results using this technique of mechanical ventilation are described and ventilatory 
strategies introduced. Despite the relative straightforwardness of the technique there is a 
need for a clinically applicable method to find the optimal lung volume obtained by setting of 
continuous distending pressure (CDP). In Chapter 3 we describe a system that integrates 
ventilator settings and dependent physiological variables. The accuracy of lung volume 
measurements using this system at various levels of end-expiratory pressures and different 
degrees of lung injury are described in Chapter 4. In Chapter 5, the value of static pressure-
volume characteristics as estimators of optimal airway pressures is addressed. Dynamic 
changes in abdominal and rib cage displacement resulting from changes in CDP during 
HFOV are described in Chapter 6. Even when lung volume and CDP are considered 
optimal, a selected group of patients may benefit from the combination of HFOV and inhaled 
nitric oxide (iNO). In Chapter 7 technical aspects of dosage of iNO during HFOV are 
presented. With HFOV, relatively large gas flows are generated. When HFOV is combined 
with iNO, additional large NO flows are generated. In Chapter 8 the occupational 
consequences for both adjecent patients and intensive care staff of combined iNO and 
HFOV therapy are discussed. 
Chapter 2 
Three strategies of setting CDP or targeted lung volume during rescue HFOV in 35 children 
subsequently admitted to two tertiary care paediatric intensive care units in a four year 
period were described. First, the “open-lung strategy” designed to rapidly recruit and 
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maintain optimal lung volume in diffuse alveolar disease (DAD) and pulmonary 
haemorrhage. Second, the “low-volume” -strategy in persistent airleak where CDP was 
reduced until the airleak ceases. Third, the “open-airway”-strategy in obstructive airway 
disease where CDP was used to recruit and stent the airways. Respiratory insufficiency was 
classified as resulting from DAD in 27 (77%) patients and obstructive small airway disease 
in five (8%) patients. In one patient with concurrent small airway disease, HFOV therapy 
was aimed at resolution of persistent airleak.  In four patients HFOV was combined with iNO 
therapy, two of the seven non-survivors died as a result of respiratory failure. Three patients 
developed a new airleak during HFOV. Nine patients developed chronic lung disease. One 
of four patients treated with the combined HFOV iNO therapy responded to therapy.  
Increasing oxygenation index over time predicted adverse outcome resulting from 
respiratory failure. We concluded that HFOV is a safe and effective modality of mechanical 
ventilation with very few side effects. HFOV may be used early in the disease process. 
Chapter 3 
A system that integrates measurements obtained from the ventilator, continuous blood gas 
analysis and lung volume changes, was developed, tested and described. The system, in 
part based on respiratory inductive plethysmography (RIP), was modified to sample at high 
rates, in order to record rib cage and abdominal displacement during HFOV. The linearity 
and accuracy of the device for the estimation of lung volume changes was confirmed. The 
relation between continuous distending pressure and lung volume, oxygenation, 
oxygenation index (OI) and the ratio of pressure amplitudes at the distal end and the 
proximal opening of the endotracheal tube (OPR) as estimators of optimal continuous 
distending pressure (CDP) during HFOV as well as the changes of these dependent 
variables with time were made available in real time.  
Chapter 4 
Accuracy of lung volume measurements with the designed measurement system was 
assessed during conventional mechanical ventilation at varying positive end-expiratory 
pressure (PEEP) levels and with progressive severity of lung injury. Measurement bias 
increased and precision decreased from the initial calibration with increasing severity of 
injury and proved to be PEEP dependent. To obtain optimal accuracy, the system has to be 
recalibrated at the mean lung volume and severity of illness under study. The accuracy of 
the measurement system is comparable to other monitoring devices that are currently in 
clinical use, but are not validated during HFOV. 
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Omitting calibration and weighing both RIP signals (obtained from rib cage and abdominal 
displacement) equally did not significantly reduce accuracy. Accuracy was dependent on the 
weight factor used, and this weight factor may be species dependent. Weight factors 
obtained from the literature and obtained in animal experiments should therefore not be 
extrapolated to human measurements.  We have shown that with this technique it is 
possible to accurately measure both relative mean lung volume changes and tidal volume 
changes, provided some conditions are met.  
Chapter 5 
In a mathematical model of the ARDS respiratory system, we demonstrated that opening of 
collapsed lung units (recruitment) may still take place with increasing airway pressures until 
high pressures are reached. During this procedure previously collapsed lung units may open 
and immediately become overdistended. The characteristics of the inflation limb of the P-V 
curve are not uniquely related to alveolar recruitment and overdistention, but also by chest 
wall properties and rate of recruitment. Following complete alveolar recruitment, decreasing 
airway pressure initially resulted in  a decrease of alveolar overstretching while alveoli 
remained open. As a consequence, a procedure aimed at opening collapsed alveoli may 
facilitate subsequent reduction of airway pressures with avoidance of atelectasis, 
overstretching, and high airway pressures.  
Static pressure-volume characteristics proved to be moderate estimators of optimal airway 
pressures. The good correlation between P-V characteristics and optimal PEEP or CDP 
reported in the literature may be limited to a group of animals or patients of comparable 
body size and with comparable degree of acute lung injury. Optimal PEEP increased with 
degree of lung injury, while the safe plateau pressures did not. As a consequence, tidal 
volumes that can be applied with avoidance of end-expiratory collapse and end-inspiratory 
overdistention decrease with increasing disease severity to a level that may result in 
inadequate conventional mechanical ventilation. If the assumptions in our model are correct, 
this finding suggests that a lung volume recruitment manoeuvre and a ventilation mode with 
smaller tidal volumes, such as HFOV, may be of benefit, especially in severe ARDS. 
Chapter 6 
Mechanical ventilation leads to both rib cage and abdominal displacement. We have shown 
that during HFOV rib cage and abdominal displacement are not synchronous and of equal 
magnitude. The phase difference between rib cage and abdominal displacement and the 
mutual relation of these movements depend on the imposed airway pressure and 
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subsequent lung volume. In seven of eight piglets, maximal tidal displacement of the chest 
wall was a moderate estimator of optimal airway pressure. Abdominal displacement was 
minimal in the pressure range coinciding with optimal airway pressure. Monitoring of tidal 
volume and abdominal displacement during HFOV may be of value during HFOV, but further 
research in human patients is warranted. 
Chapter 7 
During HFOV, standard rotameter flow control of both nitric oxide (NO) and ventilator flow 
may lead to unpredictable and clinically unacceptable NO concentration. Moderate, and 
clinically acceptable, dosage accuracy was obtained when an electronic mass flow controller 
(MFC) was used for NO flow control, with ventilator flow controlled with a rotameter. 
Maximal dosage accuracy was obtained with both NO and bias gas flow controlled with a 
MFC. The standard method for measurement of nitric oxide and nitric dioxide concentrations 
in dry air is chemiluminescence. Alternatively, these concentrations can be measured by the 
use of electrochemical sensors. The standard chemiluminescence analyser used was 
sensitive to humidification of ventilation gasses. The electrochemical analyser we assessed 
displayed a systematic error comparable to that obtained with chemiluminescence, but its 
precision was significantly lower. Absolute measurement error was nevertheless small and 
without clinical relevance. For purposes of monitoring NO concentration during iNO therapy, 
based on calculation and accurate flow regulation, when small measurement errors are not 
relevant, electrochemical measurement of NO concentrations with the an electrochemical 
sensor is as clinically useful as that obtained with a chemiluminescence analyser. Based on 
our work, a commercially available device has been developed for nitric oxide dosage and 
monitroing of therapy during HFOV. 
Chapter 8 
Nitric oxide and its higher oxides are toxic when levels of safe concentration or exposure 
time are exceeded. When iNO therapy is used in combination with HFOV, high gas NO 
flows may be needed to obtain sufficient NO concentration in the inspired gas. We assessed 
the potential environmental exposure of intensive care staff and adjacent patients to NO and 
NO2 pollution during NO inhalational therapy combined with HFOV in four situations. We 
found increased levels of both NO and NO2, but within occupational safety limits. 
Concentrations decreased with increasing distance to the ventilator exhaust valve, and 
could be further decreased by the use of waste gas exhaust system.  
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In chapter 9 our  findings, their interrelationship and future perspectives are discussed. 
(Chapters 10 and 11 are the English and Dutch summaries of the thesis.) 
 
 Hoofdstuk 11 
Op weg naar optimaal long volume tijdens hoog-frequent 
oscillatoire beademing 
 
Samenvatting 
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Hoofdstuk 1 
Bij een belangrijk aantal patienten leidt een tekort aan of afwijkend long surfactant tot acute 
ademnood. Bij te vroeg geboren patienten leidt een tekort aan surfactant tot het neonataal 
respiratoir distress syndoorm (nRDS), bij het acuut respiratoir distress syndroom (ARDS) is 
er sprake van afwijkend surfactant. Bij patiënten die aan een dergelijk ademnood syndroom 
lijden kan een abnormale functie van long surfactant ertoe leiden dat hun longen neigen tot 
samenvallen met ernstige zuurstofnood als gevolg. Bij metingen van de mechanische 
eigenschappen van het respiratoir systeem wordt een gestoorde druk-volume relatie gezien. 
Experimentele en klinische studies hebben de voordelen van verhoogde druk aan het einde 
van de uitademing tijdens mechanische ventilatie aangetoond, op voorwaarde dat de 
samengevallen longdelen door voldoende hoge luchtwegdruk zijn geopend; rekrutering van 
longvolume. Hoog -frequent oscillerende ventilatie (HFOV) is een alternatieve manier van 
mechanisch beademen, waarmee het longvolume kan worden gerekruteerd en 
gehandhaafd terwijl hoge drukken aan het eind van de inademing en cyclisch heropenen 
van longdelen die aan het eind van de uitademing zijn samengevallen kan worden 
vermeden. Hoofdstuk 1 verschaft de nodige achtergrondinformatie en geeft de bedoeling en 
opbouw van dit proefschrift aan. In hoofdstuk 2 zijn onze eerste ervaringen met deze 
techniek van mechanische ventilatie beschreven en de gebruikte geïntroduceerde 
strategieën geïntroduceerd. Ondanks  de relatieve eenvoud van de techniek is er een 
behoefte aan een klinisch toepasbare methode om het optimale longvolume te vinden dat 
door instelling van de gemiddelde luchtwegdruk (CDP) wordt verkregen. In hoofdstuk 3 
beschrijven wij een systeem dat ventilator instellingen en afhankelijke fysiologische 
variabelen integreert. De nauwkeurigheid van de metingen van het longvolume met dit 
systeem bij diverse niveaus van eind-uitademings druk en bij verschillende graden van 
longschade wordt beschreven in hoofdstuk 4. In hoofdstuk 5 wordt de waarde van statische 
druk-volume karakteristieken als schatters van optimale luchtwegdruk besproken. De 
dynamische veranderingen in de verplaatsing van de buik en ribbenkast, die optreden bij 
CDP veranderingen tijdens HFOV, vormen het onderwerp van hoofdstuk 6. Zelfs wanneer 
het longvolume en CDP als optimaal worden beschouwd, kan een geselecteerde groep 
patiënten van de combinatie van HFOV en geïnhaleerd stikstofoxide (iNO) profiteren. In 
hoofdstuk 7 worden de technische aspecten van dosering van iNO tijdens HFOV besproken. 
Bij HFOV wordt gebruik gemaakt van vrij grote gasstromen, bij toediening van NO kunnen 
dan ook grote hoeveelheden van dit gas in de omgeving terecht komen. In hoofdstuk 8 
worden de gevolgen voor het directe milieu en daarmee voor een blootstelling van andere 
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patiënten en voor het personeel van NO en NO2 tijdens gecombineerde iNO en HFOV 
therapie besproken. 
Hoofdstuk 2  
Drie strategieën worden beschreven met een verschillende gemiddelde luchtwegdruk en 
longvolume tijdens rescue HFOV bij 35 opeenvolgend opgenomen kinderen gedurende 4 
jaar in twee afdelingen voor pediatrische intensieve zorg. Ten eerste, de "open-long 
strategie" die bedoeld is om bij diffuse aandoeningen van de longblaasjes (DAD) snel een 
optimaal longvolume te bereiken en te handhaven. Ook bij longbloeding werd deze strategie 
gebruikt. Ten tweede, de "lage-volume-strategie” die haar toepassing vond bij patiënten met 
een blijvend luchtlekkage naar het longweefsel of naar buiten de long. Ten derde, de "open-
luchtweg-strategie” waarbij CDP bij obstructieve aandoeningen van de kleine luchtwegen 
werd gebruikt om de luchtwegen te openen en open te houden Bij 27 (77%) patienten was 
er sprake van DAD, bij 5 (8%) patiënten was er sprake van een obstructieve aandoening 
van de kleine luchtwegen. Bij een van deze vijf patiënten was er ook sprake van een ernstig 
luchtlekkage syndroom, en werd de HFOV therapie gericht op resolutie van de luchtlekkage. 
Bij vier patiënten werd HFOV gecombineerd met iNO, twee van de zeven niet-overlevenden 
stierven als gevolg van falende beademing. Drie patiënten ontwikkelden een nieuw luchtlek 
syndroom tijdens HFOV. Negen patiënten ontwikkelden chronische longziekte. Één van vier 
patiënten die met de gecombineerde HFOV en iNO therapie werden behandeld, reageerde 
gunstig op de combinatietherapie. Een met de tijd stijgende oxygenatie-index voorspelde 
een ongunstig resultaat tengevolge van tekort schietende beademing. Wij concludeerden 
dat HFOV bij een juist gebruik effectief en veilig is en weinig ongewenste neveneffecten 
kent. HFOV kan vroeg in het ziekteproces worden ingezet. 
 
Hoofdstuk 3  
Een systeem dat metingen integreert, afkomstig van de beademingsmachine, de continue 
bloedgasanalyse en longvolume metingen, werd ontwikkeld, getest en beschreven. Het 
systeem, voor een deel gebaseerd op respiratoire inductieplethysmografie (RIP), werd  
aangepast om verplaatsingen van ribbenkast en buik tijdens HFOV te registreren. De 
lineariteit en de nauwkeurigheid van het apparaat voor de schatting van de veranderingen 
van het longvolume werden bepaald. De relatie tussen gemiddelde luchtwegdruk en 
longvolume, oxygenatie, oxygenatieindex (OI) en de verhouding van drukamplitude aan de 
openingen aan het begin en einde van de beademingsbuis (OPR) als schatters van optimale 
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luchtwegdruk tijdens HFOV waren direct beschikbaar. Ook de veranderingen van deze 
afhankelijke variabelen als functie van de tijd kon worden afgelezen.  
Hoofdstuk 4  
De nauwkeurigheid van de metingen van het longvolume met het ontworpen meetsysteem 
werd beoordeeld tijdens conventionele mechanische ventilatie op variërende positieve eind-
uitademings druk (PEEP) niveaus en met toenemende ernst van longschade. De afwijking 
van de oorspronkelijke calibratie en de spreiding van de meetfout nam toe met toenemende 
ernst van longschade en bleek PEEP afhankelijk te zijn. Om optimale nauwkeurigheid te 
verkrijgen, moet het systeem bij het gemiddelde longvolume en bij de mate van ziekte in 
studie opnieuw worden geijkt. De nauwkeurigheid van het systeem is vergelijkbaar met 
andere meetmethodieken die momenteel klinisch gebruikt worden bij conventionele 
mechanische ventilatie, maar die niet gevalideerd zijn voor gebruik tijdens HFOV. De 
nauwkeurigheid was wel afhankelijk van de gebruikte weegfactor, en deze weegfactor kan 
soort-afhankelijk zijn. Gebruik van in de literatuur genoemde weegfactoren bij proefdieren is 
af te raden bij humane metingen. Wij hebben aangetoond dat met deze techniek het 
mogelijk is om zowel relatieve veranderingen van het gemiddelde longvolume als 
teugvolume veranderingen nauwkeurig te meten zijn als aan een aantal voorwaarden 
voldaan is. 
Hoofdstuk 5 
In een wiskundig model van het ademhalingssysteem met ARDS, toonden wij aan dat het 
openen van samengevallen longdelen (rekrutering) met stijgende luchtwegdruk kan 
voortduren tot een zeer hoge druk wordt bereikt. Tijdens deze procedure kunnen de eerder 
samengevallen longdelen openen en onmiddellijk overrekt zijn. De kenmerken van het 
inademingsbeen van de P-V kromme worden niet uitsluitend bepaald door het openen en 
overrekken van de kleinste longdelen, maar ook door eigenschappen van de borstkas en de 
snelheid waarmee de longdelen open gaan. Nadat het grootste deel van de samengevallen 
longdelen was geopend, resulteerde een dalende luchtwegdruk aanvankelijk in een afname 
van het aantal overrekte longdelen terwijl deze wel open bleven. Een procedure die op het 
openen van samengevallen longdeeltjes is gericht kan verdere vermindering van 
luchtwegdruk vergemakkelijken terwijl samenvallen en overreking van de long en de 
noodzaak tot het gebruik van hoge luchtweg druk worden vermeden. De kenmerken van de 
statische P-V kromme bleken matige schatters voor de optimale luchtwegdruk te zijn. De 
goede correlatie tussen P-V kenmerken en optimale eind-uitademings druk of CDP die in de 
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literatuur wordt gemeld kan mogelijk  worden verklaard doordat groepen proefdieren en 
patiënten met vergelijkbare ernst van longschade werden vergeleken. De optimale eind-
uitademings druk steeg met de ernst van longschade, terwijl de veilige plateaudruk eerder 
afnam. Dat kan er toe leiden dat de teugvolumes waarbij samenvallen aan het einde van de 
uitademing en  overrekking aan het einde van de inademing wordt vermeden afnemen met 
toenemende ernst van acute longschade. Bij de ernstigste vormen van acute longschade 
kan dat resulteren in ontoereikende veilige conventionele mechanische beademing. Als de 
veronderstellingen in ons model correct zijn, zou een manoeuvre gericht op het openen van 
samengevallen longdelen in combinatie met een manier van beademen waarbij kleine 
teugvolumes worden gebruikt, zoals HFOV, vooral bij de ernstigere vormen van acute 
longbeschadiging van nut kunnen zijn. 
Hoofdstuk 6  
Tijdens mechanische beademing bewegen zowel ribbenkast als buik. Wij hebben 
aangetoond dat ribbenkast en buik tijdens HFOV niet gelijktijdig en in dezelfde mate 
bewegen. Het faseverschil tussen buik en ribbenkast beweging en de onderlinge verhouding 
van deze bewegingen is afhankelijk van de opgelegde luchtwegdruk en dus het longvolume. 
Bij zeven van de acht biggen werd een maximum teugvolume gevonden in het drukgebied, 
overeenkomend met de optimale luchtwegdruk. De optimale luchtwegdruk was daarbij 
gedefinieerd als de laagste druk, waarbij de fysiologische shunt fractie nog juist kleiner was 
dan 0.1. De uitslagen van de buikbewegingen waren ook het minst rond deze druk. Tijdens 
hoog-frequent beademen zou het bewaken van het teugvolume en de buikbewegingen van 
klinisch belang kunnen zijn, maar verder onderzoek bij humane patiënten is noodzakelijk om 
deze veronderstelling te toetsen. 
Hoofdstuk 7 
Tijdens HFOV kan het gebruik van standaard gasstroomregelaars (rotameter) voor zowel 
stikstof monoxide (NO) als ventilator gas stroom tot onvoorspelbare concentraties NO in het 
beademingsgas leiden. Deze onvoorspelbaarheid maakt deze methode klinisch 
onaanvaardbaar. Een redelijke en klinisch aanvaardbare doseringsnauwkeurigheid werd 
verkregen met een elektronisch gestuurde gasstroomregelaar (massflow controller) voor de 
NO gasstroom, terwijl de ventilator gasstroom met rotameter werd gecontroleerd. De 
hoogste nauwkeurigheid werd bereikt indien beide gasstromen electronisch werden 
gestuurd. De standaardmethode voor meting van NO en stikstofdioxide (NO2) concentraties 
in droge lucht is chemoluminescentie. Electrochemische meting van deze concentraties is 
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een alternatieve methode. De standaard gebruikte chemoluminescentiemeter bleek gevoelig 
te zijn voor bevochtiging van het beademingsgas. De elektrochemische sensor toonde een 
systematische fout vergelijkbaar met die van chemoluminescentie, maar de precisie van de 
electrochemische methode was beduidend lager. Dit werd veroorzaakt door meetfouten bij 
lage NO concentraties die in absolute zin klein waren, maar groot in relatie tot de werkelijke 
waarde. Wanneer kleine meetfouten acceptabel zijn bij de controle van NO-
inhalatietherapie, en de NO dosering nauwkeurig kan worden geregeld, is elektrochemische 
meting van NO concentraties klinisch even nuttig als metingen verkregen met een 
chemoluminescentie meter. Op basis van onze studies is een commercieel systeem 
beschikbaar gekomen, waarmee nauwkeurig NO kan worden toegediend tijdens HFOV en 
NO en NO2 concentraties gemeten. 
Hoofdstuk 8 
Stikstofmonoxide en zijn hogere oxiden zijn giftig bij hoge concentraties of lange tijden van 
blootstelling aan het gas. Als de NO inhalatie (iNO)  therapie in combinatie met HFOV wordt 
gebruikt, zijn hoge NO gasvolumes vereist om voldoende NO concentratie in het 
beademingsgas te bereiken. Wij hebben de mogelijke gevolgen voor de omgeving van 
personeel op een afdeling voor intensieve zorg en patiënten die in de buurt liggen van een 
patient die behandeld wordt met de combinatie van iNO en HFOV in vier situaties gemeten. 
Wij vonden verhoogde niveaus van zowel NO als NO2 in de omgeving, maar deze 
concentraties bleven binnen de veiligheidsrichtlijnen. De concentraties verminderden met 
toenemende afstand van de gasuitlaat van de beademingsmachine, en konden verder 
worden verlaagd door het met NO en nitreuze gassen verontreinigde uitademingsgas op te 
vangen bij de uitademingsklep van de beademingsmachine en af te voeren. 
In hoofdstuk 9 worden de bevindingen in onderling verband bediscussieerd en worden 
toekomstperspectieven besproken. (Hoofdstuk 10 en 11 vormen de Engelstalige 
respectievelijk Nederlandstalige samenvattingen van het proefschrift.)
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Veel mensen hebben bijgedragen tot de voltooiing van dit proefschrift. Daarom wil ik 
iedereen bedanken die mij op enigerlei wijze heeft geholpen. Een aantal wil ik graag met 
name noemen, in het besef dat een dergelijke opsomming nooit compleet kan zijn. 
John Roord bood mij de gelegenheid om dit onderzoek uit te voeren en had altijd het volste 
vertrouwen in een gunstige uitkomst. Zijn begeleiding, met name in de afrondende fase van 
dit proefschrift, is van grote waarde geweest. 
 
Hans van Vught stond aan de basis van mijn HFOV gerelateerde onderzoek. Hij 
organiseerde de “HFOV-groep” en bracht daarbij een samenwerking tussen het WKZ 
Utrecht en het Vumc tot stand, waarbij onderzoekers uit diverse disciplines bij elkaar werden 
gebracht. Geregeld waren er besprekingen van onderzoeksvoorstellen en resultaten in het 
WKZ, die vrijwel zonder uitzondering tot een geanimeerde discussie in een vriendelijke 
atmosfeer aanleiding gaven. Voor een belangrijk deel ontstonden de onderzoeksideeën 
tijdens wandelingen in Snowbird en Ovifat, waarbij het voor kon komen dat we zo verdiept 
waren in de discussie dat we uiteindelijk verdwaalden. Het mag een wonder heten dat wij 
uiteindelijk steeds weer de bewoonde wereld hebben bereikt. Ik heb de positieve maar ook 
kritische en altijd kundige begeleiding bijzonder gewaardeerd. Ik hoop dat onze 
samenwerking zal worden voortgezet. 
 
Huib van Genderingen ben ik meer dan dankbaar voor zijn ondersteuning bij mijn gedachten 
vorming en zijn hulp bij het schrijven. Hij was mijn dagelijkse gesprekspartner op de 
werkvloer. Regelmatig kwamen wij bij elkaar om ideeën te toetsen.  Meestal kon Huib mijn 
ideeën ontkrachten. Het was vooral plezierig als dat niet lukte, omdat ik altijd wist dat Huib 
een kritisch filter was. Zijn bijdrage is van onschatbare waarde geweest. Ik hoop ook bij 
volgende projecten nog lang met Huib samen te kunnen werken.  
 
De promotiecommissie, prof.dr.ir. J. H. van Bemmel, dr. J. R. C. Jansen, prof.dr. R. J. B. J. 
Gemke, prof.dr. A. R. J. Girbes en prof.dr. R. M. Heethaar ben ik dank verschuldigd voor het 
beoordelen van het manuscript. 
  
Tom Leenhoven, onnavolgbaar in het bedenken van onderzoeks vragen, praktische 
oplossingen en het samenbrengen van experts overal vandaan, heeft bijzonder veel 
bijgedragen bij de uiteindelijke totstandkoming van dit werk. Onze samenwerking gaat vele 
jaren terug. Eigenlijk hebben wij aan het einde van de tachtiger jaren  samen een van de 
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eerste prototypes van de hoog frequent oscillator gebouwd. Ook aan het project van de AD 
convertor die via de parallelle computer poort kon worden uitgelezen en waarbij we een 
computer hebben opgeblazen, bewaar ik goede herinneringen. Bij onze wandeling op de 
Axamer Lizum, waar we de eerste ideeën over geïntegreerde metingen tijdens HFOV 
bespraken, had ik niet verwacht dat dit uiteindelijk tot dit resultaat zou leiden.  
 
Dr. John Arnold.  John, Thank you for the hospitality rendered at your department in Boston 
and for the effort you took to introduce me to high frequency oscillatory ventilation. Since 
then we had many stimulating discussions on the subject of HFOV, mechanical ventilation 
and critical care in general, whisky and the art of making espresso. Its is always stimulating 
meeting with you, and I do hope our co-operation will continue. 
 
Dr. Keith Hickling. Keith, chapter 5 is mainly based on your previous work. Although we 
never actually met, your insights and the many stimulating discussions via E-mail during the 
preparation of this manuscript were of considerable value. Thank you for your contribution 
from down under. 
 
Els Duval ondersteunde mij bij de eerste dierexperimenten in Utrecht en heeft veel werk 
verzet voor de analyse van de klinische gegevens. Ik dank haar voor haar hulp daarbij en 
hoop dat zij binnen afzienbare tijd haar eigen proefschrift zal kunnen afronden.  
 
Jos Jansen was gelukkig bereid kritisch en creatief mee te denken toen wij verklaringen 
zochten voor de long mechanische veranderingen die optreden tijdens HFOV. Al bij de 
eerste experimenten mocht ik gebruik maken van je expertise en praktische hulp. Het was 
en is een voorrecht met je samen te mogen werken. 
 
Reinoud Gemke en Frans Plötz, in successie medisch hoofd van de intensive care kinderen 
dank ik voor de mogelijkheid die zij mij boden dit onderzoek in relatieve rust te kunnen doen 
en hun kritische bijdrage bij mijn voordrachten. Het zou fijn zijn als het beademings 
gerelateerde onderzoek op onze afdeling kan worden voortgezet. De eerste stappen 
daartoe zijn gezet. 
 
Renata Sibarani-Ponsen, als anesthesioloog-kinder intensivist verbonden aan onze afdeling, 
belangrijke trait d’union tussen de IC kinderen en de rest van de wereld en een uitstekend 
clinica. Lieve Renata, wat zou ik zonder jou hebben moeten beginnen. Dank je wel voor 
alles wat je met oneindig geduld hebt geleerd. Je bent een kanjer. 
  157 
 
Marre Hassing en Moniek op de Coul, mijn kamergenoten en maatjes in de tijd dat ik de 
onderzoeken deed en de resultaten moest verwerken, hebben veel dagelijks werk zonder 
morren overgenomen. Zij hebben de merkwaardigste geluiden gehoord van zowel mij als 
mijn computer –bijna een twee-eenheid ondertussen - als er weer eens een berekening 
misging. Beiden hebben uiteindelijk gekozen voor voortzetting van hun carrière in de 
algemene praktijk. Gelukkig ontmoeten wij elkaar nog geregeld, bijvoorbeeld tijdens APLS 
cursussen. 
 
Martin Kneyber, Dana-Anne de Gast-Bakker en Marc van Heerde, fellow op de IC kinderen, 
hebben van mij minder begeleiding gekregen dan ik eigenlijk graag had willen geven, maar 
zij hebben –zover ik weet- daar niet over geklaagd. We gaan er weer tegenaan. 
 
Mariska en Tom, betere paranimfen kan ik niet wensen, fijn dat jullie me ook bij de openbare 
verdediging willen bijstaan. 
 
Mijn moeder en grootouders hebben mij altijd aangemoedigd tot studie, eerlijkheid en 
zelfredzaamheid. Ik ben dankbaar dat zij aanwezig konden zijn bij de uitreiking van mijn 
artsen bul. De afronding van mijn specialisatie mochten zij niet meer meemaken. Wat 
zouden ze trots geweest zijn op dit resultaat. 
 
Berend en Thomas, jullie hebben me leren relativeren en zijn veel belangrijker dan enig 
proefschrift. Als kritische lezers vinden jullie dit boekje natuurlijk maar niets; je kunt er niet 
eens kan uit worden voorgelezen en de plaatjes zijn ook niet leuk. Het boekje op zich is ook 
niet zo belangrijk. Wat wel belangrijk is dat je altijd kritische vragen blijft stellen en 
onbevooroordeeld kunt luisteren naar nieuwe meningen. Voorlopig zijn jullie daar gelukkig 
erg sterk in. 
 
Lieve Karin, jij hebt de hele weg meegemaakt vanaf de middelbare school. De laatste jaren 
heb je zelfs je eigen carrière op een laag pitje gezet om een stabiele basis voor de jongens 
en mij te kunnen verzorgen. Zonder jouw opofferings gezindheid zou het mij nooit gelukt zijn 
dit werk te combineren met een gezinsleven zoals ons dat voor ogen stond. Dit boekje zou 
er dan dus nooit gekomen zijn. Ik kan je niet genoeg vertellen hoe blij ik met je ben, en heus 
niet alleen omdat ik nou eindelijk dit boekje af kon maken. 
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